1	MDR1	NN	O	mdr1	nn	2	SENT_1	[p1l87t268r269b316],
2	polymorphism	NN	O	polymorphism	nsubj	3	SENT_1	[p1l299t265r742b330],
3	influences	VBZ	O	influence	_	0	SENT_1	[p1l772t264r1084b316],
4	the	DT	O	the	det	5	SENT_1	[p1l1109t265r1209b316],
5	outcome	NN	O	outcome	dobj	3	SENT_1	[p1l1236t271r1504b316],
6	of	IN	O	of	_	0	SENT_1	[p1l1531t264r1595b316],
7	multiple	JJ	O	multiple	amod	9	SENT_1	[p1l1621t265r1873b330],
8	myeloma	NN	O	myeloma	nn	9	SENT_1	[p1l89t348r369b413],
9	patients	NNS	O	patient	prep_of	5	SENT_1	[p1l398t349r646b412],

1	Gabriele	NNP	PERSON	Gabriele	nn	2	SENT_2	[p1l14t688r442b779],
2	Buda	NNP	PERSON	Buda	_	0	SENT_2	[p1l490t689r778b793],
3	,	,	O	,	_	0	SENT_2	[p1l490t689r778b793],
4	1	CD	NUMBER	1	number	5	SENT_2	[p1l832t670r920b741],
5	*	CD	NUMBER	*	appos	2	SENT_2	[p1l832t670r920b741],
6	Valentina	NNP	PERSON	Valentina	nn	7	SENT_2	[p1l964t689r1465b779],
7	Maggini	NNP	PERSON	Maggini	dep	5	SENT_2	[p1l1507t693r1955b807],
8	,	,	O	,	_	0	SENT_2	[p1l1507t693r1955b807],
9	2	CD	NUMBER	2	number	10	SENT_2	[p1l2003t670r2097b741],
10	*	CD	NUMBER	*	appos	2	SENT_2	[p1l2003t670r2097b741],
11	Sara	NNP	PERSON	Sara	prep	10	SENT_2	[p1l14t837r233b921],
12	Galimberti	NNP	PERSON	Galimberti	nn	33	SENT_2	[p1l277t812r902b935],
13	,1	CD	NUMBER	,1	num	33	SENT_2	[p1l277t812r902b935],
14	Alessandro	NNP	PERSON	Alessandro	nn	33	SENT_2	[p1l951t832r1516b920],
15	Martino	NNP	PERSON	Martino	nn	33	SENT_2	[p1l1563t812r2057b935],
16	,2	CD	NUMBER	,2	num	33	SENT_2	[p1l1563t812r2057b935],
17	Nicola	NNP	PERSON	Nicola	nn	33	SENT_2	[p1l11t972r342b1061],
18	Giuliani	NNP	PERSON	Giuliani	nn	33	SENT_2	[p1l388t952r877b1076],
19	,3	CD	NUMBER	,3	num	33	SENT_2	[p1l388t952r877b1076],
20	Fortunato	NNP	PERSON	Fortunato	nn	33	SENT_2	[p1l925t979r1437b1061],
21	Morabito	NNP	PERSON	Morabito	nn	33	SENT_2	[p1l1484t952r2041b1076],
22	,4	CD	NUMBER	,4	num	33	SENT_2	[p1l1484t952r2041b1076],
23	Giovenzio	NNP	O	Giovenzio	nn	33	SENT_2	[p1l14t1117r526b1204],
24	Genestreti	NNP	O	Genestreti	nn	33	SENT_2	[p1l574t1095r1173b1217],
25	,5	CD	NUMBER	,5	num	33	SENT_2	[p1l574t1095r1173b1217],
26	Pasquale	NNP	PERSON	Pasquale	nn	33	SENT_2	[p1l1221t1113r1669b1230],
27	Iacopino	NNP	PERSON	Iacopino	nn	33	SENT_2	[p1l13t1237r538b1372],
28	,6	CD	NUMBER	,6	num	33	SENT_2	[p1l13t1237r538b1372],
29	Vittorio	NNP	PERSON	Vittorio	nn	33	SENT_2	[p1l579t1260r989b1346],
30	Rizzoli	NNP	PERSON	Rizzoli	nn	33	SENT_2	[p1l1037t1237r1463b1360],
31	,3	CD	NUMBER	,3	num	33	SENT_2	[p1l1037t1237r1463b1360],
32	Roberto	NNP	PERSON	Roberto	nn	33	SENT_2	[p1l1511t1256r1921b1346],
33	Barale	NNP	PERSON	Barale	dep	11	SENT_2	[p1l13t1400r408b1523],
34	,2	CD	NUMBER	,2	num	33	SENT_2	[p1l13t1400r408b1523],
35	Anna	NNP	PERSON	Anna	nn	37	SENT_2	[p1l452t1426r727b1509],
36	M.	NNP	PERSON	M.	nn	37	SENT_2	[p1l770t1428r900b1509],
37	Rossi2	NNP	PERSON	Rossi2	dep	2	SENT_2	[p1l949t1400r1263b1509],
38	and	CC	O	and	_	0	SENT_2	[p1l1310t1420r1499b1510],
39	Mario	NNP	PERSON	Mario	conj_and	37	SENT_2	[p1l1542t1423r1850b1509],

1	Petrinil	NN	O	petrinil	_	0	SENT_3	[p1l13t1584r403b1693],

1	1Department	NN	O	1department	_	0	SENT_4	[p1l16t1738r566b1860],
2	of	IN	O	of	_	0	SENT_4	[p1l600t1755r694b1860],
3	Oncology	NNP	O	Oncology	nn	83	SENT_4	[p1l717t1756r1122b1860],
4	,	,	O	,	_	0	SENT_4	[p1l717t1756r1122b1860],
5	Transplants	NNPS	O	Transplants	dep	83	SENT_4	[p1l1176t1756r1672b1860],
6	and	CC	O	and	_	0	SENT_4	[p1l1712t1755r1874b1835],
7	Advanced	NNP	ORGANIZATION	Advanced	nn	8	SENT_4	[p1l6t1896r428b1976],
8	Technologies	NNPS	ORGANIZATION	Technologies	conj_and	5	SENT_4	[p1l472t1896r1016b2001],
9	,	,	O	,	_	0	SENT_4	[p1l472t1896r1016b2001],
10	Section	NN	O	section	appos	5	SENT_4	[p1l1065t1899r1361b1976],
11	of	IN	O	of	_	0	SENT_4	[p1l1404t1896r1496b2001],
12	Hematology	NNP	O	Hematology	prep_of	10	SENT_4	[p1l1514t1896r2044b2001],
13	,	,	O	,	_	0	SENT_4	[p1l1514t1896r2044b2001],
14	Pisa	NNP	ORGANIZATION	Pisa	nn	15	SENT_4	[p1l9t2042r185b2118],
15	University	NNP	ORGANIZATION	University	appos	5	SENT_4	[p1l235t2042r678b2143],
16	,	,	O	,	_	0	SENT_4	[p1l235t2042r678b2143],
17	Pisa	NNP	LOCATION	Pisa	appos	5	SENT_4	[p1l722t2042r918b2130],
18	,	,	O	,	_	0	SENT_4	[p1l722t2042r918b2130],
19	Italy	NNP	LOCATION	Italy	appos	5	SENT_4	[p1l962t2039r1175b2143],
20	,	,	O	,	_	0	SENT_4	[p1l962t2039r1175b2143],
21	2Department	NN	O	2department	appos	5	SENT_4	[p1l1220t2021r1777b2143],
22	of	IN	O	of	_	0	SENT_4	[p1l1812t2039r1904b2143],
23	Biology	NNP	O	Biology	prep_of	21	SENT_4	[p1l9t2181r336b2285],
24	,	,	O	,	_	0	SENT_4	[p1l9t2181r336b2285],
25	Pisa	NNP	ORGANIZATION	Pisa	nn	26	SENT_4	[p1l381t2184r556b2260],
26	University	NNP	ORGANIZATION	University	conj_and	23	SENT_4	[p1l607t2184r1050b2285],
27	,	,	O	,	_	0	SENT_4	[p1l607t2184r1050b2285],
28	Pisa	NNP	LOCATION	Pisa	conj_and	23	SENT_4	[p1l1094t2184r1289b2272],
29	,	,	O	,	_	0	SENT_4	[p1l1094t2184r1289b2272],
30	Italy	NNP	LOCATION	Italy	conj_and	23	SENT_4	[p1l1333t2181r1547b2285],
31	,	,	O	,	_	0	SENT_4	[p1l1333t2181r1547b2285],
32	3	CD	NUMBER	3	num	33	SENT_4	[p1l1593t2163r1628b2211],
33	Hematology	NNP	O	Hematology	conj_and	23	SENT_4	[p1l1630t2181r2145b2285],
34	and	CC	O	and	_	0	SENT_4	[p1l12t2321r174b2400],
35	BMT	NN	ORGANIZATION	bmt	nn	36	SENT_4	[p1l210t2326r441b2400],
36	Center	NN	ORGANIZATION	center	conj_and	23	SENT_4	[p1l477t2326r770b2413],
37	,	,	O	,	_	0	SENT_4	[p1l477t2326r770b2413],
38	Parma	NNP	ORGANIZATION	Parma	nn	39	SENT_4	[p1l816t2328r1102b2400],
39	University	NNP	ORGANIZATION	University	appos	36	SENT_4	[p1l1152t2324r1595b2426],
40	,	,	O	,	_	0	SENT_4	[p1l1152t2324r1595b2426],
41	Parma	NNP	ORGANIZATION	Parma	appos	36	SENT_4	[p1l1639t2328r1946b2413],
42	,	,	O	,	_	0	SENT_4	[p1l1639t2328r1946b2413],
43	Italy	NNP	LOCATION	Italy	appos	36	SENT_4	[p1l9t2464r222b2568],
44	,	,	O	,	_	0	SENT_4	[p1l9t2464r222b2568],
45	4Haematology	NNP	O	4Haematology	nn	50	SENT_4	[p1l269t2446r872b2568],
46	Service	NNP	O	Service	nn	50	SENT_4	[p1l910t2466r1198b2543],
47	—	NNP	O	—	nn	50	SENT_4	[p1l1234t2513r1290b2520],
48	S.	NNP	LOCATION	S.	nn	50	SENT_4	[p1l1328t2469r1394b2543],
49	Annnnziata	NNP	LOCATION	Annnnziata	nn	50	SENT_4	[p1l1435t2466r1944b2543],
50	Hospital	NNP	LOCATION	Hospital	appos	36	SENT_4	[p1l9t2604r388b2709],
51	,	,	O	,	_	0	SENT_4	[p1l9t2604r388b2709],
52	Cosenza	NNP	LOCATION	Cosenza	appos	36	SENT_4	[p1l439t2609r798b2695],
53	,	,	O	,	_	0	SENT_4	[p1l439t2609r798b2695],
54	Italy	NNP	LOCATION	Italy	appos	36	SENT_4	[p1l844t2604r1057b2709],
55	,	,	O	,	_	0	SENT_4	[p1l844t2604r1057b2709],
56	5Division	NN	O	5division	appos	36	SENT_4	[p1l1103t2588r1491b2684],
57	of	IN	O	of	_	0	SENT_4	[p1l1534t2604r1626b2710],
58	OncoHematology	NNP	O	OncoHematology	prep_of	56	SENT_4	[p1l1652t2609r1905b2685, p1l9t2747r539b2851],
59	,	,	O	,	_	0	SENT_4	[p1l1652t2609r1905b2685, p1l9t2747r539b2851],
60	‘	CD	NUMBER	‘	num	64	SENT_4	[p1l595t2746r996b2851],
61	Ospedale	NNP	PERSON	Ospedale	nn	64	SENT_4	[p1l595t2746r996b2851],
62	Civile	NNP	PERSON	Civile	nn	64	SENT_4	[p1l1038t2747r1279b2827],
63	Infermi	NNP	PERSON	Infermi	nn	64	SENT_4	[p1l1315t2747r1678b2851],
64	’	NN	O	’	prep_of	56	SENT_4	[p1l1315t2747r1678b2851],
65	,	,	O	,	_	0	SENT_4	[p1l1315t2747r1678b2851],
66	Rimini	NNP	LOCATION	Rimini	prep_of	56	SENT_4	[p1l1722t2751r2036b2838],
67	,	,	O	,	_	0	SENT_4	[p1l1722t2751r2036b2838],
68	Italy	NNP	LOCATION	Italy	prep_of	56	SENT_4	[p1l9t2889r222b2993],
69	,	,	O	,	_	0	SENT_4	[p1l9t2889r222b2993],
70	and	CC	O	and	_	0	SENT_4	[p1l271t2889r433b2968],
71	6Bone	NN	O	6bone	nn	74	SENT_4	[p1l470t2871r717b2968],
72	Marrow	NN	O	marrow	nn	74	SENT_4	[p1l751t2894r1101b2968],
73	Transplant	NN	O	transplant	nn	74	SENT_4	[p1l1143t2889r1610b2993],
74	Unit	NN	O	unit	conj_and	58	SENT_4	[p1l1652t2891r1855b2980],
75	,	,	O	,	_	0	SENT_4	[p1l1652t2891r1855b2980],
76	Hematology	NNP	ORGANIZATION	Hematology	nn	81	SENT_4	[p1l9t3029r525b3134],
77	Department	NNP	ORGANIZATION	Department	nn	81	SENT_4	[p1l557t3036r1086b3134],
78	,	,	O	,	_	0	SENT_4	[p1l557t3036r1086b3134],
79	AO	JJ	ORGANIZATION	ao	amod	81	SENT_4	[p1l1127t3034r1279b3109],
80	Reggio	NNP	ORGANIZATION	Reggio	nn	81	SENT_4	[p1l1317t3032r1592b3134],
81	Calabria	NNP	ORGANIZATION	Calabria	appos	36	SENT_4	[p1l1637t3029r2023b3121],
82	,	,	O	,	_	0	SENT_4	[p1l1637t3029r2023b3121],
83	Italy	NNP	LOCATION	Italy	prep_of	1	SENT_4	[p1l9t3172r208b3276],

1	Received	VBN	O	receive	_	0	SENT_5	[p1l12t3523r396b3602],
2	23	CD	DATE	23	dobj	1	SENT_5	[p1l436t3531r532b3602],
3	January	NNP	DATE	January	tmod	1	SENT_5	[p1l576t3529r916b3628],
4	2007	CD	DATE	2007	num	3	SENT_5	[p1l952t3531r1180b3615],
5	;	:	O	;	_	0	SENT_5	[p1l952t3531r1180b3615],
6	accepted	VBN	O	accept	parataxis	1	SENT_5	[p1l1224t3523r1600b3626],
7	for	IN	O	for	_	0	SENT_5	[p1l1639t3523r1765b3602],
8	publication	NN	O	publication	prep_for	6	SENT_5	[p1l11t3659r510b3763],
9	12	CD	DATE	12	num	8	SENT_5	[p1l559t3667r648b3737],
10	March	NNP	DATE	March	tmod	6	SENT_5	[p1l691t3659r976b3738],
11	2007	CD	DATE	2007	num	10	SENT_5	[p1l1017t3667r1220b3738],

1	Correspondence	NN	O	correspondence	_	0	SENT_6	[p2l14t22r749b125],
2	:	:	O	:	_	0	SENT_6	[p2l14t22r749b125],
3	Gabriele	NNP	PERSON	Gabriele	nn	4	SENT_6	[p2l794t22r1155b102],
4	Buda	NNP	PERSON	Buda	dep	1	SENT_6	[p2l1197t22r1445b114],
5	,	,	O	,	_	0	SENT_6	[p2l1197t22r1445b114],
6	Department	NNP	ORGANIZATION	Department	appos	1	SENT_6	[p2l1487t28r2017b125],
7	of	IN	ORGANIZATION	of	_	0	SENT_6	[p2l2056t21r2153b102],
8	Oncology	NNP	ORGANIZATION	Oncology	prep_of	6	SENT_6	[p2l14t157r457b262],
9	,	,	O	,	_	0	SENT_6	[p2l14t157r457b262],
10	Transplants	NNPS	ORGANIZATION	Transplants	appos	1	SENT_6	[p2l500t157r1011b261],
11	and	CC	ORGANIZATION	and	_	0	SENT_6	[p2l1053t157r1214b237],
12	Advanced	NNP	ORGANIZATION	Advanced	nn	13	SENT_6	[p2l1250t157r1684b237],
13	Technologies	NNPS	ORGANIZATION	Technologies	conj_and	10	SENT_6	[p2l11t293r609b397],
14	,	,	O	,	_	0	SENT_6	[p2l11t293r609b397],
15	Section	NN	O	section	appos	1	SENT_6	[p2l654t296r971b373],
16	of	IN	O	of	_	0	SENT_6	[p2l1012t293r1109b372],
17	Hematology	NNP	O	Hematology	prep_of	15	SENT_6	[p2l1137t293r1697b397],
18	,	,	O	,	_	0	SENT_6	[p2l1137t293r1697b397],
19	Pisa	NNP	ORGANIZATION	Pisa	nn	24	SENT_6	[p2l1740t296r1914b372],
20	University	NNP	ORGANIZATION	University	nn	24	SENT_6	[p2l11t431r485b532],
21	,	,	O	,	_	0	SENT_6	[p2l11t431r485b532],
22	Pisa	NNP	LOCATION	Pisa	dep	24	SENT_6	[p2l528t431r724b519],
23	,	,	O	,	_	0	SENT_6	[p2l528t431r724b519],
24	Italy	NNP	LOCATION	Italy	appos	1	SENT_6	[p2l765t428r976b532],
25	.	.	O	.	_	0	SENT_6	[p2l765t428r976b532],

1	E	NN	O	e	nn	3	SENT_7	[p2l1020t428r1332b507],
2	—	CD	NUMBER	—	num	3	SENT_7	[p2l1020t428r1332b507],
3	mail	NN	O	mail	_	0	SENT_7	[p2l1020t428r1332b507],
4	:	:	O	:	_	0	SENT_7	[p2l1020t428r1332b507],
5	ga.buda@libero.it	NN	O	ga.buda@libero.it	dep	3	SENT_7	[p2l1376t428r2140b532],

1	*	NN	O	*	nsubj	4	SENT_8	[p2l14t734r308b813],
2	These	DT	O	these	det	3	SENT_8	[p2l14t734r308b813],
3	authors	NNS	O	author	dep	1	SENT_8	[p2l339t734r668b813],
4	contributed	VBD	O	contribute	_	0	SENT_8	[p2l699t734r1211b813],
5	equally	RB	O	equally	advmod	4	SENT_8	[p2l1241t734r1552b839],
6	to	TO	O	to	_	0	SENT_8	[p2l1575t750r1661b813],
7	this	DT	O	this	det	8	SENT_8	[p2l1692t734r1849b813],
8	study	NN	O	study	prep_to	4	SENT_8	[p2l1881t734r2135b839],
9	.	.	O	.	_	0	SENT_8	[p2l1881t734r2135b839],

1	Introduction	NN	O	introduction	_	0	SENT_9	[p2l19t1086r801b1191],

1	Patients	NNS	O	patient	nsubj	8	SENT_10	[p2l7t1300r274b1359],
2	with	IN	O	with	_	0	SENT_10	[p2l301t1298r451b1359],
3	multiple	JJ	O	multiple	amod	4	SENT_10	[p2l477t1298r761b1377],
4	myeloma	NN	O	myeloma	prep_with	1	SENT_10	[p2l789t1298r1101b1378],
5	(	CD	NUMBER	(	num	7	SENT_10	[p2l1133t1298r1334b1372],
6	MM	NN	O	mm	nn	7	SENT_10	[p2l1133t1298r1334b1372],
7	)	NN	O	)	dep	4	SENT_10	[p2l1133t1298r1334b1372],
8	have	VBP	O	have	_	0	SENT_10	[p2l1366t1298r1519b1359],
9	a	DT	O	a	det	11	SENT_10	[p2l1547t1320r1581b1359],
10	median	JJ	O	median	amod	11	SENT_10	[p2l1608t1298r1860b1359],
11	survival	NN	O	survival	dobj	8	SENT_10	[p2l1888t1298r2150b1359],
12	of	IN	O	of	_	0	SENT_10	[p2l8t1402r82b1464],
13	3	CD	DURATION	3	num	14	SENT_10	[p2l102t1409r134b1464],
14	years	NNS	NUMBER	year	prep_of	11	SENT_10	[p2l167t1425r336b1484],
15	when	WRB	O	when	advmod	16	SENT_10	[p2l363t1402r546b1464],
16	treated	VBN	O	treat	advcl	8	SENT_10	[p2l573t1402r807b1464],
17	with	IN	O	with	_	0	SENT_10	[p2l833t1402r984b1464],
18	standard	JJ	O	standard	amod	21	SENT_10	[p2l1013t1402r1491b1464],
19	—	NN	O	—	nn	21	SENT_10	[p2l1013t1402r1491b1464],
20	dose	NN	O	dose	nn	21	SENT_10	[p2l1013t1402r1491b1464],
21	chemotherapy	NN	O	chemotherapy	prep_with	16	SENT_10	[p2l1521t1402r2019b1483],
22	.	.	O	.	_	0	SENT_10	[p2l1521t1402r2019b1483],

1	An	DT	O	a	det	3	SENT_11	[p2l2050t1406r2150b1463],
2	improved	VBN	O	improve	amod	3	SENT_11	[p2l7t1507r335b1587],
3	survival	NN	O	survival	nsubjpass	6	SENT_11	[p2l383t1507r646b1568],
4	has	VBZ	O	have	aux	6	SENT_11	[p2l692t1507r800b1568],
5	been	VBN	O	be	auxpass	6	SENT_11	[p2l846t1507r1005b1568],
6	shown	VBN	O	show	_	0	SENT_11	[p2l1052t1507r1271b1568],
7	with	IN	O	with	_	0	SENT_11	[p2l1316t1507r1467b1568],
8	high	JJ	O	high	amod	11	SENT_11	[p2l1513t1507r1847b1587],
9	—	NN	O	—	nn	11	SENT_11	[p2l1513t1507r1847b1587],
10	dose	NN	O	dose	nn	11	SENT_11	[p2l1513t1507r1847b1587],
11	therapy	NN	O	therapy	prep_with	6	SENT_11	[p2l1894t1507r2153b1587],
12	coupled	VBN	O	couple	partmod	11	SENT_11	[p2l8t1611r276b1690],
13	with	IN	O	with	_	0	SENT_11	[p2l302t1611r452b1672],
14	stem	NN	O	stem	nn	20	SENT_11	[p2l482t1623r639b1672],
15	cell	NN	O	cell	nn	20	SENT_11	[p2l668t1611r777b1672],
16	rescue	NN	O	rescue	nn	20	SENT_11	[p2l806t1632r1014b1672],
17	(	CD	NUMBER	(	num	20	SENT_11	[p2l1048t1611r1448b1691],
18	autologous	JJ	O	autologous	amod	20	SENT_11	[p2l1048t1611r1448b1691],
19	stem	NN	O	stem	nn	20	SENT_11	[p2l1478t1623r1635b1672],
20	cell	NN	O	cell	prep_with	12	SENT_11	[p2l1665t1611r1775b1672],
21	transplantation	NN	O	transplantation	dep	20	SENT_11	[p2l1801t1611r2145b1690, p2l6t1717r224b1787],
22	,	,	O	,	_	0	SENT_11	[p2l1801t1611r2145b1690, p2l6t1717r224b1787],
23	ASCT	NN	O	asct	nn	24	SENT_11	[p2l258t1716r508b1790],
24	)	NN	O	)	appos	20	SENT_11	[p2l258t1716r508b1790],
25	.	.	O	.	_	0	SENT_11	[p2l258t1716r508b1790],

1	However	RB	O	however	_	0	SENT_12	[p2l545t1720r867b1787],
2	,	,	O	,	_	0	SENT_12	[p2l545t1720r867b1787],
3	despite	IN	O	despite	dep	1	SENT_12	[p2l904t1715r1139b1796],
4	initial	JJ	O	initial	amod	6	SENT_12	[p2l1173t1715r1369b1777],
5	good	JJ	O	good	amod	6	SENT_12	[p2l1404t1715r1572b1797],
6	responses	NNS	O	response	pobj	3	SENT_12	[p2l1606t1737r1946b1796],
7	,	,	O	,	_	0	SENT_12	[p2l1606t1737r1946b1796],
8	most	JJS	O	most	amod	9	SENT_12	[p2l1983t1727r2150b1777],
9	patients	NNS	O	patient	appos	6	SENT_12	[p2l6t1822r271b1900],
10	relapse	NN	O	relapse	dep	9	SENT_12	[p2l322t1820r570b1900],
11	.	.	O	.	_	0	SENT_12	[p2l322t1820r570b1900],

1	Traditional	JJ	O	traditional	amod	3	SENT_13	[p2l622t1820r1004b1881],
2	prognostic	JJ	O	prognostic	amod	3	SENT_13	[p2l1052t1822r1413b1900],
3	factors	NNS	O	factor	nsubj	4	SENT_13	[p2l1463t1820r1686b1881],
4	account	VBP	O	account	_	0	SENT_13	[p2l1738t1832r2004b1881],
5	for	IN	O	for	_	0	SENT_13	[p2l2053t1820r2150b1881],
6	only	RB	O	only	advmod	8	SENT_13	[p2l8t1924r156b2006],
7	15-20	CD	PERCENT	15-20	num	8	SENT_13	[p2l221t1930r484b1988],
8	%	NN	PERCENT	%	prep_for	4	SENT_13	[p2l221t1930r484b1988],
9	of	IN	O	of	_	0	SENT_13	[p2l548t1924r622b1986],
10	outcome	NN	O	outcome	nn	11	SENT_13	[p2l674t1937r970b1986],
11	heterogeneity	NN	O	heterogeneity	prep_of	8	SENT_13	[p2l1031t1924r1491b2006],
12	in	IN	O	in	_	0	SENT_13	[p2l1549t1926r1614b1985],
13	MM	NN	O	mm	nn	14	SENT_13	[p2l1674t1929r1822b1985],
14	patients	NNS	O	patient	prep_in	11	SENT_13	[p2l1883t1926r2148b2005],
15	(	CD	NUMBER	(	num	16	SENT_13	[p2l12t2029r314b2109],
16	Barlogie	NNP	PERSON	Barlogie	dep	11	SENT_13	[p2l12t2029r314b2109],
17	et	FW	O	et	nn	18	SENT_13	[p2l358t2042r416b2090],
18	al	FW	O	al	dep	16	SENT_13	[p2l443t2029r520b2099],
19	,	,	O	,	_	0	SENT_13	[p2l443t2029r520b2099],
20	2004	CD	DATE	2004	num	21	SENT_13	[p2l564t2029r771b2103],
21	)	NN	O	)	appos	11	SENT_13	[p2l564t2029r771b2103],
22	.	.	O	.	_	0	SENT_13	[p2l564t2029r771b2103],

1	In	IN	O	in	_	0	SENT_14	[p2l817t2033r887b2089],
2	this	DT	O	this	det	3	SENT_14	[p2l928t2029r1049b2090],
3	context	NN	O	context	prep_in	17	SENT_14	[p2l1092t2041r1359b2099],
4	,	,	O	,	_	0	SENT_14	[p2l1092t2041r1359b2099],
5	an	DT	O	a	det	7	SENT_14	[p2l1404t2051r1483b2090],
6	altered	JJ	O	altered	amod	7	SENT_14	[p2l1525t2029r1752b2090],
7	expression	NN	O	expression	appos	3	SENT_14	[p2l1795t2031r2149b2108],
8	of	IN	O	of	_	0	SENT_14	[p2l8t2133r82b2194],
9	the	DT	O	the	det	12	SENT_14	[p2l113t2133r217b2194],
10	multidrug	JJ	O	multidrug	amod	12	SENT_14	[p2l260t2133r604b2213],
11	resistance	NN	O	resistance	nn	12	SENT_14	[p2l645t2135r970b2194],
12	gene	NN	O	gene	prep_of	7	SENT_14	[p2l1012t2154r1164b2213],
13	(	CD	NUMBER	(	num	15	SENT_14	[p2l1211t2133r1485b2207],
14	MDR1	NN	O	mdr1	nn	15	SENT_14	[p2l1211t2133r1485b2207],
15	)	NN	O	)	nsubj	17	SENT_14	[p2l1211t2133r1485b2207],
16	may	MD	O	may	aux	17	SENT_14	[p2l1533t2154r1678b2213],
17	represent	VB	O	represent	_	0	SENT_14	[p2l1717t2145r2028b2212],
18	an	DT	O	a	det	21	SENT_14	[p2l2071t2154r2150b2194],
19	additional	JJ	O	additional	amod	21	SENT_14	[p2l8t2237r352b2299],
20	prognostic	JJ	O	prognostic	amod	21	SENT_14	[p2l384t2239r744b2319],
21	marker	NN	O	marker	dobj	17	SENT_14	[p2l778t2237r1037b2309],
22	,	,	O	,	_	0	SENT_14	[p2l778t2237r1037b2309],
23	as	IN	O	as	mark	25	SENT_14	[p2l1074t2260r1135b2299],
24	previously	RB	DATE	previously	advmod	25	SENT_14	[p2l1169t2237r1522b2319],
25	reported	VBN	O	report	dep	21	SENT_14	[p2l1552t2237r1841b2318],
26	in	IN	O	in	_	0	SENT_14	[p2l1874t2239r1939b2298],
27	acute	JJ	O	acute	amod	29	SENT_14	[p2l1974t2249r2149b2299],
28	myeloid	JJ	O	myeloid	amod	29	SENT_14	[p2l7t2342r280b2422],
29	leukaemia	NN	O	leukaemia	prep_in	25	SENT_14	[p2l326t2342r670b2403],
30	(	CD	NUMBER	(	num	31	SENT_14	[p2l722t2342r947b2416],
31	AML	NN	ORGANIZATION	aml	dep	35	SENT_14	[p2l722t2342r947b2416],
32	)	CD	NUMBER	)	num	33	SENT_14	[p2l722t2342r947b2416],
33	patients	NNS	O	patient	dep	31	SENT_14	[p2l999t2344r1264b2422],
34	(	CD	NUMBER	(	dep	35	SENT_14	[p2l1318t2342r1710b2416],
35	Galimberti	NNP	PERSON	Galimberti	dep	29	SENT_14	[p2l1318t2342r1710b2416],
36	et	FW	O	et	nn	37	SENT_14	[p2l1759t2355r1817b2403],
37	al	FW	O	al	dep	35	SENT_14	[p2l1844t2342r1921b2413],
38	,	,	O	,	_	0	SENT_14	[p2l1844t2342r1921b2413],
39	2003	CD	DATE	2003	appos	37	SENT_14	[p2l1970t2348r2147b2413],
40	;	:	O	;	_	0	SENT_14	[p2l1970t2348r2147b2413],
41	Schaich	NNP	PERSON	Schaich	dep	37	SENT_14	[p2l8t2446r265b2507],
42	et	FW	O	et	nn	43	SENT_14	[p2l330t2458r389b2507],
43	al	FW	O	al	dep	41	SENT_14	[p2l416t2446r492b2516],
44	,	,	O	,	_	0	SENT_14	[p2l416t2446r492b2516],
45	2005	CD	DATE	2005	num	46	SENT_14	[p2l560t2446r767b2520],
46	)	NN	O	)	appos	43	SENT_14	[p2l560t2446r767b2520],
47	.	.	O	.	_	0	SENT_14	[p2l560t2446r767b2520],

1	The	DT	O	the	det	3	SENT_15	[p2l835t2446r963b2507],
2	MDR	NN	ORGANIZATION	mdr	nn	3	SENT_15	[p2l1027t2450r1217b2507],
3	phenotype	NN	O	phenotype	nsubj	4	SENT_15	[p2l1280t2446r1636b2526],
4	results	VBZ	O	result	_	0	SENT_15	[p2l1703t2446r1917b2507],
5	from	IN	O	from	_	0	SENT_15	[p2l1983t2446r2149b2507],
6	expression	NN	O	expression	prep_from	4	SENT_15	[p2l8t2551r362b2629],
7	of	IN	O	of	_	0	SENT_15	[p2l431t2549r505b2610],
8	MDR	NN	O	mdr	nn	9	SENT_15	[p2l560t2554r778b2610],
9	]	NN	O	]	prep_of	6	SENT_15	[p2l560t2554r778b2610],
10	and	CC	O	and	_	0	SENT_15	[p2l853t2549r977b2610],
11	its	PRP$	O	its	poss	14	SENT_15	[p2l1044t2551r1119b2610],
12	170-kDa	JJ	O	170-kda	amod	14	SENT_15	[p2l1195t2549r1478b2610],
13	protein	NN	O	protein	nn	14	SENT_15	[p2l1544t2551r1792b2629],
14	product	NN	O	product	prep_of	6	SENT_15	[p2l1859t2549r2147b2629],
15	,	,	O	,	_	0	SENT_15	[p2l1859t2549r2147b2629],

1	Abstract	JJ	O	abstract	_	0	SENT_16	[p2l8t2753r308b2805],

1	The	DT	O	the	det	7	SENT_17	[p2l9t2890r113b2939],
2	multidrug	JJ	O	multidrug	amod	7	SENT_17	[p2l134t2890r414b2955],
3	resistance	NN	O	resistance	nn	7	SENT_17	[p2l434t2892r699b2939],
4	gene	NN	O	gene	nn	7	SENT_17	[p2l720t2908r843b2955],
5	(	CD	NUMBER	(	num	7	SENT_17	[p2l868t2890r1091b2950],
6	MDR1	NN	O	mdr1	nn	7	SENT_17	[p2l868t2890r1091b2950],
7	)	NN	O	)	nsubjpass	10	SENT_17	[p2l868t2890r1091b2950],
8	has	VBZ	O	have	aux	10	SENT_17	[p2l1116t2890r1204b2939],
9	been	VBN	O	be	auxpass	10	SENT_17	[p2l1223t2890r1353b2939],
10	reported	VBN	O	report	_	0	SENT_17	[p2l1373t2890r1608b2954],
11	to	TO	O	to	aux	16	SENT_17	[p2l1629t2900r1682b2939],
12	be	VB	O	be	cop	16	SENT_17	[p2l1703t2890r1765b2939],
13	an	DT	O	a	det	16	SENT_17	[p2l1787t2908r1851b2939],
14	additional	JJ	O	additional	amod	16	SENT_17	[p2l1872t2890r2152b2940],
15	prognostic	JJ	O	prognostic	amod	16	SENT_17	[p2l9t2977r302b3040],
16	factor	NN	O	factor	xcomp	10	SENT_17	[p2l329t2975r487b3024],
17	in	IN	O	in	_	0	SENT_17	[p2l513t2977r566b3024],
18	acute	JJ	O	acute	amod	19	SENT_17	[p2l593t2985r736b3024],
19	myeloid	JJ	O	myeloid	amod	21	SENT_17	[p2l762t2975r984b3040],
20	leukaemia	NN	O	leukaemia	nn	21	SENT_17	[p2l1010t2975r1290b3024],
21	patients	NNS	O	patient	prep_in	16	SENT_17	[p2l1314t2977r1544b3039],
22	.	.	O	.	_	0	SENT_17	[p2l1314t2977r1544b3039],

1	This	DT	O	this	det	2	SENT_18	[p2l1574t2975r1691b3024],
2	study	NN	O	study	nsubj	3	SENT_18	[p2l1719t2975r1869b3040],
3	evaluated	VBD	O	evaluate	_	0	SENT_18	[p2l1893t2975r2151b3024],
4	the	DT	O	the	det	6	SENT_18	[p2l9t3060r93b3109],
5	prognostic	JJ	O	prognostic	amod	6	SENT_18	[p2l130t3061r424b3125],
6	role	NN	O	role	dobj	3	SENT_18	[p2l462t3059r565b3109],
7	of	IN	O	of	_	0	SENT_18	[p2l604t3059r665b3109],
8	MDR	NN	O	mdr	prep_of	6	SENT_18	[p2l692t3063r868b3109],
9	]	CD	NUMBER	]	num	8	SENT_18	[p2l692t3063r868b3109],
10	in	IN	O	in	_	0	SENT_18	[p2l912t3061r965b3109],
11	the	DT	O	the	det	12	SENT_18	[p2l1002t3059r1087b3109],
12	outcome	NN	O	outcome	prep_in	3	SENT_18	[p2l1126t3069r1367b3109],
13	of	IN	O	of	_	0	SENT_18	[p2l1405t3059r1465b3109],
14	115	CD	NUMBER	115	num	17	SENT_18	[p2l1502t3065r1589b3109],
15	multiple	JJ	O	multiple	amod	17	SENT_18	[p2l1629t3059r1861b3124],
16	myeloma	NN	O	myeloma	nn	17	SENT_18	[p2l1898t3060r2152b3125],
17	patients	NNS	O	patient	prep_of	12	SENT_18	[p2l9t3147r225b3209],
18	treated	VBN	O	treat	partmod	17	SENT_18	[p2l255t3145r445b3194],
19	with	IN	O	with	_	0	SENT_18	[p2l473t3145r595b3194],
20	DAV	NN	O	dav	nn	22	SENT_18	[p2l625t3148r765b3194],
21	(	CD	NUMBER	(	num	22	SENT_18	[p2l797t3145r1258b3205],
22	dexamethasone	NN	O	dexamethasone	prep_with	18	SENT_18	[p2l797t3145r1258b3205],
23	,	,	O	,	_	0	SENT_18	[p2l797t3145r1258b3205],
24	doxorubicin	NN	O	doxorubicin	nn	27	SENT_18	[p2l1291t3145r1629b3194],
25	[	NN	O	[	nn	27	SENT_18	[p2l1666t3145r2012b3210],
26	adryamicin	NN	O	adryamicin	nn	27	SENT_18	[p2l1666t3145r2012b3210],
27	]	NN	O	]	appos	22	SENT_18	[p2l1666t3145r2012b3210],
28	and	CC	O	and	_	0	SENT_18	[p2l2051t3145r2152b3194],
29	vincristine	NN	O	vincristine	nn	31	SENT_18	[p2l7t3230r318b3290],
30	)	NN	O	)	nn	31	SENT_18	[p2l7t3230r318b3290],
31	regimen	NN	O	regimen	appos	22	SENT_18	[p2l355t3231r578b3295],
32	followed	VBN	O	follow	partmod	27	SENT_18	[p2l610t3229r845b3279],
33	by	IN	O	by	_	0	SENT_18	[p2l876t3230r943b3295],
34	autologous	JJ	O	autologous	amod	35	SENT_18	[p2l973t3229r1275b3295],
35	transplantation	NN	O	transplantation	agent	32	SENT_18	[p2l1307t3230r1743b3294],
36	.	.	O	.	_	0	SENT_18	[p2l1307t3230r1743b3294],

1	In	IN	O	in	_	0	SENT_19	[p2l1779t3233r1836b3279],
2	particular	JJ	O	particular	prep_in	24	SENT_19	[p2l1867t3229r2150b3294],
3	,	,	O	,	_	0	SENT_19	[p2l1867t3229r2150b3294],
4	when	WRB	O	when	advmod	5	SENT_19	[p2l8t3314r155b3364],
5	investigating	VBG	O	investigate	advcl	24	SENT_19	[p2l181t3316r530b3380],
6	the	DT	O	the	det	8	SENT_19	[p2l554t3315r639b3364],
7	C3435T	NN	O	c3435t	nn	8	SENT_19	[p2l665t3317r880b3364],
8	polymorphism	NN	O	polymorphism	dobj	5	SENT_19	[p2l905t3315r1327b3380],
9	,	,	O	,	_	0	SENT_19	[p2l905t3315r1327b3380],
10	a	DT	O	a	det	12	SENT_19	[p2l1356t3332r1384b3364],
11	prognostic	JJ	O	prognostic	amod	12	SENT_19	[p2l1407t3316r1701b3380],
12	value	NN	O	value	appos	8	SENT_19	[p2l1724t3315r1868b3364],
13	of	IN	O	of	_	0	SENT_19	[p2l1894t3314r1954b3364],
14	MDR	NN	O	mdr	prep_of	12	SENT_19	[p2l1969t3318r2145b3364],
15	]	CD	NUMBER	]	num	16	SENT_19	[p2l1969t3318r2145b3364],
16	genotypes	NNS	O	genotype	dep	5	SENT_19	[p2l10t3409r281b3465],
17	for	IN	O	for	_	0	SENT_19	[p2l302t3399r380b3449],
18	overall	JJ	O	overall	amod	19	SENT_19	[p2l400t3399r583b3449],
19	survival	NN	O	survival	prep_for	16	SENT_19	[p2l602t3399r815b3449],
20	(	CD	NUMBER	(	num	22	SENT_19	[p2l838t3399r963b3459],
21	OS	NN	O	os	nn	22	SENT_19	[p2l838t3399r963b3459],
22	)	NN	O	)	nsubjpass	24	SENT_19	[p2l838t3399r963b3459],
23	was	VBD	O	be	auxpass	24	SENT_19	[p2l986t3417r1085b3449],
24	observed	VBN	O	observe	_	0	SENT_19	[p2l1106t3399r1362b3449],
25	.	.	O	.	_	0	SENT_19	[p2l1106t3399r1362b3449],

1	Our	PRP$	O	we	poss	2	SENT_20	[p2l1386t3402r1497b3449],
2	data	NNS	O	datum	nsubj	3	SENT_20	[p2l1516t3399r1631b3449],
3	suggested	VBD	O	suggest	_	0	SENT_20	[p2l1651t3399r1913b3465],
4	a	DT	O	a	dep	5	SENT_20	[p2l1932t3417r1960b3449],
5	longer	RBR	O	longer	advmod	3	SENT_20	[p2l1978t3399r2152b3465],
6	OS	NNP	O	OS	tmod	3	SENT_20	[p2l10t3488r89b3535],
7	for	IN	O	for	mark	14	SENT_20	[p2l134t3485r212b3535],
8	patients	NNS	O	patient	nsubj	14	SENT_20	[p2l253t3487r469b3550],
9	with	IN	O	with	_	0	SENT_20	[p2l509t3485r632b3535],
10	C/T	NN	O	c/t	nn	13	SENT_20	[p2l675t3487r780b3537],
11	and	CC	O	and	_	0	SENT_20	[p2l823t3485r924b3535],
12	T/T	NN	O	t/t	conj_and	10	SENT_20	[p2l965t3487r1068b3537],
13	genotypes	NNS	O	genotype	prep_with	8	SENT_20	[p2l1110t3495r1382b3550],
14	(	VBP	O	(	advcl	3	SENT_20	[p2l1429t3485r1685b3550],
15	log	NN	O	log	nn	18	SENT_20	[p2l1429t3485r1685b3550],
16	—	CD	NUMBER	—	num	18	SENT_20	[p2l1429t3485r1685b3550],
17	rank	NN	O	rank	nn	18	SENT_20	[p2l1429t3485r1685b3550],
18	test	NN	O	test	nn	23	SENT_20	[p2l1725t3495r1833b3542],
19	,	,	O	,	_	0	SENT_20	[p2l1725t3495r1833b3542],
20	P	NN	O	p	appos	18	SENT_20	[p2l1876t3489r1915b3534],
21	=	JJ	O	=	amod	23	SENT_20	[p2l1941t3508r1987b3525],
22	002	CD	NUMBER	002	tmod	21	SENT_20	[p2l2015t3485r2146b3545],
23	)	NN	O	)	dobj	14	SENT_20	[p2l2015t3485r2146b3545],
24	compared	VBN	O	compare	_	0	SENT_20	[p2l10t3569r285b3634],
25	with	IN	O	with	prepc_compared_with	14	SENT_20	[p2l309t3569r431b3619],
26	patients	NNS	O	patient	pobj	14	SENT_20	[p2l456t3571r672b3634],
27	with	IN	O	with	_	0	SENT_20	[p2l697t3569r820b3619],
28	C/C	NN	O	c/c	nn	29	SENT_20	[p2l846t3572r955b3621],
29	genotype	NN	O	genotype	prep_with	26	SENT_20	[p2l981t3579r1243b3635],
30	.	.	O	.	_	0	SENT_20	[p2l981t3579r1243b3635],

1	Keywords	NNPS	O	Keywords	_	0	SENT_21	[p2l9t3654r299b3720],
2	:	:	O	:	_	0	SENT_21	[p2l9t3654r299b3720],
3	multidrug	JJ	O	multidrug	amod	4	SENT_21	[p2l339t3654r619b3720],
4	resistance	NN	O	resistance	dep	1	SENT_21	[p2l644t3656r923b3712],
5	,	,	O	,	_	0	SENT_21	[p2l644t3656r923b3712],
6	multiple	JJ	O	multiple	amod	7	SENT_21	[p2l951t3654r1182b3719],
7	myeloma	NN	O	myeloma	appos	1	SENT_21	[p2l1208t3654r1476b3720],
8	,	,	O	,	_	0	SENT_21	[p2l1208t3654r1476b3720],
9	chemotherapy	NN	O	chemotherapy	appos	1	SENT_21	[p2l1504t3654r1910b3720],
10	.	.	O	.	_	0	SENT_21	[p2l1504t3654r1910b3720],

1	P	NN	O	p	nsubj	11	SENT_22	[p3l587t74r954b133],
2	—	CD	NUMBER	—	num	3	SENT_22	[p3l587t74r954b133],
3	glycoprotein	NN	O	glycoprotein	dep	1	SENT_22	[p3l587t74r954b133],
4	(	CD	NUMBER	(	num	5	SENT_22	[p3l1032t74r1204b133],
5	P	NN	O	p	dep	1	SENT_22	[p3l1032t74r1204b133],
6	—	CD	NUMBER	—	num	8	SENT_22	[p3l1032t74r1204b133],
7	gp	NN	O	gp	nn	8	SENT_22	[p3l1032t74r1204b133],
8	)	NN	O	)	dep	5	SENT_22	[p3l1032t74r1204b133],
9	,	,	O	,	_	0	SENT_22	[p3l1032t74r1204b133],
10	also	RB	O	also	advmod	5	SENT_22	[p3l1280t74r1373b119],
11	designated	VBN	O	designate	_	0	SENT_22	[p3l1449t74r1710b133],
12	as	IN	O	as	_	0	SENT_22	[p3l1785t90r1830b119],
13	adenosine	NN	O	adenosine	nn	14	SENT_22	[p3l1906t74r2152b119],
14	triphosphate	NN	O	triphosphate	prep_as	11	SENT_22	[p3l586t150r900b209],
15	(	CD	NUMBER	(	num	16	SENT_22	[p3l943t150r1312b210],
16	ATP	NN	O	atp	dep	11	SENT_22	[p3l943t150r1312b210],
17	)	SYM	O	)	dep	16	SENT_22	[p3l943t150r1312b210],
18	-	:	O	-	_	0	SENT_22	[p3l943t150r1312b210],
19	binding	VBG	O	bind	parataxis	11	SENT_22	[p3l943t150r1312b210],
20	cassette	NN	O	cassette	nn	22	SENT_22	[p3l1351t159r1534b196],
21	(	CD	NUMBER	(	num	22	SENT_22	[p3l1577t151r1730b205],
22	ABC	NNP	ORGANIZATION	ABC	dobj	19	SENT_22	[p3l1577t151r1730b205],
23	)	CD	NUMBER	)	num	24	SENT_22	[p3l1577t151r1730b205],
24	transporter	NN	O	transporter	dep	22	SENT_22	[p3l1772t159r2050b209],
25	B1	NN	O	b1	nn	28	SENT_22	[p3l2089t154r2147b195],
26	(	CD	NUMBER	(	num	28	SENT_22	[p3l15t241r335b315],
27	ABCB1	NN	O	abcb1	nn	28	SENT_22	[p3l15t241r335b315],
28	)	NN	O	)	dep	24	SENT_22	[p3l15t241r335b315],
29	.	.	O	.	_	0	SENT_22	[p3l15t241r335b315],

1	P-gp	NN	O	p-gp	nsubj	5	SENT_23	[p3l382t246r538b322],
2	is	VBZ	O	be	cop	5	SENT_23	[p3l583t243r632b302],
3	a	DT	O	a	det	5	SENT_23	[p3l676t263r710b302],
4	transmembrane	JJ	O	transmembrane	amod	5	SENT_23	[p3l751t241r1283b302],
5	protein	NN	O	protein	dep	25	SENT_23	[p3l1326t243r1572b321],
6	that	WDT	O	that	nsubj	7	SENT_23	[p3l1614t241r1747b302],
7	acts	VBZ	O	act	rcmod	5	SENT_23	[p3l1791t253r1914b302],
8	as	IN	O	as	_	0	SENT_23	[p3l1958t263r2020b302],
9	an	DT	O	a	det	11	SENT_23	[p3l2064t263r2143b302],
10	energy	NN	O	energy	nn	11	SENT_23	[p3l11t346r618b426],
11	—	NN	O	—	prep_as	7	SENT_23	[p3l11t346r618b426],
12	dependent	JJ	O	dependent	amod	15	SENT_23	[p3l11t346r618b426],
13	drug	NN	O	drug	nn	15	SENT_23	[p3l674t346r830b426],
14	efflux	NN	O	efflux	nn	15	SENT_23	[p3l886t346r1075b407],
15	pump	NN	O	pump	dobj	7	SENT_23	[p3l1127t367r1326b425],
16	for	IN	O	for	_	0	SENT_23	[p3l1383t346r1480b407],
17	chemotherapeutic	JJ	O	chemotherapeutic	amod	18	SENT_23	[p3l1535t346r2143b425],
18	drugs	NNS	O	drug	prep_for	15	SENT_23	[p3l11t450r214b530],
19	,	,	O	,	_	0	SENT_23	[p3l11t450r214b530],
20	commonly	RB	O	commonly	advmod	21	SENT_23	[p3l256t450r622b530],
21	used	VBN	O	use	partmod	18	SENT_23	[p3l658t450r809b511],
22	in	IN	O	in	_	0	SENT_23	[p3l848t452r913b510],
23	haematological	JJ	O	haematological	amod	24	SENT_23	[p3l951t450r1462b530],
24	malignancies	NNS	O	malignancy	prep_in	21	SENT_23	[p3l1501t450r1936b530],
25	(	VBP	O	(	_	0	SENT_23	[p3l1980t450r2142b524],
26	Van	NNP	PERSON	Van	nn	28	SENT_23	[p3l1980t450r2142b524],
27	der	NNP	PERSON	der	nn	28	SENT_23	[p3l11t554r118b615],
28	Holt	NNP	PERSON	Holt	dobj	25	SENT_23	[p3l186t554r339b615],
29	et	FW	O	et	nn	30	SENT_23	[p3l408t567r467b615],
30	al	FW	O	al	nsubj	25	SENT_23	[p3l494t554r569b624],
31	,	,	O	,	_	0	SENT_23	[p3l494t554r569b624],
32	2005	CD	DATE	2005	num	33	SENT_23	[p3l640t554r846b628],
33	)	NN	O	)	appos	30	SENT_23	[p3l640t554r846b628],
34	.	.	O	.	_	0	SENT_23	[p3l640t554r846b628],

1	More	JJR	O	more	mwe	2	SENT_24	[p3l917t558r1099b615],
2	than	IN	O	than	quantmod	3	SENT_24	[p3l1167t554r1318b615],
3	50	CD	NUMBER	50	num	6	SENT_24	[p3l1388t560r1463b615],
4	single	JJ	O	single	amod	6	SENT_24	[p3l1533t554r1722b634],
5	nucleotide	NN	O	nucleotide	nn	6	SENT_24	[p3l1791t554r2142b615],
6	polymorphisms	NNS	O	polymorphism	nsubj	7	SENT_24	[p3l9t657r539b738],
7	(	VBP	O	(	_	0	SENT_24	[p3l589t658r818b731],
8	SNPS	NNS	O	snp	dobj	7	SENT_24	[p3l589t658r818b731],
9	)	CD	NUMBER	)	nsubjpass	12	SENT_24	[p3l589t658r818b731],
10	have	VBP	O	have	aux	12	SENT_24	[p3l868t657r1020b719],
11	been	VBN	O	be	auxpass	12	SENT_24	[p3l1063t658r1220b719],
12	reported	VBN	O	report	rcmod	8	SENT_24	[p3l1265t657r1553b737],
13	for	IN	O	for	_	0	SENT_24	[p3l1597t657r1694b719],
14	MDR1	NN	O	mdr1	prep_for	12	SENT_24	[p3l1734t662r1976b728],
15	;	:	O	;	_	0	SENT_24	[p3l1734t662r1976b728],
16	this	DT	O	this	det	17	SENT_24	[p3l2021t658r2142b719],
17	study	NN	O	study	nsubj	18	SENT_24	[p3l11t762r194b842],
18	focused	VBD	O	focus	parataxis	7	SENT_24	[p3l214t762r470b823],
19	on	IN	O	on	_	0	SENT_24	[p3l494t784r579b823],
20	C3435T	NN	O	c3435t	nn	23	SENT_24	[p3l604t765r867b823],
21	(	CD	NUMBER	(	num	23	SENT_24	[p3l895t762r1311b836],
22	rs1045642	NN	O	rs1045642	nn	23	SENT_24	[p3l895t762r1311b836],
23	)	NN	O	)	prep_on	18	SENT_24	[p3l895t762r1311b836],
24	,	,	O	,	_	0	SENT_24	[p3l895t762r1311b836],
25	which	WDT	O	which	nsubjpass	27	SENT_24	[p3l1335t762r1538b823],
26	is	VBZ	O	be	auxpass	27	SENT_24	[p3l1562t764r1610b823],
27	associated	VBN	O	associate	rcmod	23	SENT_24	[p3l1635t762r1972b823],
28	with	IN	O	with	_	0	SENT_24	[p3l1993t762r2143b823],
29	P-gp	JJ	O	p-gp	amod	33	SENT_24	[p3l10t866r429b946],
30	—	NN	O	—	nn	33	SENT_24	[p3l10t866r429b946],
31	altered	JJ	O	altered	amod	33	SENT_24	[p3l10t866r429b946],
32	substrate	NN	O	substrate	nn	33	SENT_24	[p3l476t866r775b927],
33	speciﬁcity	NN	O	speciﬁcity	prep_with	27	SENT_24	[p3l821t866r1169b946],
34	.	.	O	.	_	0	SENT_24	[p3l821t866r1169b946],

1	This	DT	O	this	det	2	SENT_25	[p3l1219t866r1363b927],
2	SNP	NN	O	snp	nsubj	7	SENT_25	[p3l1410t869r1554b927],
3	is	VBZ	O	be	cop	4	SENT_25	[p3l1602t868r1650b927],
4	synonymous	JJ	O	synonymous	_	0	SENT_25	[p3l1698t888r2140b946],
5	,	,	O	,	_	0	SENT_25	[p3l1698t888r2140b946],
6	but	CC	O	but	_	0	SENT_25	[p3l8t970r122b1031],
7	seems	VBZ	O	seem	conj_but	4	SENT_25	[p3l146t991r341b1031],
8	to	TO	O	to	aux	11	SENT_25	[p3l364t981r430b1031],
9	be	VB	O	be	cop	11	SENT_25	[p3l453t969r530b1031],
10	nonetheless	RB	O	nonetheless	advmod	11	SENT_25	[p3l554t969r942b1031],
11	related	JJ	O	related	xcomp	7	SENT_25	[p3l967t970r1193b1031],
12	to	TO	O	to	_	0	SENT_25	[p3l1215t981r1281b1031],
13	gene	NN	O	gene	nn	14	SENT_25	[p3l1308t991r1458b1050],
14	expression	NN	O	expression	prep_to	11	SENT_25	[p3l1482t972r1853b1049],
15	,	,	O	,	_	0	SENT_25	[p3l1482t972r1853b1049],
16	perhaps	RB	O	perhaps	advmod	14	SENT_25	[p3l1878t970r2142b1049],
17	by	IN	O	by	_	0	SENT_25	[p3l8t1073r91b1154],
18	non	JJ	O	non	amod	19	SENT_25	[p3l120t1073r553b1134],
19	—	NN	O	—	prep_by	16	SENT_25	[p3l120t1073r553b1134],
20	random	JJ	O	random	amod	21	SENT_25	[p3l120t1073r553b1134],
21	coding	NN	O	coding	dep	14	SENT_25	[p3l586t1073r813b1154],
22	usage	NN	O	usage	nn	24	SENT_25	[p3l844t1095r1026b1154],
23	(	CD	NUMBER	(	num	24	SENT_25	[p3l1062t1073r1604b1154],
24	Kimchi-Sarfaty	NNP	O	Kimchi-Sarfaty	dep	21	SENT_25	[p3l1062t1073r1604b1154],
25	et	FW	O	et	nn	26	SENT_25	[p3l1634t1086r1692b1134],
26	al	FW	O	al	tmod	11	SENT_25	[p3l1718t1073r1794b1144],
27	,	,	O	,	_	0	SENT_25	[p3l1718t1073r1794b1144],
28	2007	CD	DATE	2007	num	29	SENT_25	[p3l1828t1073r2034b1147],
29	)	NN	O	)	appos	26	SENT_25	[p3l1828t1073r2034b1147],
30	.	.	O	.	_	0	SENT_25	[p3l1828t1073r2034b1147],

1	This	DT	O	this	det	2	SENT_26	[p3l93t1178r237b1239],
2	polymorphism	NN	O	polymorphism	nsubjpass	5	SENT_26	[p3l276t1178r777b1258],
3	has	VBZ	O	have	aux	5	SENT_26	[p3l816t1178r924b1239],
4	been	VBN	O	be	auxpass	5	SENT_26	[p3l962t1178r1120b1239],
5	reported	VBN	O	report	_	0	SENT_26	[p3l1159t1178r1447b1257],
6	to	TO	O	to	aux	7	SENT_26	[p3l1486t1190r1552b1239],
7	have	VB	O	have	xcomp	5	SENT_26	[p3l1592t1178r1745b1239],
8	prognostic	JJ	O	prognostic	amod	9	SENT_26	[p3l1783t1180r2143b1258],
9	Value	NN	O	value	dobj	7	SENT_26	[p3l8t1282r184b1343],
10	in	IN	O	in	_	0	SENT_26	[p3l217t1284r282b1342],
11	AML	NN	ORGANIZATION	aml	nn	13	SENT_26	[p3l313t1286r487b1342],
12	(	CD	NUMBER	(	num	13	SENT_26	[p3l524t1282r894b1356],
13	Iamroziak	NNP	O	Iamroziak	prep_in	9	SENT_26	[p3l524t1282r894b1356],
14	et	FW	O	et	nn	15	SENT_26	[p3l925t1295r984b1343],
15	al	FW	O	al	dep	13	SENT_26	[p3l1011t1282r1087b1352],
16	,	,	O	,	_	0	SENT_26	[p3l1011t1282r1087b1352],
17	2004	CD	DATE	2004	num	18	SENT_26	[p3l1122t1282r1329b1355],
18	)	NN	O	)	appos	13	SENT_26	[p3l1122t1282r1329b1355],
19	,	,	O	,	_	0	SENT_26	[p3l1122t1282r1329b1355],
20	but	CC	O	but	_	0	SENT_26	[p3l1362t1282r1494b1353],
21	,	,	O	,	_	0	SENT_26	[p3l1362t1282r1494b1353],
22	to	TO	O	to	_	0	SENT_26	[p3l1528t1294r1594b1343],
23	the	DT	O	the	det	24	SENT_26	[p3l1628t1282r1731b1343],
24	best	JJS	O	best	prep_to	33	SENT_26	[p3l1762t1282r1895b1343],
25	of	IN	O	of	_	0	SENT_26	[p3l1929t1282r2003b1343],
26	our	PRP$	O	we	poss	27	SENT_26	[p3l2026t1304r2143b1343],
27	knowledge	NN	O	knowledge	prep_of	24	SENT_26	[p3l9t1385r387b1465],
28	,	,	O	,	_	0	SENT_26	[p3l9t1385r387b1465],
29	this	DT	O	this	nsubj	33	SENT_26	[p3l427t1385r548b1446],
30	is	VBZ	O	be	cop	33	SENT_26	[p3l587t1387r635b1446],
31	the	DT	O	the	det	33	SENT_26	[p3l674t1385r777b1446],
32	ﬁrst	NN	O	ﬁrst	nn	33	SENT_26	[p3l816t1385r946b1446],
33	report	NN	O	report	conj_but	5	SENT_26	[p3l984t1397r1193b1464],
34	regarding	VBG	O	regard	_	0	SENT_26	[p3l1231t1385r1552b1465],
35	the	DT	O	the	det	36	SENT_26	[p3l1589t1385r1692b1446],
36	inﬂuence	NN	O	inﬂuence	prep_regarding	33	SENT_26	[p3l1731t1385r2039b1446],
37	of	IN	O	of	_	0	SENT_26	[p3l2078t1385r2153b1446],
38	MDR1	NN	O	mdr1	nn	39	SENT_26	[p3l7t1493r223b1549],
39	polymorphisms	NNS	O	polymorphism	prep_of	36	SENT_26	[p3l262t1489r790b1569],
40	on	IN	O	on	_	0	SENT_26	[p3l825t1510r910b1550],
41	the	DT	O	the	det	42	SENT_26	[p3l940t1489r1044b1550],
42	outcome	NN	O	outcome	prep_on	39	SENT_26	[p3l1076t1500r1371b1550],
43	of	IN	O	of	_	0	SENT_26	[p3l1404t1488r1477b1550],
44	MM	NN	O	mm	prep_of	42	SENT_26	[p3l1499t1493r1664b1550],
45	.	.	O	.	_	0	SENT_26	[p3l1499t1493r1664b1550],

1	doi	FW	O	doi	_	0	SENT_27	[p3l85t1754r645b1787],
2	:	:	O	:	_	0	SENT_27	[p3l85t1754r645b1787],
3	lO	NN	O	lo	dep	1	SENT_27	[p3l85t1754r645b1787],
4	.	.	O	.	_	0	SENT_27	[p3l85t1754r645b1787],

1	l111/j	NN	O	l111/j	_	0	SENT_28	[p3l85t1754r645b1787],
2	.1365	CD	DURATION	.1365	number	3	SENT_28	[p3l85t1754r645b1787],
3	-2141.2007.06605	CD	DURATION	-2141.2007.06605	num	1	SENT_28	[p3l85t1754r645b1787],
4	.	.	O	.	_	0	SENT_28	[p3l85t1754r645b1787],

1	x	CC	O	x	cc	3	SENT_29	[p3l85t1754r645b1787],
2	Journal	NNP	O	Journal	nn	3	SENT_29	[p3l675t1754r774b1780],
3	Compilation	NNP	O	Compilation	nsubj	5	SENT_29	[p3l786t1754r954b1787],
4	©	CD	NUMBER	©	num	3	SENT_29	[p3l966t1757r989b1780],
5	2007	CD	DATE	2007	_	0	SENT_29	[p3l1000t1756r1070b1780],
6	Blackwell	NNP	ORGANIZATION	Blackwell	nn	8	SENT_29	[p3l1083t1754r1209b1780],
7	Publishing	NNP	ORGANIZATION	Publishing	nn	8	SENT_29	[p3l1222t1754r1360b1787],
8	Ltd	NNP	ORGANIZATION	Ltd	dep	5	SENT_29	[p3l1372t1754r1420b1784],
9	,	,	O	,	_	0	SENT_29	[p3l1372t1754r1420b1784],
10	British	NNP	MISC	British	appos	8	SENT_29	[p3l1433t1754r1516b1780],
11	Journa/ofHaemato/ogy	NNP	O	Journa/ofHaemato/ogy	dep	10	SENT_29	[p3l1525t1754r1866b1787],
12	,	,	O	,	_	0	SENT_29	[p3l1525t1754r1866b1787],
13	137	CD	NUMBER	137	appos	8	SENT_29	[p3l1880t1756r1939b1784],
14	,	,	O	,	_	0	SENT_29	[p3l1880t1756r1939b1784],
15	454-456	CD	NUMBER	454-456	appos	8	SENT_29	[p3l1950t1756r2075b1780],

1	Patient	NN	O	patient	_	0	SENT_30	[p3l14t1958r318b2028],
2	and	CC	O	and	_	0	SENT_30	[p3l354t1956r511b2028],
3	methods	NNS	O	method	conj_and	1	SENT_30	[p3l555t1956r931b2028],

1	A	DT	O	a	det	2	SENT_31	[p3l7t2139r62b2196],
2	total	NN	O	total	nsubjpass	31	SENT_31	[p3l87t2135r239b2196],
3	of	IN	O	of	_	0	SENT_31	[p3l266t2135r340b2196],
4	115	CD	NUMBER	115	num	5	SENT_31	[p3l364t2142r472b2196],
5	patients	NNS	O	patient	prep_of	2	SENT_31	[p3l500t2137r764b2215],
6	(	IN	O	(	_	0	SENT_31	[p3l797t2135r900b2209],
7	64	CD	NUMBER	64	num	8	SENT_31	[p3l797t2135r900b2209],
8	males	NNS	O	male	prep_(	31	SENT_31	[p3l928t2135r1115b2196],
9	and	CC	O	and	_	0	SENT_31	[p3l1144t2135r1267b2196],
10	51	CD	NUMBER	51	num	11	SENT_31	[p3l1295t2142r1364b2196],
11	females	NNS	O	female	conj_and	8	SENT_31	[p3l1397t2135r1695b2209],
12	)	RB	O	)	advmod	31	SENT_31	[p3l1397t2135r1695b2209],
13	,	,	O	,	_	0	SENT_31	[p3l1397t2135r1695b2209],
14	with	IN	O	with	_	0	SENT_31	[p3l1722t2135r1872b2196],
15	a	DT	O	a	det	17	SENT_31	[p3l1899t2157r1933b2196],
16	mean	JJ	O	mean	amod	17	SENT_31	[p3l1959t2157r2142b2196],
17	age	NN	O	age	prep_with	31	SENT_31	[p3l10t2262r117b2320],
18	at	IN	O	at	_	0	SENT_31	[p3l177t2252r236b2301],
19	diagnosis	NN	O	diagnosis	prep_at	17	SENT_31	[p3l296t2240r605b2320],
20	of	IN	O	of	_	0	SENT_31	[p3l667t2240r741b2301],
21	59-5	CD	NUMBER	59-5	num	22	SENT_31	[p3l791t2246r923b2301],
22	years	NNS	NUMBER	year	prep_of	19	SENT_31	[p3l955t2262r1142b2320],
23	,	,	O	,	_	0	SENT_31	[p3l955t2262r1142b2320],
24	(	NN	O	(	nn	25	SENT_31	[p3l1209t2240r1437b2320],
25	range	NN	O	range	nsubjpass	31	SENT_31	[p3l1209t2240r1437b2320],
26	,	,	O	,	_	0	SENT_31	[p3l1209t2240r1437b2320],
27	34-83	CD	NUMBER	34-83	num	28	SENT_31	[p3l1500t2246r1695b2301],
28	years	NNS	NUMBER	year	appos	25	SENT_31	[p3l1727t2240r1922b2320],
29	)	CD	NUMBER	)	dep	28	SENT_31	[p3l1727t2240r1922b2320],
30	were	VBD	O	be	auxpass	31	SENT_31	[p3l1985t2262r2142b2301],
31	studied	VBN	O	study	_	0	SENT_31	[p3l10t2343r272b2405],
32	.	.	O	.	_	0	SENT_31	[p3l10t2343r272b2405],

1	All	DT	O	all	det	2	SENT_32	[p3l307t2343r404b2404],
2	patients	NNS	O	patient	nsubjpass	4	SENT_32	[p3l436t2346r700b2423],
3	were	VBD	O	be	auxpass	4	SENT_32	[p3l733t2365r890b2405],
4	treated	VBN	O	treat	_	0	SENT_32	[p3l923t2344r1156b2405],
5	with	IN	O	with	_	0	SENT_32	[p3l1188t2343r1338b2405],
6	DAV	NN	O	dav	nn	8	SENT_32	[p3l1371t2347r1542b2404],
7	[	CD	NUMBER	[	num	8	SENT_32	[p3l1582t2344r2141b2417],
8	Dexamethasone	NN	O	dexamethasone	prep_with	4	SENT_32	[p3l1582t2344r2141b2417],
9	40	CD	NUMBER	40	num	10	SENT_32	[p3l9t2453r85b2508],
10	mg/m2	NN	O	mg/m2	dep	8	SENT_32	[p3l119t2434r368b2528],
11	,	,	O	,	_	0	SENT_32	[p3l119t2434r368b2528],
12	days	NNS	DURATION	day	appos	8	SENT_32	[p3l418t2447r562b2528],
13	1-4	CD	NUMBER	1-4	dep	12	SENT_32	[p3l617t2453r747b2518],
14	;	:	O	;	_	0	SENT_32	[p3l617t2453r747b2518],
15	Doxorubicin	NNP	O	Doxorubicin	dep	12	SENT_32	[p3l797t2446r1227b2508],
16	(	CD	NUMBER	(	num	15	SENT_32	[p3l1280t2446r1728b2527],
17	Adryamicin	NNP	O	Adryamicin	dep	15	SENT_32	[p3l1280t2446r1728b2527],
18	)	CD	NUMBER	)	number	19	SENT_32	[p3l1280t2446r1728b2527],
19	50	CD	NUMBER	50	num	20	SENT_32	[p3l1783t2453r1858b2508],
20	mg/m2	NN	O	mg/m2	dep	17	SENT_32	[p3l1890t2434r2140b2528],
21	,	,	O	,	_	0	SENT_32	[p3l1890t2434r2140b2528],
22	day	NN	DURATION	day	appos	8	SENT_32	[p3l10t2552r129b2632],
23	1	CD	NUMBER	1	num	22	SENT_32	[p3l167t2558r215b2622],
24	;	:	O	;	_	0	SENT_32	[p3l167t2558r215b2622],
25	Vincristine	NNP	ORGANIZATION	Vincristine	nn	27	SENT_32	[p3l248t2554r620b2613],
26	1	CD	NUMBER	1	num	27	SENT_32	[p3l661t2558r684b2612],
27	mg	NN	O	mg	dep	8	SENT_32	[p3l722t2574r845b2632],
28	,	,	O	,	_	0	SENT_32	[p3l722t2574r845b2632],
29	day	NN	DURATION	day	nn	32	SENT_32	[p3l882t2552r1001b2632],
30	1	CD	NUMBER	1	num	32	SENT_32	[p3l1038t2552r1089b2626],
31	]	NN	O	]	nn	32	SENT_32	[p3l1038t2552r1089b2626],
32	chemotherapy	NN	O	chemotherapy	appos	8	SENT_32	[p3l1134t2552r1631b2632],
33	.	.	O	.	_	0	SENT_32	[p3l1134t2552r1631b2632],

1	Cyclophosph	JJ	O	cyclophosph	amod	3	SENT_33	[p3l1670t2552r2139b2632],
2	—	NN	O	—	nn	3	SENT_33	[p3l1670t2552r2139b2632],
3	amide	NN	O	amide	_	0	SENT_33	[p3l10t2655r215b2717],
4	(	CD	NUMBER	(	number	5	SENT_33	[p3l249t2656r312b2729],
5	4	CD	NUMBER	4	dep	3	SENT_33	[p3l249t2656r312b2729],
6	g/m2	NN	O	g/m2	nn	7	SENT_33	[p3l345t2641r532b2736],
7	)	NN	O	)	dep	5	SENT_33	[p3l345t2641r532b2736],
8	and	CC	O	and	_	0	SENT_33	[p3l568t2655r692b2717],
9	G	NN	O	g	dep	5	SENT_33	[p3l722t2659r945b2717],
10	.	.	O	.	_	0	SENT_33	[p3l722t2659r945b2717],

1	—	NN	O	—	_	0	SENT_34	[p3l722t2659r945b2717],
2	.	.	O	.	_	0	SENT_34	[p3l722t2659r945b2717],

1	CSF	NN	O	csf	nsubjpass	7	SENT_35	[p3l722t2659r945b2717],
2	(	CD	NUMBER	(	num	1	SENT_35	[p3l979t2656r1041b2729],
3	5	CD	NUMBER	5	num	5	SENT_35	[p3l979t2656r1041b2729],
4	pg/kg/d	NN	O	pg/kg/d	nn	5	SENT_35	[p3l1078t2655r1361b2736],
5	)	NN	O	)	dep	1	SENT_35	[p3l1078t2655r1361b2736],
6	were	VBD	O	be	auxpass	7	SENT_35	[p3l1394t2677r1551b2717],
7	used	VBN	O	use	_	0	SENT_35	[p3l1580t2655r1732b2717],
8	to	TO	O	to	aux	9	SENT_35	[p3l1760t2668r1826b2717],
9	mobilise	VB	O	mobilise	xcomp	7	SENT_35	[p3l1857t2655r2142b2717],
10	peripheral	JJ	O	peripheral	amod	13	SENT_35	[p3l9t2759r353b2839],
11	blood	NN	O	blood	nn	13	SENT_35	[p3l424t2759r620b2820],
12	stem	NN	O	stem	nn	13	SENT_35	[p3l693t2771r849b2820],
13	cells	NNS	O	cell	dobj	9	SENT_35	[p3l923t2759r1078b2820],
14	.	.	O	.	_	0	SENT_35	[p3l923t2759r1078b2820],

1	Melphalan	JJ	O	melphalan	amod	2	SENT_36	[p3l1153t2759r1512b2839],
2	(	NN	O	(	nsubjpass	16	SENT_36	[p3l1590t2759r1733b2833],
3	200	CD	NUMBER	200	num	4	SENT_36	[p3l1590t2759r1733b2833],
4	mg/m2	NN	O	mg/m2	dep	2	SENT_36	[p3l1766t2745r1996b2840],
5	or	CC	O	or	_	0	SENT_36	[p3l2072t2781r2143b2820],
6	100	CD	NUMBER	100	num	7	SENT_36	[p3l17t2877r126b2933],
7	mg/m2	NN	O	mg/m2	conj_or	2	SENT_36	[p3l159t2858r409b2952],
8	,	,	O	,	_	0	SENT_36	[p3l159t2858r409b2952],
9	for	IN	O	for	_	0	SENT_36	[p3l447t2871r544b2933],
10	patients	NNS	O	patient	prep_for	7	SENT_36	[p3l579t2873r843b2951],
11	over	IN	O	over	_	0	SENT_36	[p3l881t2893r1026b2933],
12	65	CD	DURATION	65	num	14	SENT_36	[p3l1063t2877r1137b2933],
13	years	NNS	NUMBER	year	nn	14	SENT_36	[p3l1169t2871r1364b2952],
14	)	NN	O	)	prep_over	10	SENT_36	[p3l1169t2871r1364b2952],
15	was	VBD	O	be	auxpass	16	SENT_36	[p3l1405t2893r1527b2932],
16	used	VBN	O	use	_	0	SENT_36	[p3l1564t2871r1716b2933],
17	as	IN	O	as	_	0	SENT_36	[p3l1753t2893r1815b2933],
18	a	DT	O	a	det	20	SENT_36	[p3l1853t2893r1887b2933],
19	conditioning	NN	O	conditioning	nn	20	SENT_36	[p3l1923t2871r2138b2933, p3l9t2976r253b3055],
20	regimen	NN	O	regimen	prep_as	16	SENT_36	[p3l324t2976r597b3055],
21	for	IN	O	for	_	0	SENT_36	[p3l668t2974r765b3035],
22	each	DT	O	each	det	25	SENT_36	[p3l835t2974r983b3035],
23	ASCT	NNP	O	ASCT	nn	25	SENT_36	[p3l1052t2977r1252b3036],
24	(	CD	NUMBER	(	num	25	SENT_36	[p3l1327t2974r1624b3048],
25	Tribalto	NNP	O	Tribalto	prep_for	20	SENT_36	[p3l1327t2974r1624b3048],
26	et	FW	O	et	nn	27	SENT_36	[p3l1698t2987r1756b3035],
27	al	FW	O	al	dep	25	SENT_36	[p3l1783t2974r1859b3045],
28	,	,	O	,	_	0	SENT_36	[p3l1783t2974r1859b3045],
29	2000	CD	DATE	2000	num	30	SENT_36	[p3l1932t2975r2138b3048],
30	)	NN	O	)	appos	25	SENT_36	[p3l1932t2975r2138b3048],
31	.	.	O	.	_	0	SENT_36	[p3l1932t2975r2138b3048],

1	Complete	JJ	O	complete	amod	5	SENT_37	[p3l11t3079r337b3158],
2	response	NN	O	response	nn	5	SENT_37	[p3l371t3100r663b3158],
3	(	CD	NUMBER	(	num	5	SENT_37	[p3l701t3079r858b3153],
4	CR	JJ	O	cr	amod	5	SENT_37	[p3l701t3079r858b3153],
5	)	NN	O	)	nsubjpass	7	SENT_37	[p3l701t3079r858b3153],
6	was	VBD	O	be	auxpass	7	SENT_37	[p3l896t3101r1017b3140],
7	deﬁned	VBN	O	deﬁned	_	0	SENT_37	[p3l1053t3079r1301b3140],
8	as	IN	O	as	_	0	SENT_37	[p3l1335t3101r1396b3140],
9	the	DT	O	the	det	10	SENT_37	[p3l1430t3079r1534b3140],
10	disappearance	NN	O	disappearance	prep_as	7	SENT_37	[p3l1568t3079r2043b3158],
11	of	IN	O	of	_	0	SENT_37	[p3l2078t3079r2152b3140],
12	the	DT	O	the	det	15	SENT_37	[p3l9t3183r112b3244],
13	M	NN	O	m	nn	15	SENT_37	[p3l163t3187r656b3262],
14	—	NN	O	—	nn	15	SENT_37	[p3l163t3187r656b3262],
15	component	NN	O	component	prep_of	10	SENT_37	[p3l163t3187r656b3262],
16	from	IN	O	from	_	0	SENT_37	[p3l706t3183r872b3244],
17	both	DT	O	both	preconj	18	SENT_37	[p3l920t3183r1077b3244],
18	serum	NN	O	serum	prep_from	7	SENT_37	[p3l1128t3204r1335b3244],
19	and	CC	O	and	_	0	SENT_37	[p3l1386t3183r1510b3244],
20	urine	NN	O	urine	prep_from	7	SENT_37	[p3l1561t3185r1755b3253],
21	,	,	O	,	_	0	SENT_37	[p3l1561t3185r1755b3253],
22	and	CC	O	and	_	0	SENT_37	[p3l1809t3183r1932b3244],
23	<	JJR	O	<	conj_and	18	SENT_37	[p3l1985t3188r2140b3246],
24	5	CD	PERCENT	5	number	25	SENT_37	[p3l1985t3188r2140b3246],
25	%	NN	PERCENT	%	amod	27	SENT_37	[p3l1985t3188r2140b3246],
26	plasma	NN	O	plasma	nn	27	SENT_37	[p3l9t3286r246b3366],
27	cells	NNS	O	cell	dep	23	SENT_37	[p3l295t3286r432b3347],
28	in	IN	O	in	_	0	SENT_37	[p3l483t3288r548b3347],
29	bone	NN	O	bone	nn	30	SENT_37	[p3l595t3286r761b3347],
30	marrow	NN	O	marrow	prep_in	7	SENT_37	[p3l811t3308r1093b3347],
31	.	.	O	.	_	0	SENT_37	[p3l811t3308r1093b3347],

1	Patients	NNS	O	patient	nsubjpass	3	SENT_38	[p3l1146t3288r1412b3347],
2	were	VBD	O	be	auxpass	3	SENT_38	[p3l1460t3308r1617b3347],
3	deﬁned	VBN	O	deﬁned	_	0	SENT_38	[p3l1667t3286r1915b3348],
4	as	IN	O	as	prep	3	SENT_38	[p3l1966t3308r2027b3347],
5	in	IN	O	in	pcomp	4	SENT_38	[p3l2077t3288r2142b3347],
6	partial	JJ	O	partial	amod	9	SENT_38	[p3l9t3391r226b3470],
7	response	NN	O	response	nn	9	SENT_38	[p3l274t3412r566b3470],
8	(	CD	NUMBER	(	num	9	SENT_38	[p3l619t3391r768b3465],
9	PR	NN	O	pr	pobj	5	SENT_38	[p3l619t3391r768b3465],
10	)	CD	NUMBER	)	tmod	3	SENT_38	[p3l619t3391r768b3465],
11	when	WRB	O	when	advmod	18	SENT_38	[p3l820t3391r1002b3452],
12	the	DT	O	the	det	16	SENT_38	[p3l1049t3391r1153b3452],
13	initial	JJ	O	initial	amod	16	SENT_38	[p3l1201t3391r1396b3452],
14	monoclonal	JJ	O	monoclonal	amod	16	SENT_38	[p3l1444t3391r1848b3452],
15	protein	NN	O	protein	nn	16	SENT_38	[p3l1895t3393r2142b3470],
16	value	NN	O	value	nsubjpass	18	SENT_38	[p3l7t3495r183b3556],
17	was	VBD	O	be	auxpass	18	SENT_38	[p3l223t3516r345b3556],
18	reduced	VBN	O	reduce	advcl	3	SENT_38	[p3l388t3495r656b3556],
19	to	TO	O	to	_	0	SENT_38	[p3l697t3507r763b3556],
20	<	JJR	O	<	prep_to	18	SENT_38	[p3l809t3500r1005b3558],
21	50	CD	PERCENT	50	number	22	SENT_38	[p3l809t3500r1005b3558],
22	%	NN	PERCENT	%	amod	20	SENT_38	[p3l809t3500r1005b3558],
23	with	IN	O	with	_	0	SENT_38	[p3l1047t3495r1197b3556],
24	the	DT	O	the	det	25	SENT_38	[p3l1238t3495r1341b3556],
25	stability	NN	O	stability	prep_with	18	SENT_38	[p3l1384t3495r1650b3575],
26	of	IN	O	of	_	0	SENT_38	[p3l1689t3495r1764b3556],
27	lytic	JJ	O	lytic	amod	29	SENT_38	[p3l1795t3495r1936b3575],
28	bone	NN	O	bone	nn	29	SENT_38	[p3l1976t3495r2142b3556],
29	lesions	NNS	O	lesion	prep_of	25	SENT_38	[p3l8t3598r251b3659],
30	.	.	O	.	_	0	SENT_38	[p3l8t3598r251b3659],

1	Stable	JJ	O	stable	amod	5	SENT_39	[p3l280t3598r478b3659],
2	disease	NN	O	disease	nn	5	SENT_39	[p3l502t3598r732b3659],
3	(	CD	NUMBER	(	num	5	SENT_39	[p3l760t3598r911b3672],
4	SD	NN	O	sd	nn	5	SENT_39	[p3l760t3598r911b3672],
5	)	NN	O	)	nsubjpass	7	SENT_39	[p3l760t3598r911b3672],
6	was	VBD	O	be	auxpass	7	SENT_39	[p3l939t3620r1061b3659],
7	deﬁned	VBN	O	deﬁned	_	0	SENT_39	[p3l1086t3598r1334b3659],
8	as	IN	O	as	_	0	SENT_39	[p3l1358t3620r1419b3659],
9	the	DT	O	the	det	10	SENT_39	[p3l1443t3598r1546b3659],
10	failure	NN	O	failure	prep_as	7	SENT_39	[p3l1570t3598r1783b3659],
11	to	TO	O	to	aux	12	SENT_39	[p3l1806t3610r1871b3659],
12	achieve	VB	O	achieve	xcomp	7	SENT_39	[p3l1898t3598r2142b3659],
13	either	CC	O	either	preconj	14	SENT_39	[p3l10t3702r202b3763],
14	CR	JJ	O	cr	dobj	12	SENT_39	[p3l241t3705r347b3763],
15	or	CC	O	or	_	0	SENT_39	[p3l384t3723r455b3763],
16	PR	NN	O	pr	conj_or	14	SENT_39	[p3l494t3706r609b3772],
17	,	,	O	,	_	0	SENT_39	[p3l494t3706r609b3772],
18	while	IN	O	while	_	0	SENT_39	[p3l647t3702r827b3763],
19	progressive	JJ	O	progressive	amod	23	SENT_39	[p3l865t3704r1242b3782],
20	disease	NN	O	disease	nn	23	SENT_39	[p3l1283t3701r1512b3763],
21	(	NN	O	(	nn	23	SENT_39	[p3l1556t3702r1714b3775],
22	PD	NN	O	pd	nn	23	SENT_39	[p3l1556t3702r1714b3775],
23	)	NN	O	)	prep_while	7	SENT_39	[p3l1556t3702r1714b3775],
24	required	VBN	O	require	partmod	23	SENT_39	[p3l1759t3701r2044b3781],
25	at	IN	O	at	advmod	30	SENT_39	[p3l2083t3714r2143b3763],
26	least	JJS	O	least	pobj	25	SENT_39	[p4l8t18r156b79],
27	a	DT	O	a	det	30	SENT_39	[p4l188t40r222b79],
28	25	CD	PERCENT	25	number	29	SENT_39	[p4l254t24r400b81],
29	%	NN	PERCENT	%	amod	30	SENT_39	[p4l254t24r400b81],
30	increase	NN	O	increase	dobj	24	SENT_39	[p4l434t20r701b79],
31	in	IN	O	in	_	0	SENT_39	[p4l735t20r799b79],
32	paraprotein	NN	O	paraprotein	prep_in	24	SENT_39	[p4l830t20r1243b98],
33	.	.	O	.	_	0	SENT_39	[p4l830t20r1243b98],

1	DNA	NN	O	dna	nsubjpass	3	SENT_40	[p4l1279t22r1455b79],
2	was	VBD	O	be	auxpass	3	SENT_40	[p4l1484t40r1606b79],
3	extracted	VBN	O	extract	_	0	SENT_40	[p4l1639t18r1945b79],
4	from	IN	O	from	_	0	SENT_40	[p4l1977t18r2142b79],
5	whole	JJ	O	whole	amod	6	SENT_40	[p4l7t123r208b184],
6	blood	NN	O	blood	prep_from	3	SENT_40	[p4l243t123r439b184],
7	of	IN	O	of	_	0	SENT_40	[p4l476t123r550b184],
8	each	DT	O	each	det	9	SENT_40	[p4l578t123r726b184],
9	patient	NN	O	patient	prep_of	6	SENT_40	[p4l762t125r1014b202],
10	.	.	O	.	_	0	SENT_40	[p4l762t125r1014b202],

1	Genotyping	VBG	O	genotype	_	0	SENT_41	[p4l1056t125r1452b203],
2	was	VBD	O	be	auxpass	3	SENT_41	[p4l1486t145r1607b184],
3	carried	VBN	O	carry	aux	1	SENT_41	[p4l1646t123r1878b184],
4	out	RP	O	out	prt	3	SENT_41	[p4l1916t135r2028b184],
5	by	IN	O	by	_	0	SENT_41	[p4l2063t123r2145b203],
6	using	VBG	O	use	agent	3	SENT_41	[p4l10t229r190b307],
7	the	DT	O	the	det	8	SENT_41	[p4l213t226r317b288],
8	Taqman	NN	MISC	taqman	dobj	6	SENT_41	[p4l342t229r622b306],
9	assay	NN	O	assay	nn	11	SENT_41	[p4l648t248r818b307],
10	(	CD	NUMBER	(	num	11	SENT_41	[p4l845t227r1018b300],
11	ABI	NNP	O	ABI	nsubj	1	SENT_41	[p4l845t227r1018b300],
12	,	,	O	,	_	0	SENT_41	[p4l845t227r1018b300],
13	Applied	NNP	O	Applied	nn	14	SENT_41	[p4l1044t226r1311b306],
14	Biosystems	NNP	O	Biosystems	appos	11	SENT_41	[p4l1336t229r1724b307],
15	,	,	O	,	_	0	SENT_41	[p4l1336t229r1724b307],
16	Foster	NNP	LOCATION	Foster	nn	21	SENT_41	[p4l1753t231r1958b288],
17	City	NNP	LOCATION	City	nn	21	SENT_41	[p4l1984t229r2140b307],
18	,	,	O	,	_	0	SENT_41	[p4l1984t229r2140b307],
19	CA	NNP	LOCATION	CA	appos	21	SENT_41	[p4l11t334r134b401],
20	,	,	O	,	_	0	SENT_41	[p4l11t334r134b401],
21	USA	NNP	LOCATION	USA	appos	14	SENT_41	[p4l192t331r394b404],
22	)	CD	NUMBER	)	num	21	SENT_41	[p4l192t331r394b404],
23	.	.	O	.	_	0	SENT_41	[p4l192t331r394b404],

1	The	DT	O	the	det	4	SENT_42	[p4l453t330r581b391],
2	MGB	NNP	O	MGB	nn	4	SENT_42	[p4l637t334r816b392],
3	Taqman	NNP	O	Taqman	nn	4	SENT_42	[p4l874t333r1154b410],
4	probes	NNS	O	probe	nsubjpass	8	SENT_42	[p4l1209t330r1433b410],
5	and	CC	O	and	_	0	SENT_42	[p4l1492t330r1615b391],
6	primers	NNS	O	primer	conj_and	4	SENT_42	[p4l1670t332r1930b410],
7	were	VBD	O	be	auxpass	8	SENT_42	[p4l1985t352r2142b391],
8	synthesised	VBN	O	synthesise	_	0	SENT_42	[p4l10t435r388b515],
9	by	IN	O	by	_	0	SENT_42	[p4l411t435r493b515],
10	ABI	NN	O	abus	nn	12	SENT_42	[p4l511t438r641b495],
11	(	CD	NUMBER	(	num	12	SENT_42	[p4l672t419r1032b514],
12	TaqMan	NNP	O	TaqMan	agent	8	SENT_42	[p4l672t419r1032b514],
13	®	CD	NUMBER	®	num	16	SENT_42	[p4l672t419r1032b514],
14	SNP	NN	O	snp	nn	16	SENT_42	[p4l1059t438r1203b496],
15	Genotyping	NN	O	genotyping	nn	16	SENT_42	[p4l1230t437r1626b515],
16	Assays	NNS	O	assay	nsubj	17	SENT_42	[p4l1647t435r1914b515],
17	)	VBP	O	)	rcmod	12	SENT_42	[p4l1647t435r1914b515],
18	,	,	O	,	_	0	SENT_42	[p4l1647t435r1914b515],
19	which	WDT	O	which	nsubj	21	SENT_42	[p4l1939t435r2142b496],
20	also	RB	O	also	advmod	21	SENT_42	[p4l10t539r136b600],
21	provided	VBD	O	provide	rcmod	12	SENT_42	[p4l173t539r476b618],
22	the	DT	O	the	det	25	SENT_42	[p4l511t539r614b600],
23	standard	JJ	O	standard	amod	25	SENT_42	[p4l652t539r944b600],
24	polymerase	NN	O	polymerase	nn	25	SENT_42	[p4l978t539r1360b619],
25	chain	NN	O	chain	iobj	21	SENT_42	[p4l1397t539r1578b600],
26	reaction	NN	O	reaction	nn	27	SENT_42	[p4l1615t541r1887b600],
27	proﬁle	NN	O	proﬁle	dobj	21	SENT_42	[p4l1923t539r2142b618],
28	and	CC	O	and	_	0	SENT_42	[p4l10t642r134b703],
29	reaction	NN	O	reaction	nn	30	SENT_42	[p4l158t644r431b703],
30	conditions	NNS	O	condition	dobj	21	SENT_42	[p4l457t642r830b703],
31	.	.	O	.	_	0	SENT_42	[p4l457t642r830b703],

1	Chi-squared	JJ	O	chi-squared	amod	2	SENT_43	[p4l859t642r1274b722],
2	test	NN	O	test	nsubjpass	4	SENT_43	[p4l1298t654r1413b703],
3	was	VBD	O	be	auxpass	4	SENT_43	[p4l1435t664r1557b703],
4	used	VBN	O	use	_	0	SENT_43	[p4l1582t642r1734b703],
5	to	TO	O	to	aux	6	SENT_43	[p4l1757t654r1823b703],
6	compare	VB	O	compare	xcomp	4	SENT_43	[p4l1851t664r2142b722],
7	the	DT	O	the	det	9	SENT_43	[p4l8t747r112b808],
8	genotype	NN	O	genotype	nn	9	SENT_43	[p4l152t759r455b827],
9	distributions	NNS	O	distribution	dobj	6	SENT_43	[p4l495t747r924b808],
10	in	IN	O	in	_	0	SENT_43	[p4l965t749r1029b807],
11	each	DT	O	each	det	12	SENT_43	[p4l1069t746r1217b808],
12	class	NN	O	class	prep_in	6	SENT_43	[p4l1257t747r1405b808],
13	of	IN	O	of	_	0	SENT_43	[p4l1445t746r1519b808],
14	response	NN	O	response	prep_of	12	SENT_43	[p4l1548t768r1856b826],
15	.	.	O	.	_	0	SENT_43	[p4l1548t768r1856b826],

1	Overall	JJ	O	overall	amod	5	SENT_44	[p4l1900t746r2143b808],
2	survival	NN	O	survival	nn	5	SENT_44	[p4l10t850r271b911],
3	(	CD	NUMBER	(	num	5	SENT_44	[p4l308t851r462b924],
4	OS	NN	O	os	nn	5	SENT_44	[p4l308t851r462b924],
5	)	NN	O	)	nsubjpass	7	SENT_44	[p4l308t851r462b924],
6	was	VBD	O	be	auxpass	7	SENT_44	[p4l499t872r620b911],
7	calculated	VBN	O	calculate	_	0	SENT_44	[p4l656t850r990b911],
8	in	IN	O	in	_	0	SENT_44	[p4l1023t852r1088b911],
9	months	NNS	DURATION	month	prep_in	7	SENT_44	[p4l1121t850r1377b911],
10	from	IN	O	from	_	0	SENT_44	[p4l1411t850r1576b911],
11	diagnosis	NN	O	diagnosis	prep_from	7	SENT_44	[p4l1610t850r1920b931],
12	up	IN	O	up	advmod	11	SENT_44	[p4l1955t872r2040b930],
13	to	TO	O	to	_	0	SENT_44	[p4l2074t862r2140b911],
14	September	NNP	DATE	September	prep_to	12	SENT_44	[p4l10t955r367b1034],
15	2006	CD	DATE	2006	num	14	SENT_44	[p4l409t960r585b1025],
16	,	,	O	,	_	0	SENT_44	[p4l409t960r585b1025],
17	considering	VBG	O	consider	xcomp	7	SENT_44	[p4l630t955r1021b1035],
18	a	DT	O	a	det	19	SENT_44	[p4l1064t977r1097b1016],
19	maximum	NN	O	maximum	dobj	17	SENT_44	[p4l1139t957r1489b1016],
20	of	IN	O	of	_	0	SENT_44	[p4l1532t955r1606b1016],
21	60	CD	DURATION	60	num	22	SENT_44	[p4l1640t960r1714b1016],
22	months	NNS	NUMBER	month	prep_of	19	SENT_44	[p4l1748t955r2003b1016],
23	for	IN	O	for	_	0	SENT_44	[p4l2047t955r2143b1016],
24	each	DT	O	each	det	25	SENT_44	[p4l10t1059r158b1120],
25	patient	NN	O	patient	prep_for	22	SENT_44	[p4l185t1061r437b1138],
26	.	.	O	.	_	0	SENT_44	[p4l185t1061r437b1138],

1	Cox	NN	PERSON	cox	nn	3	SENT_45	[p4l469t1062r606b1120],
2	regression	NN	O	regression	nn	3	SENT_45	[p4l632t1061r970b1139],
3	analysis	NN	O	analysis	nsubjpass	5	SENT_45	[p4l999t1059r1254b1139],
4	was	VBD	O	be	auxpass	5	SENT_45	[p4l1281t1080r1403b1120],
5	applied	VBN	O	apply	_	0	SENT_45	[p4l1432t1059r1678b1138],
6	to	TO	O	to	aux	7	SENT_45	[p4l1705t1071r1771b1120],
7	determine	VB	O	determine	xcomp	5	SENT_45	[p4l1801t1059r2142b1120],
8	the	DT	O	the	det	9	SENT_45	[p4l9t1162r112b1223],
9	contribution	NN	O	contribution	dobj	7	SENT_45	[p4l153t1162r580b1223],
10	of	IN	O	of	_	0	SENT_45	[p4l623t1162r696b1223],
11	the	DT	O	the	det	12	SENT_45	[p4l726t1162r829b1223],
12	polymorphism	NN	O	polymorphism	prep_of	9	SENT_45	[p4l869t1162r1369b1242],
13	and	CC	O	and	_	0	SENT_45	[p4l1411t1162r1534b1223],
14	other	JJ	O	other	amod	15	SENT_45	[p4l1575t1162r1753b1223],
15	factors	NNS	O	factor	conj_and	12	SENT_45	[p4l1792t1162r2015b1223],
16	on	IN	O	on	_	0	SENT_45	[p4l2057t1184r2142b1223],
17	survival	NN	O	survival	nn	18	SENT_45	[p4l10t1267r271b1328],
18	rate	NN	O	rate	prep_on	7	SENT_45	[p4l312t1279r437b1328],
19	that	WDT	O	that	nsubjpass	21	SENT_45	[p4l477t1267r610b1328],
20	was	VBD	O	be	auxpass	21	SENT_45	[p4l648t1289r770b1328],
21	represented	VBN	O	represent	rcmod	18	SENT_45	[p4l812t1267r1201b1346],
22	as	IN	O	as	_	0	SENT_45	[p4l1243t1289r1305b1328],
23	Kaplan	NNP	PERSON	Kaplan	prep_as	21	SENT_45	[p4l1347t1267r1841b1347],
24	.	.	O	.	_	0	SENT_45	[p4l1347t1267r1841b1347],

1	—	NN	O	—	_	0	SENT_46	[p4l1347t1267r1841b1347],
2	.	.	O	.	_	0	SENT_46	[p4l1347t1267r1841b1347],

1	Meyer	NNP	PERSON	Meyer	_	0	SENT_47	[p4l1347t1267r1841b1347],
2	survival	NN	O	survival	nn	3	SENT_47	[p4l1882t1267r2143b1328],
3	curves	NNS	O	curve	dep	1	SENT_47	[p4l10t1392r238b1432],
4	.	.	O	.	_	0	SENT_47	[p4l10t1392r238b1432],

1	Statistical	JJ	MISC	statistical	amod	2	SENT_48	[p4l269t1371r590b1432],
2	signiﬁcance	NN	O	signiﬁcance	nsubj	9	SENT_48	[p4l617t1371r1007b1451],
3	was	VBD	O	be	auxpass	4	SENT_48	[p4l1032t1392r1154b1432],
4	inferred	VBN	O	infer	rcmod	2	SENT_48	[p4l1182t1371r1448b1432],
5	from	IN	O	from	_	0	SENT_48	[p4l1475t1371r1640b1432],
6	P	NN	O	p	nn	8	SENT_48	[p4l1664t1371r1947b1432],
7	—	NN	O	—	nn	8	SENT_48	[p4l1664t1371r1947b1432],
8	values	NNS	O	value	prep_from	4	SENT_48	[p4l1664t1371r1947b1432],
9	(	VBP	O	(	_	0	SENT_48	[p4l1979t1371r2140b1444],
10	0-05	CD	NUMBER	0-05	num	12	SENT_48	[p4l1979t1371r2140b1444],
11	threshold	JJ	O	threshold	amod	12	SENT_48	[p4l9t1474r353b1548],
12	)	NN	O	)	dobj	9	SENT_48	[p4l9t1474r353b1548],
13	or	CC	O	or	_	0	SENT_48	[p4l392t1496r463b1535],
14	95	CD	PERCENT	95	number	15	SENT_48	[p4l494t1480r640b1537],
15	%	NN	PERCENT	%	amod	16	SENT_48	[p4l494t1480r640b1537],
16	CI	NN	O	ci	dobj	9	SENT_48	[p4l675t1478r770b1535],
17	.	.	O	.	_	0	SENT_48	[p4l675t1478r770b1535],

1	Results	NNS	O	result	_	0	SENT_49	[p4l14t1717r318b1789],

1	Patient	NN	O	patient	nn	2	SENT_50	[p4l10t1898r247b1957],
2	response	NN	O	response	nsubjpass	4	SENT_50	[p4l275t1917r566b1975],
3	was	VBD	O	be	auxpass	4	SENT_50	[p4l591t1917r714b1957],
4	evaluated	VBN	O	evaluate	_	0	SENT_50	[p4l743t1896r1060b1957],
5	1	CD	DURATION	1	num	6	SENT_50	[p4l1094t1902r1117b1956],
6	month	NN	NUMBER	month	tmod	4	SENT_50	[p4l1155t1896r1382b1957],
7	after	IN	O	after	_	0	SENT_50	[p4l1410t1896r1561b1957],
8	DAV	NN	O	dav	nn	9	SENT_50	[p4l1588t1899r1758b1956],
9	therapy	NN	O	therapy	prep_after	4	SENT_50	[p4l1783t1896r2040b1976],
10	by	IN	O	by	_	0	SENT_50	[p4l2063t1896r2145b1976],
11	grouping	VBG	O	group	agent	4	SENT_50	[p4l10t2001r318b2080],
12	CR	NN	O	cr	dobj	11	SENT_50	[p4l381t2003r487b2061],
13	+	CC	O	+	_	0	SENT_50	[p4l518t2014r562b2060],
14	PR	NN	O	pr	nn	15	SENT_50	[p4l597t2004r695b2060],
15	(	NN	O	(	conj_+	12	SENT_50	[p4l761t1999r1020b2073],
16	722	CD	PERCENT	722	dep	17	SENT_50	[p4l761t1999r1020b2073],
17	%	NN	PERCENT	%	advmod	18	SENT_50	[p4l761t1999r1020b2073],
18	)	CD	NUMBER	)	dep	15	SENT_50	[p4l761t1999r1020b2073],
19	vs.	CC	O	vs.	prep	18	SENT_50	[p4l1087t2021r1171b2060],
20	SD	NN	O	sd	dep	19	SENT_50	[p4l1239t2003r1334b2061],
21	+	CC	O	+	_	0	SENT_50	[p4l1369t2014r1413b2060],
22	PD	NN	O	pd	nn	23	SENT_50	[p4l1448t2004r1551b2060],
23	(	NN	O	(	dep	15	SENT_50	[p4l1620t1999r1904b2073],
24	278	CD	PERCENT	278	number	25	SENT_50	[p4l1620t1999r1904b2073],
25	%	NN	PERCENT	%	num	26	SENT_50	[p4l1620t1999r1904b2073],
26	)	CD	NUMBER	)	dep	23	SENT_50	[p4l1620t1999r1904b2073],
27	.	.	O	.	_	0	SENT_50	[p4l1620t1999r1904b2073],

1	Most	JJS	O	most	amod	2	SENT_51	[p4l1969t2004r2142b2060],
2	patients	NNS	O	patient	nsubj	3	SENT_51	[p4l9t2106r273b2183],
3	underwent	VBD	O	undergo	ccomp	19	SENT_51	[p4l311t2104r674b2165],
4	ASCT	NNP	ORGANIZATION	ASCT	dobj	3	SENT_51	[p4l709t2107r909b2165],
5	and	CC	O	and	_	0	SENT_51	[p4l948t2104r1072b2165],
6	1	CD	DURATION	1	num	7	SENT_51	[p4l1116t2110r1139b2164],
7	month	NN	NUMBER	month	dobj	3	SENT_51	[p4l1177t2104r1404b2165],
8	after	IN	O	after	_	0	SENT_51	[p4l1442t2104r1592b2165],
9	ﬁrst	JJ	O	ﬁrst	amod	10	SENT_51	[p4l1629t2104r1760b2165],
10	transplantation	NN	O	transplantation	prep_after	3	SENT_51	[p4l1796t2104r2139b2183, p4l9t2210r226b2278],
11	,	,	O	,	_	0	SENT_51	[p4l1796t2104r2139b2183, p4l9t2210r226b2278],
12	the	DT	O	the	det	13	SENT_51	[p4l256t2208r360b2269],
13	response	NN	O	response	nsubjpass	19	SENT_51	[p4l390t2229r681b2287],
14	of	IN	O	of	_	0	SENT_51	[p4l711t2208r785b2269],
15	99	CD	NUMBER	99	num	17	SENT_51	[p4l806t2214r880b2269],
16	valuable	JJ	O	valuable	amod	17	SENT_51	[p4l909t2208r1186b2269],
17	individuals	NNS	O	individual	prep_of	13	SENT_51	[p4l1215t2208r1586b2269],
18	was	VBD	O	be	auxpass	19	SENT_51	[p4l1615t2229r1737b2269],
19	categorised	VBN	O	categorise	_	0	SENT_51	[p4l1767t2208r2142b2288],
20	in	IN	O	in	_	0	SENT_51	[p4l10t2313r75b2372],
21	two	CD	NUMBER	two	num	22	SENT_51	[p4l105t2323r228b2372],
22	classes	NNS	O	class	prep_in	19	SENT_51	[p4l262t2311r492b2372],
23	:	:	O	:	_	0	SENT_51	[p4l262t2311r492b2372],
24	improved	VBN	O	improve	amod	26	SENT_51	[p4l527t2311r854b2391],
25	(	CD	NUMBER	(	num	26	SENT_51	[p4l890t2312r1024b2385],
26	CR	NN	O	cr	dobj	19	SENT_51	[p4l890t2312r1024b2385],
27	+	CC	O	+	_	0	SENT_51	[p4l1055t2326r1099b2372],
28	PR	NN	O	pr	dobj	19	SENT_51	[p4l1134t2316r1232b2372],
29	=	JJ	O	=	dep	28	SENT_51	[p4l1264t2340r1320b2360],
30	687	CD	PERCENT	687	num	31	SENT_51	[p4l1355t2312r1588b2385],
31	%	NN	PERCENT	%	iobj	29	SENT_51	[p4l1355t2312r1588b2385],
32	)	CD	NUMBER	)	dobj	29	SENT_51	[p4l1355t2312r1588b2385],
33	versus	CC	O	versus	cc	32	SENT_51	[p4l1625t2333r1820b2372],
34	stable	JJ	O	stable	amod	32	SENT_51	[p4l1851t2311r2039b2372],
35	or	CC	O	or	_	0	SENT_51	[p4l2072t2333r2143b2372],
36	progressed	VBD	O	progress	conj_or	19	SENT_51	[p4l9t2416r370b2496],
37	(	CD	NUMBER	(	num	38	SENT_51	[p4l432t2416r556b2490],
38	SD	NN	O	sd	dobj	36	SENT_51	[p4l432t2416r556b2490],
39	+	CC	O	+	_	0	SENT_51	[p4l591t2431r635b2476],
40	PD	NN	O	pd	dobj	36	SENT_51	[p4l669t2421r772b2476],
41	=	JJ	O	=	rcmod	40	SENT_51	[p4l809t2445r865b2465],
42	31-3	CD	PERCENT	31-3	num	43	SENT_51	[p4l900t2416r1155b2490],
43	%	NN	PERCENT	%	iobj	41	SENT_51	[p4l900t2416r1155b2490],
44	)	CD	NUMBER	)	dobj	41	SENT_51	[p4l900t2416r1155b2490],
45	.	.	O	.	_	0	SENT_51	[p4l900t2416r1155b2490],

1	The	DT	O	the	det	3	SENT_52	[p4l1215t2416r1343b2477],
2	genotype	NN	O	genotype	nn	3	SENT_52	[p4l1401t2428r1704b2496],
3	frequencies	NNS	O	frequency	nsubj	4	SENT_52	[p4l1763t2416r2141b2496],
4	obtained	VBN	O	obtain	_	0	SENT_52	[p4l10t2520r305b2581],
5	(	JJ	O	(	amod	7	SENT_52	[p4l365t2520r615b2593],
6	33/115	CD	NUMBER	33/115	tmod	5	SENT_52	[p4l365t2520r615b2593],
7	C/C	NN	O	c/c	dobj	4	SENT_52	[p4l675t2523r826b2590],
8	;	:	O	;	_	0	SENT_52	[p4l675t2523r826b2590],
9	55/115	CD	NUMBER	55/115	num	10	SENT_52	[p4l886t2523r1107b2583],
10	C/T	NN	O	c/t	dep	7	SENT_52	[p4l1167t2522r1314b2590],
11	;	:	O	;	_	0	SENT_52	[p4l1167t2522r1314b2590],
12	27/115	CD	NUMBER	27/115	num	14	SENT_52	[p4l1372t2523r1595b2583],
13	T/T	NN	O	t/t	nn	14	SENT_52	[p4l1653t2520r1805b2593],
14	)	NN	O	)	nsubj	15	SENT_52	[p4l1653t2520r1805b2593],
15	were	VBD	O	be	parataxis	4	SENT_52	[p4l1864t2541r2021b2581],
16	in	IN	O	in	_	0	SENT_52	[p4l2077t2522r2142b2580],
17	agreement	NN	O	agreement	prep_in	15	SENT_52	[p4l10t2635r359b2703],
18	with	IN	O	with	_	0	SENT_52	[p4l388t2623r539b2684],
19	Hardy	NNP	PERSON	Hardy	prep_with	17	SENT_52	[p4l570t2623r1155b2703],
20	.	.	O	.	_	0	SENT_52	[p4l570t2623r1155b2703],

1	—	NN	O	—	_	0	SENT_53	[p4l570t2623r1155b2703],
2	.	.	O	.	_	0	SENT_53	[p4l570t2623r1155b2703],

1	Weinberg	NNP	PERSON	Weinberg	_	0	SENT_54	[p4l570t2623r1155b2703],
2	equilibrium	NN	O	equilibrium	dep	1	SENT_54	[p4l1187t2623r1601b2702],
3	.	.	O	.	_	0	SENT_54	[p4l1187t2623r1601b2702],

1	Survival	NN	O	survival	nn	2	SENT_55	[p4l94t2727r364b2788],
2	analysis	NN	O	analysis	nsubjpass	5	SENT_55	[p4l406t2727r662b2807],
3	could	MD	O	could	aux	5	SENT_55	[p4l705t2727r892b2788],
4	be	VB	O	be	auxpass	5	SENT_55	[p4l931t2727r1008b2788],
5	performed	VBN	O	perform	_	0	SENT_55	[p4l1049t2727r1405b2806],
6	on	IN	O	on	_	0	SENT_55	[p4l1448t2748r1533b2788],
7	68	CD	NUMBER	68	num	8	SENT_55	[p4l1575t2732r1650b2788],
8	patients	NNS	O	patient	prep_on	5	SENT_55	[p4l1693t2729r1957b2806],
9	who	WP	O	who	nsubjpass	11	SENT_55	[p4l1997t2727r2140b2788],
10	were	VBD	O	be	auxpass	11	SENT_55	[p4l7t2852r164b2891],
11	exposed	VBN	O	expose	rcmod	8	SENT_55	[p4l219t2830r488b2910],
12	to	TO	O	to	_	0	SENT_55	[p4l539t2842r605b2891],
13	DAV	NN	O	dav	nn	14	SENT_55	[p4l661t2834r831b2891],
14	therapy	NN	O	therapy	prep_to	11	SENT_55	[p4l882t2830r1139b2910],
15	and	CC	O	and	_	0	SENT_55	[p4l1190t2830r1313b2891],
16	tandem	JJ	O	tandem	amod	17	SENT_55	[p4l1365t2830r1621b2891],
17	ASCT	NN	O	asct	conj_and	14	SENT_55	[p4l1671t2833r1871b2892],
18	(	CD	NUMBER	(	number	19	SENT_55	[p4l1930t2830r2139b2904],
19	54/68	CD	NUMBER	54/68	num	20	SENT_55	[p4l1930t2830r2139b2904],
20	patients	NNS	O	patient	dep	14	SENT_55	[p4l9t2935r299b3014],
21	)	CD	NUMBER	)	dep	20	SENT_55	[p4l9t2935r299b3014],
22	or	CC	O	or	_	0	SENT_55	[p4l351t2957r422b2996],
23	single	JJ	O	single	amod	24	SENT_55	[p4l467t2935r656b3015],
24	ASCT	NN	O	asct	conj_or	14	SENT_55	[p4l699t2937r899b2996],
25	(	CD	NUMBER	(	number	26	SENT_55	[p4l948t2935r1158b3009],
26	14/68	CD	NUMBER	14/68	num	27	SENT_55	[p4l948t2935r1158b3009],
27	patients	NNS	O	patient	dep	24	SENT_55	[p4l1205t2935r1518b3014],
28	)	CD	NUMBER	)	dep	24	SENT_55	[p4l1205t2935r1518b3014],
29	.	.	O	.	_	0	SENT_55	[p4l1205t2935r1518b3014],

1	Our	PRP$	O	we	poss	3	SENT_56	[p4l1568t2938r1704b2996],
2	preliminary	JJ	O	preliminary	amod	3	SENT_56	[p4l1747t2935r2145b3015],
3	data	NNS	O	datum	nsubj	4	SENT_56	[p4l10t3039r152b3100],
4	showed	VBD	O	show	_	0	SENT_56	[p4l192t3039r444b3100],
5	a	DT	O	a	det	7	SENT_56	[p4l485t3060r518b3100],
6	mean	JJ	O	mean	amod	7	SENT_56	[p4l558t3060r742b3100],
7	OS	NN	O	os	nsubj	11	SENT_56	[p4l783t3042r881b3100],
8	of	IN	O	of	_	0	SENT_56	[p4l924t3039r998b3100],
9	44	CD	DURATION	44	num	10	SENT_56	[p4l1028t3045r1105b3099],
10	months	NNS	NUMBER	month	prep_of	7	SENT_56	[p4l1137t3039r1393b3100],
11	(	VBP	O	(	ccomp	4	SENT_56	[p4l1439t3039r1624b3112],
12	6-60	CD	NUMBER	6-60	num	13	SENT_56	[p4l1439t3039r1624b3112],
13	months	NNS	NUMBER	month	tmod	11	SENT_56	[p4l1658t3039r1962b3112],
14	)	RB	O	)	advmod	11	SENT_56	[p4l1658t3039r1962b3112],
15	.	.	O	.	_	0	SENT_56	[p4l1658t3039r1962b3112],

1	Our	PRP$	O	we	poss	2	SENT_57	[p4l2007t3042r2143b3100],
2	data	NNS	O	datum	nsubj	3	SENT_57	[p4l10t3141r152b3202],
3	suggested	VBD	O	suggest	dep	14	SENT_57	[p4l195t3141r515b3222],
4	a	DT	O	a	dep	5	SENT_57	[p4l560t3163r594b3202],
5	longer	RBR	O	longer	advmod	3	SENT_57	[p4l635t3141r849b3222],
6	OS	NNP	O	OS	tmod	3	SENT_57	[p4l893t3145r991b3203],
7	for	IN	O	for	_	0	SENT_57	[p4l1036t3141r1132b3202],
8	patients	NNS	O	patient	prep_for	3	SENT_57	[p4l1175t3143r1439b3221],
9	with	IN	O	with	_	0	SENT_57	[p4l1482t3141r1631b3202],
10	C/T	NN	O	c/t	nn	13	SENT_57	[p4l1676t3144r1805b3205],
11	and	CC	O	and	_	0	SENT_57	[p4l1849t3141r1973b3202],
12	T/T	NN	O	t/t	conj_and	10	SENT_57	[p4l2016t3144r2142b3205],
13	genotypes	NNS	O	genotype	prep_with	8	SENT_57	[p4l10t3258r342b3326],
14	(	VBP	O	(	_	0	SENT_57	[p4l392t3246r522b3326],
15	Fig	NN	O	fig	dobj	14	SENT_57	[p4l392t3246r522b3326],
16	1	CD	NUMBER	1	num	15	SENT_57	[p4l559t3253r607b3317],
17	;	:	O	;	_	0	SENT_57	[p4l559t3253r607b3317],
18	P	NN	O	p	dep	15	SENT_57	[p4l651t3251r700b3306],
19	=	JJ	O	=	amod	18	SENT_57	[p4l731t3275r787b3295],
20	0-02	CD	NUMBER	0-02	tmod	19	SENT_57	[p4l822t3252r975b3317],
21	,	,	O	,	_	0	SENT_57	[p4l822t3252r975b3317],
22	log-rank	JJ	O	log-rank	amod	24	SENT_57	[p4l1021t3246r1309b3326],
23	test	NN	O	test	nn	24	SENT_57	[p4l1351t3246r1492b3320],
24	)	NN	O	)	appos	15	SENT_57	[p4l1351t3246r1492b3320],
25	that	WDT	O	that	nsubj	27	SENT_57	[p4l1541t3246r1674b3307],
26	also	RB	O	also	advmod	27	SENT_57	[p4l1718t3246r1843b3307],
27	showed	VBD	O	show	rcmod	24	SENT_57	[p4l1891t3246r2142b3307],
28	a	DT	O	a	det	30	SENT_57	[p4l10t3372r44b3411],
29	higher	JJR	O	higher	amod	30	SENT_57	[p4l75t3350r289b3430],
30	percentage	NN	O	percentage	dobj	27	SENT_57	[p4l320t3362r680b3430],
31	of	IN	O	of	_	0	SENT_57	[p4l713t3350r787b3411],
32	survivors	NNS	O	survivor	prep_of	30	SENT_57	[p4l810t3352r1116b3411],
33	compared	VBN	O	compare	_	0	SENT_57	[p4l1150t3350r1487b3429],
34	with	IN	O	with	prepc_compared_with	27	SENT_57	[p4l1516t3350r1666b3411],
35	patients	NNS	O	patient	pobj	27	SENT_57	[p4l1697t3352r1961b3429],
36	with	IN	O	with	_	0	SENT_57	[p4l1992t3350r2142b3411],
37	C/C	NN	O	c/c	nn	38	SENT_57	[p4l11t3457r144b3518],
38	genotype	NN	O	genotype	prep_with	35	SENT_57	[p4l175t3466r479b3534],
39	(	CD	NUMBER	(	num	40	SENT_57	[p4l514t3454r676b3528],
40	80-4	CD	NUMBER	80-4	nsubj	14	SENT_57	[p4l514t3454r676b3528],
41	vs	CC	O	vs	_	0	SENT_57	[p4l705t3476r772b3515],
42	545	CD	PERCENT	545	num	43	SENT_57	[p4l805t3459r1028b3524],
43	%	NN	PERCENT	%	conj_vs	40	SENT_57	[p4l805t3459r1028b3524],
44	,	,	O	,	_	0	SENT_57	[p4l805t3459r1028b3524],
45	P	NN	O	p	appos	40	SENT_57	[p4l1060t3458r1107b3514],
46	=	JJ	O	=	amod	48	SENT_57	[p4l1139t3482r1195b3503],
47	0-03	CD	NUMBER	0-03	tmod	46	SENT_57	[p4l1229t3454r1414b3528],
48	)	NN	O	)	dep	45	SENT_57	[p4l1229t3454r1414b3528],
49	.	.	O	.	_	0	SENT_57	[p4l1229t3454r1414b3528],

1	The	DT	O	the	det	7	SENT_58	[p4l1447t3454r1574b3515],
2	adjusted	JJ	O	adjusted	amod	7	SENT_58	[p4l1607t3454r1887b3534],
3	hazard	NN	O	hazard	nn	7	SENT_58	[p4l1916t3454r2142b3515],
4	ratio	NN	O	ratio	nn	7	SENT_58	[p4l10t3560r165b3619],
5	(	CD	NUMBER	(	num	7	SENT_58	[p4l211t3558r377b3632],
6	HR	NN	DURATION	hr	nn	7	SENT_58	[p4l211t3558r377b3632],
7	)	NN	O	)	nsubj	13	SENT_58	[p4l211t3558r377b3632],
8	was	VBD	O	be	cop	13	SENT_58	[p4l421t3579r542b3619],
9	0-12	CD	PERCENT	0-12	num	13	SENT_58	[p4l583t3564r717b3619],
10	(	CD	PERCENT	(	number	11	SENT_58	[p4l763t3558r936b3632],
11	95	CD	PERCENT	95	dep	12	SENT_58	[p4l763t3558r936b3632],
12	%	NN	PERCENT	%	dep	13	SENT_58	[p4l763t3558r936b3632],
13	CI	NN	O	ci	_	0	SENT_58	[p4l978t3561r1075b3628],
14	,	,	O	,	_	0	SENT_58	[p4l978t3561r1075b3628],
15	0-02-0-59	CD	NUMBER	0-02-0-59	num	16	SENT_58	[p4l1117t3558r1484b3631],
16	)	NN	O	)	appos	13	SENT_58	[p4l1117t3558r1484b3631],
17	,	,	O	,	_	0	SENT_58	[p4l1117t3558r1484b3631],
18	taking	VBG	O	take	partmod	13	SENT_58	[p4l1524t3558r1734b3638],
19	in	RP	O	in	prt	18	SENT_58	[p4l1773t3560r1838b3618],
20	account	NN	O	account	nn	21	SENT_58	[p4l1878t3570r2143b3619],
21	age	NN	O	age	dobj	18	SENT_58	[p4l10t3683r135b3742],
22	,	,	O	,	_	0	SENT_58	[p4l10t3683r135b3742],
23	sex	NN	O	sex	nn	28	SENT_58	[p4l177t3683r295b3732],
24	,	,	O	,	_	0	SENT_58	[p4l177t3683r295b3732],
25	chemotherapy	NN	O	chemotherapy	nn	28	SENT_58	[p4l338t3661r821b3741],
26	and	CC	O	and	_	0	SENT_58	[p4l859t3661r982b3722],
27	ASCT	NN	ORGANIZATION	asct	nn	28	SENT_58	[p4l1019t3664r1219b3723],
28	response	NN	O	response	nsubjpass	37	SENT_58	[p4l1258t3683r1568b3741],
29	,	,	O	,	_	0	SENT_58	[p4l1258t3683r1568b3741],
30	whether	IN	O	whether	dep	32	SENT_58	[p4l1607t3661r1880b3722],
31	or	CC	O	or	dep	32	SENT_58	[p4l1920t3683r1991b3722],
32	not	RB	O	not	dep	28	SENT_58	[p4l2030t3673r2142b3722],
33	a	DT	DURATION	a	det	35	SENT_58	[p5l10t41r44b80],
34	second	JJ	DURATION	second	amod	35	SENT_58	[p5l70t19r300b80],
35	ASCT	NN	O	asct	dep	32	SENT_58	[p5l323t22r523b80],
36	was	VBD	O	be	auxpass	37	SENT_58	[p5l546t41r668b80],
37	performed	VBN	O	perform	conj_and	13	SENT_58	[p5l693t19r1050b98],
38	and	CC	O	and	_	0	SENT_58	[p5l1077t19r1200b80],
39	traditional	JJ	O	traditional	amod	40	SENT_58	[p5l1224t19r1580b80],
40	factors	NNS	O	factor	nsubj	41	SENT_58	[p5l1606t19r1828b80],
41	involved	VBN	O	involve	conj_and	13	SENT_58	[p5l1855t19r2142b80],

1	Short	NNP	O	Short	nn	2	SENT_59	[p5l1697t369r1883b434],
2	Report	NNP	O	Report	_	0	SENT_59	[p5l1920t373r2151b451],

1	1-O0	CD	NUMBER	1-o0	num	3	SENT_60	[p5l119t604r166b720],
2	Overall	JJ	O	overall	amod	3	SENT_60	[p5l30t1163r79b1357],
3	survival	NN	O	survival	_	0	SENT_60	[p5l31t928r78b1139],
4	0-60	CD	NUMBER	0-60	num	5	SENT_60	[p5l119t1269r166b1390],
5	0-80	CD	NUMBER	0-80	dep	3	SENT_60	[p5l119t936r166b1057],

1	o	NN	O	o	_	0	SENT_61	[p5l119t1602r166b1633],
2	‘	CD	NUMBER	‘	num	1	SENT_61	[p5l119t1637r165b1684],
3	I	PRP	O	I	nsubj	4	SENT_61	[p5l119t1637r165b1684],
4	’	VBP	O	’	rcmod	1	SENT_61	[p5l119t1637r165b1684],
5	o	NN	O	o	dobj	4	SENT_61	[p5l119t1691r166b1722],

1	Months	NNS	DURATION	month	_	0	SENT_62	[p5l1046t1804r1249b1851],

1	Observed	VBN	O	observe	_	0	SENT_63	[p5l433t1904r679b1947],
2	:	:	O	:	_	0	SENT_63	[p5l433t1904r679b1947],
3	MDR_C3435T	NN	O	mdr_c3435t	dep	1	SENT_63	[p5l699t1904r1045b1952],
4	=	JJ	O	=	amod	3	SENT_63	[p5l1062t1923r1091b1940],
5	1	CD	NUMBER	1	number	6	SENT_63	[p5l1113t1906r1127b1946],
6	_	CD	NUMBER	_	dep	4	SENT_63	[p5l1195t1934r1227b1940],
7	_	NN	O	_	nsubj	11	SENT_63	[p5l1241t1934r1273b1940],
8	_	CD	NUMBER	_	num	7	SENT_63	[p5l1288t1934r1319b1940],
9	_	SYM	O	_	dep	11	SENT_63	[p5l1334t1934r1365b1940],
10	-	:	O	-	_	0	SENT_63	[p5l1380t1934r1396b1940],
11	Observed	VBN	O	observe	rcmod	3	SENT_63	[p5l1430t1904r1676b1947],
12	:	:	O	:	_	0	SENT_63	[p5l1430t1904r1676b1947],
13	MDR_C3435T	NN	O	mdr_c3435t	dep	3	SENT_63	[p5l1696t1904r2042b1952],
14	=	JJ	O	=	amod	13	SENT_63	[p5l2059t1923r2087b1940],
15	2	CD	NUMBER	2	number	16	SENT_63	[p5l2106t1906r2133b1946],
16	.....	CD	NUMBER	.....	num	17	SENT_63	[p5l198t2008r354b2014],
17	....	NN	O	....	dep	13	SENT_63	[p5l198t2008r354b2014],
18	.	.	O	.	_	0	SENT_63	[p5l364t2008r391b2014],

1	.	.	O	.	_	0	SENT_64	[p5l364t2008r391b2014],

1	Predicted	VBN	O	predict	_	0	SENT_65	[p5l435t1979r673b2020],
2	:	:	O	:	_	0	SENT_65	[p5l435t1979r673b2020],
3	MDR_C3435T	NN	O	mdr_c3435t	dobj	1	SENT_65	[p5l693t1978r1038b2026],
4	=	JJ	O	=	advmod	7	SENT_65	[p5l1056t1997r1084b2014],
5	1	CD	NUMBER	1	num	6	SENT_65	[p5l1106t1980r1121b2020],
6	*	CD	NUMBER	*	dep	4	SENT_65	[p5l1195t2008r1396b2014],
7	Predicted	VBN	O	predict	partmod	3	SENT_65	[p5l1432t1979r1670b2020],
8	:	:	O	:	_	0	SENT_65	[p5l1432t1979r1670b2020],
9	MDR_C3435T	NN	O	mdr_c3435t	dep	3	SENT_65	[p5l1690t1978r2035b2026],
10	=	JJ	O	=	amod	9	SENT_65	[p5l2053t1997r2081b2014],
11	2	CD	NUMBER	2	tmod	10	SENT_65	[p5l2099t1980r2126b2020],

1	Fig	NN	O	fig	_	0	SENT_66	[p5l9t2143r103b2214],
2	1	CD	NUMBER	1	dep	1	SENT_66	[p5l134t2147r178b2197],
3	.	.	O	.	_	0	SENT_66	[p5l134t2147r178b2197],

1	Kaplan	NNP	PERSON	Kaplan	_	0	SENT_67	[p5l221t2142r648b2213],
2	.	.	O	.	_	0	SENT_67	[p5l221t2142r648b2213],

1	—	NN	O	—	_	0	SENT_68	[p5l221t2142r648b2213],
2	.	.	O	.	_	0	SENT_68	[p5l221t2142r648b2213],

1	Meier	NNP	PERSON	Meier	nn	2	SENT_69	[p5l221t2142r648b2213],
2	plot	NN	O	plot	_	0	SENT_69	[p5l695t2142r815b2213],
3	for	IN	O	for	_	0	SENT_69	[p5l863t2142r949b2197],
4	overall	JJ	O	overall	amod	5	SENT_69	[p5l998t2142r1198b2197],
5	survival	NN	O	survival	prep_for	2	SENT_69	[p5l1247t2142r1479b2197],
6	at	IN	O	at	_	0	SENT_69	[p5l1528t2153r1581b2197],
7	60	CD	DURATION	60	num	8	SENT_69	[p5l1630t2147r1697b2197],
8	months	NNS	NUMBER	month	prep_at	2	SENT_69	[p5l1727t2142r1955b2197],
9	from	IN	O	from	_	0	SENT_69	[p5l2004t2141r2152b2197],
10	multiple	JJ	O	multiple	amod	12	SENT_69	[p5l8t2234r261b2304],
11	myeloma	NN	O	myeloma	nn	12	SENT_69	[p5l298t2234r575b2305],
12	diagnosis	NN	O	diagnosis	prep_from	2	SENT_69	[p5l612t2234r889b2305],
13	according	VBG	O	accord	_	0	SENT_69	[p5l927t2234r1222b2305],
14	to	TO	O	to	prepc_according_to	2	SENT_69	[p5l1258t2244r1317b2288],
15	MDR1	NN	O	mdr1	nn	17	SENT_69	[p5l1353t2238r1546b2288],
16	C3435T	NN	O	c3435t	nn	17	SENT_69	[p5l1591t2236r1826b2288],
17	genotype	NN	O	genotype	pobj	2	SENT_69	[p5l1863t2244r2148b2305],
18	.	.	O	.	_	0	SENT_69	[p5l1863t2244r2148b2305],

1	MDR_C3435T	NN	O	mdr_c3435t	nsubj	4	SENT_70	[p5l8t2328r452b2389],
2	=	JJ	O	=	amod	1	SENT_70	[p5l481t2351r531b2370],
3	1	CD	NUMBER	1	tmod	2	SENT_70	[p5l568t2331r589b2380],
4	includes	VBZ	O	include	_	0	SENT_70	[p5l647t2325r893b2380],
5	MDR1	NN	O	mdr1	nn	7	SENT_70	[p5l943t2330r1136b2380],
6	C/C	NN	O	c/c	nn	7	SENT_70	[p5l1195t2328r1315b2383],
7	genotypes	NNS	O	genotype	nsubj	8	SENT_70	[p5l1367t2336r1663b2398],
8	(	VBP	O	(	ccomp	4	SENT_70	[p5l1720t2325r1780b2392],
9	n	NN	O	n	dobj	8	SENT_70	[p5l1720t2325r1780b2392],
10	=	JJ	O	=	amod	9	SENT_70	[p5l1810t2351r1861b2370],
11	22	CD	NUMBER	22	tmod	10	SENT_70	[p5l1892t2325r1983b2392],
12	)	NN	O	)	nsubj	17	SENT_70	[p5l1892t2325r1983b2392],
13	and	CC	O	and	_	0	SENT_70	[p5l2042t2325r2152b2380],
14	MDR1_C3435T	NN	O	mdr1_c3435t	conj_and	12	SENT_70	[p5l8t2420r487b2480],
15	=	JJ	O	=	amod	12	SENT_70	[p5l516t2443r567b2461],
16	2	CD	NUMBER	2	tmod	15	SENT_70	[p5l598t2423r629b2471],
17	includes	VBZ	O	include	rcmod	9	SENT_70	[p5l652t2418r898b2472],
18	MDR1	NN	O	mdr1	nn	19	SENT_70	[p5l917t2422r1111b2472],
19	C/T	NN	O	c/t	nsubj	23	SENT_70	[p5l1139t2420r1254b2474],
20	and	CC	O	and	_	0	SENT_70	[p5l1276t2418r1387b2472],
21	T/T	NN	O	t/t	nn	22	SENT_70	[p5l1408t2420r1520b2474],
22	genotypes	NNS	O	genotype	conj_and	19	SENT_70	[p5l1542t2428r1839b2489],
23	(	VBP	O	(	ccomp	17	SENT_70	[p5l1865t2418r1924b2483],
24	n	NN	O	n	dobj	23	SENT_70	[p5l1865t2418r1924b2483],
25	=	JJ	O	=	advmod	23	SENT_70	[p5l1955t2443r2006b2461],
26	46	CD	NUMBER	46	num	27	SENT_70	[p5l2036t2418r2149b2484],
27	)	NN	O	)	dep	25	SENT_70	[p5l2036t2418r2149b2484],
28	.	.	O	.	_	0	SENT_70	[p5l2036t2418r2149b2484],

1	in	IN	O	in	_	0	SENT_71	[p5l9t2661r74b2720],
2	MM	NN	O	mm	nn	3	SENT_71	[p5l134t2664r282b2720],
3	prognosis	NN	O	prognosis	pobj	1	SENT_71	[p5l343t2661r688b2741],
4	.	.	O	.	_	0	SENT_71	[p5l343t2661r688b2741],

1	DAV	NN	O	dav	nn	2	SENT_72	[p5l752t2663r923b2721],
2	response	NN	O	response	nsubj	3	SENT_72	[p5l983t2681r1275b2740],
3	showed	VBD	O	show	_	0	SENT_72	[p5l1336t2659r1589b2721],
4	a	DT	O	a	det	7	SENT_72	[p5l1650t2682r1684b2721],
5	border	NN	O	border	nn	7	SENT_72	[p5l1741t2659r1970b2721],
6	line	NN	O	line	nn	7	SENT_72	[p5l2028t2659r2151b2721],
7	association	NN	O	association	dobj	3	SENT_72	[p5l9t2767r381b2827],
8	with	IN	O	with	_	0	SENT_72	[p5l423t2765r574b2827],
9	a	DT	O	a	det	11	SENT_72	[p5l620t2787r653b2827],
10	shorter	JJR	O	shorter	amod	11	SENT_72	[p5l698t2765r937b2827],
11	OS	NN	O	os	prep_with	3	SENT_72	[p5l983t2768r1081b2827],
12	(	CD	NUMBER	(	num	13	SENT_72	[p5l1132t2765r1274b2840],
13	OR	NN	O	or	dep	11	SENT_72	[p5l1132t2765r1274b2840],
14	=	JJ	O	=	amod	13	SENT_72	[p5l1306t2794r1363b2814],
15	3-66	CD	NUMBER	3-66	tmod	14	SENT_72	[p5l1398t2771r1552b2836],
16	;	:	O	;	_	0	SENT_72	[p5l1398t2771r1552b2836],
17	1-01-13-35	CD	DATE	1-01-13-35	number	18	SENT_72	[p5l1606t2765r1985b2839],
18	)	CD	NUMBER	)	dep	11	SENT_72	[p5l1606t2765r1985b2839],
19	i.e.	FW	O	i.e.	dep	18	SENT_72	[p5l2036t2767r2149b2837],
20	,	,	O	,	_	0	SENT_72	[p5l2036t2767r2149b2837],
21	non	JJ	O	non	amod	23	SENT_72	[p5l8t2869r543b2948],
22	—	NN	O	—	nn	23	SENT_72	[p5l8t2869r543b2948],
23	responders	NNS	O	responder	prep_with	3	SENT_72	[p5l8t2869r543b2948],
24	were	VBD	O	be	cop	26	SENT_72	[p5l579t2890r737b2930],
25	more	RBR	O	more	advmod	26	SENT_72	[p5l774t2890r951b2930],
26	likely	JJ	O	likely	rcmod	23	SENT_72	[p5l987t2869r1168b2949],
27	to	TO	O	to	aux	28	SENT_72	[p5l1201t2881r1267b2930],
28	have	VB	O	have	xcomp	26	SENT_72	[p5l1305t2869r1459b2930],
29	a	DT	O	a	det	31	SENT_72	[p5l1497t2891r1531b2930],
30	shorter	JJR	O	shorter	amod	31	SENT_72	[p5l1568t2869r1807b2930],
31	OS	NN	O	os	dobj	28	SENT_72	[p5l1845t2872r1963b2939],
32	;	:	O	;	_	0	SENT_72	[p5l1845t2872r1963b2939],
33	also	RB	O	also	advmod	28	SENT_72	[p5l2003t2869r2149b2939],
34	,	,	O	,	_	0	SENT_72	[p5l2003t2869r2149b2939],
35	haemoglobin	NN	O	haemoglobin	nn	37	SENT_72	[p5l8t2973r452b3055],
36	(	NN	O	(	nn	37	SENT_72	[p5l484t2974r626b3048],
37	OR	NN	O	or	prep_with	3	SENT_72	[p5l484t2974r626b3048],
38	=	JJ	O	=	amod	37	SENT_72	[p5l659t3002r715b3023],
39	011	CD	NUMBER	011	tmod	38	SENT_72	[p5l750t2980r905b3045],
40	;	:	O	;	_	0	SENT_72	[p5l750t2980r905b3045],
41	002-061	CD	NUMBER	002-061	num	42	SENT_72	[p5l934t2974r1278b3048],
42	)	NN	O	)	prep_with	3	SENT_72	[p5l934t2974r1278b3048],
43	and	CC	O	and	_	0	SENT_72	[p5l1312t2974r1436b3036],
44	beta2	NN	O	beta2	nn	45	SENT_72	[p5l1460t2974r1639b3035],
45	microglobulin	NN	O	microglobulin	prep_with	3	SENT_72	[p5l1668t2973r2151b3055],
46	(	CD	NUMBER	(	num	47	SENT_72	[p5l14t3079r156b3154],
47	OR	NN	O	or	dep	45	SENT_72	[p5l14t3079r156b3154],
48	=	JJ	O	=	amod	47	SENT_72	[p5l188t3108r244b3128],
49	46	CD	NUMBER	46	tmod	48	SENT_72	[p5l278t3085r375b3150],
50	;	:	O	;	_	0	SENT_72	[p5l278t3085r375b3150],
51	57-372	CD	NUMBER	57-372	num	52	SENT_72	[p5l423t3079r708b3153],
52	)	NN	O	)	nsubjpass	54	SENT_72	[p5l423t3079r708b3153],
53	were	VBD	O	be	auxpass	54	SENT_72	[p5l755t3101r913b3141],
54	associated	VBN	O	associate	parataxis	3	SENT_72	[p5l958t3079r1297b3141],
55	with	IN	O	with	_	0	SENT_72	[p5l1339t3079r1490b3141],
56	OS	NN	O	os	nn	58	SENT_72	[p5l1535t3082r1633b3141],
57	(	CD	NUMBER	(	num	58	SENT_72	[p5l1684t3079r1895b3154],
58	Table	NNP	O	Table	prep_with	54	SENT_72	[p5l1684t3079r1895b3154],
59	I	PRP	O	I	nsubj	60	SENT_72	[p5l1927t3079r2000b3153],
60	)	VBP	O	)	rcmod	58	SENT_72	[p5l1927t3079r2000b3153],
61	.	.	O	.	_	0	SENT_72	[p5l1927t3079r2000b3153],

1	No	DT	O	no	det	3	SENT_73	[p5l2047t3084r2149b3141],
2	signiﬁcant	JJ	O	signiﬁcant	amod	3	SENT_73	[p5l9t3183r358b3263],
3	association	NN	O	association	nsubj	4	SENT_73	[p5l394t3185r765b3244],
4	was	VBD	O	be	_	0	SENT_73	[p5l799t3204r922b3244],
5	observed	VBN	O	observe	dep	4	SENT_73	[p5l959t3183r1258b3244],
6	between	IN	O	between	_	0	SENT_73	[p5l1291t3183r1569b3244],
7	genotype	NN	O	genotype	nn	8	SENT_73	[p5l1605t3195r1909b3263],
8	distributions	NNS	O	distribution	prep_between	5	SENT_73	[p5l1946t3183r2147b3244, p5l7t3288r263b3349],
9	and	CC	O	and	_	0	SENT_73	[p5l296t3287r421b3349],
10	either	CC	O	either	dep	4	SENT_73	[p5l452t3288r644b3349],
11	DAV	NN	O	dav	nn	14	SENT_73	[p5l676t3291r847b3349],
12	or	CC	O	or	_	0	SENT_73	[p5l877t3310r949b3349],
13	ASCT	NN	ORGANIZATION	asct	conj_or	11	SENT_73	[p5l977t3290r1178b3350],
14	response	NN	O	response	dep	10	SENT_73	[p5l1211t3309r1502b3368],
15	in	IN	O	in	_	0	SENT_73	[p5l1535t3290r1600b3349],
16	the	DT	O	the	det	18	SENT_73	[p5l1630t3287r1735b3349],
17	total	JJ	O	total	amod	18	SENT_73	[p5l1765t3288r1919b3349],
18	group	NN	O	group	prep_in	14	SENT_73	[p5l1950t3309r2149b3369],
19	of	IN	O	of	_	0	SENT_73	[p5l9t3392r84b3453],
20	115	CD	NUMBER	115	num	21	SENT_73	[p5l113t3398r222b3453],
21	patients	NNS	O	patient	prep_of	18	SENT_73	[p5l255t3394r538b3472],
22	.	.	O	.	_	0	SENT_73	[p5l255t3394r538b3472],

1	Discussion	NN	O	discussion	_	0	SENT_74	[p5l14t3642r463b3712],

1	Multidrug	JJ	O	multidrug	amod	2	SENT_75	[p6l8t60r359b142],
2	resistance	NN	O	resistance	nsubjpass	5	SENT_75	[p6l409t63r734b122],
3	was	VBD	O	be	auxpass	5	SENT_75	[p6l783t83r906b122],
4	previously	RB	DATE	previously	advmod	5	SENT_75	[p6l957t60r1310b142],
5	identiﬁed	VBN	O	identiﬁed	_	0	SENT_75	[p6l1357t60r1679b123],
6	as	IN	O	as	_	0	SENT_75	[p6l1731t83r1793b122],
7	an	DT	O	a	det	10	SENT_75	[p6l1845t83r1924b122],
8	independent	JJ	O	independent	amod	10	SENT_75	[p6l1975t61r2147b122, p6l8t165r284b245],
9	prognostic	JJ	O	prognostic	amod	10	SENT_75	[p6l314t167r675b245],
10	factor	NN	O	factor	prep_as	5	SENT_75	[p6l704t165r900b226],
11	for	IN	O	for	_	0	SENT_75	[p6l930t165r1026b226],
12	OS	NNP	O	OS	prep_for	10	SENT_75	[p6l1057t168r1155b226],
13	in	IN	O	in	_	0	SENT_75	[p6l1187t167r1252b225],
14	AML	NN	ORGANIZATION	aml	nn	15	SENT_75	[p6l1279t169r1454b225],
15	patients	NNS	O	patient	prep_in	5	SENT_75	[p6l1483t167r1748b245],
16	(	CD	NUMBER	(	num	17	SENT_75	[p6l1784t165r1956b239],
17	Kim	NNP	PERSON	Kim	dep	15	SENT_75	[p6l1784t165r1956b239],
18	et	FW	O	et	nn	19	SENT_75	[p6l1987t178r2045b226],
19	al	FW	O	al	dep	15	SENT_75	[p6l2073t165r2149b236],
20	,	,	O	,	_	0	SENT_75	[p6l2073t165r2149b236],
21	2005	CD	DATE	2005	appos	19	SENT_75	[p6l9t275r185b339],
22	;	:	O	;	_	0	SENT_75	[p6l9t275r185b339],
23	Schaich	NNP	PERSON	Schaich	dep	19	SENT_75	[p6l222t269r479b330],
24	et	FW	O	et	nn	25	SENT_75	[p6l514t282r573b330],
25	al	FW	O	al	dep	23	SENT_75	[p6l599t269r676b339],
26	,	,	O	,	_	0	SENT_75	[p6l599t269r676b339],
27	2005	CD	DATE	2005	num	28	SENT_75	[p6l711t269r919b343],
28	)	NN	O	)	appos	15	SENT_75	[p6l711t269r919b343],
29	.	.	O	.	_	0	SENT_75	[p6l711t269r919b343],

1	To	TO	O	to	_	0	SENT_76	[p6l955t272r1045b330],
2	our	PRP$	O	we	poss	3	SENT_76	[p6l1082t291r1199b330],
3	knowledge	NN	O	knowledge	prep_to	9	SENT_76	[p6l1230t269r1610b349],
4	,	,	O	,	_	0	SENT_76	[p6l1230t269r1610b349],
5	this	DT	O	this	nsubj	9	SENT_76	[p6l1645t269r1766b330],
6	is	VBZ	O	be	cop	9	SENT_76	[p6l1801t271r1849b330],
7	the	DT	O	the	det	9	SENT_76	[p6l1883t269r1986b330],
8	ﬁrst	NN	O	ﬁrst	nn	9	SENT_76	[p6l2021t269r2152b330],
9	report	NN	O	report	_	0	SENT_76	[p6l9t386r218b454],
10	demonstrating	VBG	O	demonstrate	partmod	9	SENT_76	[p6l258t374r753b455],
11	a	DT	O	a	det	13	SENT_76	[p6l792t396r826b435],
12	predictive	JJ	O	predictive	amod	13	SENT_76	[p6l863t373r1198b454],
13	value	NN	O	value	dobj	10	SENT_76	[p6l1235t374r1412b435],
14	of	IN	O	of	_	0	SENT_76	[p6l1452t373r1526b435],
15	MDR	NN	O	mdr	nn	17	SENT_76	[p6l1552t378r1770b435],
16	]	CD	NUMBER	]	num	17	SENT_76	[p6l1552t378r1770b435],
17	genotypes	NNS	O	genotype	prep_of	13	SENT_76	[p6l1816t386r2150b455],
18	for	IN	O	for	_	0	SENT_76	[p6l9t478r106b539],
19	OS	NN	O	os	prep_for	10	SENT_76	[p6l144t481r242b539],
20	of	IN	O	of	_	0	SENT_76	[p6l282t478r356b539],
21	MM	NN	O	mm	nn	22	SENT_76	[p6l383t483r531b538],
22	patients	NNS	O	patient	prep_of	19	SENT_76	[p6l569t480r852b558],
23	.	.	O	.	_	0	SENT_76	[p6l569t480r852b558],

1	Similar	JJ	O	similar	nsubj	5	SENT_77	[p6l895t478r1136b539],
2	to	TO	O	to	_	0	SENT_77	[p6l1172t490r1238b539],
3	the	DT	O	the	det	4	SENT_77	[p6l1276t478r1380b539],
4	ﬁndings	NNS	O	ﬁndings	prep_to	1	SENT_77	[p6l1418t478r1689b558],
5	reported	VBD	O	report	ccomp	17	SENT_77	[p6l1728t478r2017b558],
6	for	IN	O	for	_	0	SENT_77	[p6l2055t478r2152b539],
7	AML	NN	ORGANIZATION	aml	nn	9	SENT_77	[p6l6t587r181b644],
8	(	CD	NUMBER	(	num	9	SENT_77	[p6l228t583r459b657],
9	Illmer	NNP	O	Illmer	prep_for	5	SENT_77	[p6l228t583r459b657],
10	et	FW	O	et	nn	11	SENT_77	[p6l502t596r561b645],
11	al	FW	O	al	dep	9	SENT_77	[p6l588t583r664b654],
12	,	,	O	,	_	0	SENT_77	[p6l588t583r664b654],
13	2002	CD	DATE	2002	num	14	SENT_77	[p6l709t583r917b657],
14	)	NN	O	)	appos	9	SENT_77	[p6l709t583r917b657],
15	,	,	O	,	_	0	SENT_77	[p6l709t583r917b657],
16	we	PRP	O	we	nsubj	17	SENT_77	[p6l960t605r1051b645],
17	found	VBD	O	find	_	0	SENT_77	[p6l1094t583r1297b645],
18	an	DT	O	a	det	19	SENT_77	[p6l1340t605r1418b645],
19	association	NN	O	association	nsubj	24	SENT_77	[p6l1462t585r1833b645],
20	between	IN	O	between	_	0	SENT_77	[p6l1874t583r2152b645],
21	MDR	NNP	O	MDR	prep_between	19	SENT_77	[p6l6t692r223b749],
22	]	CD	NUMBER	]	num	21	SENT_77	[p6l6t692r223b749],
23	C3435T	NN	O	c3435t	nn	24	SENT_77	[p6l261t690r525b750],
24	polymorphism	NN	O	polymorphism	xcomp	17	SENT_77	[p6l552t687r1055b769],
25	and	CC	O	and	_	0	SENT_77	[p6l1085t688r1209b749],
26	prognosis	NN	O	prognosis	xcomp	17	SENT_77	[p6l1236t690r1564b769],
27	of	IN	O	of	_	0	SENT_77	[p6l1595t687r1669b749],
28	MM	NN	O	mm	nn	29	SENT_77	[p6l1687t692r1835b749],
29	patients	NNS	O	patient	prep_of	24	SENT_77	[p6l1865t690r2149b768],
30	,	,	O	,	_	0	SENT_77	[p6l1865t690r2149b768],
31	for	IN	O	for	_	0	SENT_77	[p6l8t792r106b853],
32	which	WDT	O	which	rel	37	SENT_77	[p6l141t792r345b853],
33	different	JJ	O	different	amod	34	SENT_77	[p6l384t792r671b853],
34	hypotheses	NNS	O	hypothesis	nsubjpass	37	SENT_77	[p6l708t792r1078b872],
35	can	MD	O	can	aux	37	SENT_77	[p6l1118t813r1232b853],
36	be	VB	O	be	auxpass	37	SENT_77	[p6l1268t792r1345b853],
37	suggested	VBN	O	suggest	rcmod	29	SENT_77	[p6l1384t792r1722b872],
38	.	.	O	.	_	0	SENT_77	[p6l1384t792r1722b872],

1	The	DT	O	the	det	5	SENT_78	[p6l1763t792r1891b853],
2	MDR	NN	O	mdr	nn	5	SENT_78	[p6l1927t796r2144b853],
3	]	CD	NUMBER	]	num	5	SENT_78	[p6l1927t796r2144b853],
4	C3435T	NN	O	c3435t	nn	5	SENT_78	[p6l10t899r274b959],
5	polymorphism	NN	O	polymorphism	nsubjpass	8	SENT_78	[p6l347t896r850b978],
6	was	VBD	O	be	auxpass	8	SENT_78	[p6l922t919r1044b958],
7	previously	RB	DATE	previously	advmod	8	SENT_78	[p6l1118t896r1471b978],
8	described	VBN	O	describe	_	0	SENT_78	[p6l1542t896r1861b958],
9	to	TO	O	to	aux	11	SENT_78	[p6l1934t909r2000b958],
10	be	VB	O	be	auxpass	11	SENT_78	[p6l2073t896r2151b958],
11	involved	VBN	O	involve	xcomp	8	SENT_78	[p6l9t1001r297b1062],
12	in	IN	O	in	_	0	SENT_78	[p6l355t1003r420b1061],
13	immunological	JJ	O	immunological	amod	14	SENT_78	[p6l477t1001r992b1081],
14	mechanisms	NNS	O	mechanism	prep_in	11	SENT_78	[p6l1049t1001r1465b1062],
15	that	WDT	O	that	nsubj	17	SENT_78	[p6l1523t1001r1656b1062],
16	may	MD	O	may	aux	17	SENT_78	[p6l1712t1023r1857b1081],
17	modify	VB	O	modify	rcmod	14	SENT_78	[p6l1910t1001r2154b1081],
18	OS	NNP	O	OS	dobj	17	SENT_78	[p6l10t1108r126b1166],
19	.	.	O	.	_	0	SENT_78	[p6l10t1108r126b1166],

1	In	IN	O	in	_	0	SENT_79	[p6l159t1109r229b1165],
2	particular	JJ	O	particular	prep_in	7	SENT_79	[p6l257t1105r605b1184],
3	,	,	O	,	_	0	SENT_79	[p6l257t1105r605b1184],
4	this	DT	O	this	det	5	SENT_79	[p6l635t1105r756b1166],
5	polymorphism	NN	O	polymorphism	nsubjpass	7	SENT_79	[p6l784t1105r1287b1185],
6	was	VBD	O	be	auxpass	7	SENT_79	[p6l1314t1127r1436b1166],
7	linked	VBN	O	link	_	0	SENT_79	[p6l1464t1105r1674b1166],
8	to	TO	O	to	_	0	SENT_79	[p6l1701t1117r1767b1166],
9	the	DT	O	the	det	10	SENT_79	[p6l1797t1105r1901b1166],
10	release	NN	O	release	prep_to	7	SENT_79	[p6l1930t1105r2151b1166],
11	of	IN	O	of	_	0	SENT_79	[p6l9t1209r84b1271],
12	some	DT	O	some	det	13	SENT_79	[p6l110t1232r285b1271],
13	cytokines	NNS	O	cytokine	prep_of	10	SENT_79	[p6l321t1210r654b1291],
14	,	,	O	,	_	0	SENT_79	[p6l321t1210r654b1291],
15	such	JJ	O	such	_	0	SENT_79	[p6l693t1209r845b1271],
16	as	IN	O	as	_	0	SENT_79	[p6l881t1232r943b1271],
17	interleukin-2	NN	O	interleukin-2	prep_such_as	13	SENT_79	[p6l979t1209r1417b1271],
18	and	CC	O	and	_	0	SENT_79	[p6l1457t1210r1581b1272],
19	-4	CD	NUMBER	-4	prep_such_as	13	SENT_79	[p6l1618t1216r1702b1281],
20	,	,	O	,	_	0	SENT_79	[p6l1618t1216r1702b1281],
21	interferon	NN	O	interferon	appos	19	SENT_79	[p6l1739t1209r2151b1288],
22	-	:	O	-	_	0	SENT_79	[p6l1739t1209r2151b1288],
23	*	NN	O	*	nn	24	SENT_79	[p6l1739t1209r2151b1288],
24	y	NN	O	y	dep	19	SENT_79	[p6l1739t1209r2151b1288],
25	and	CC	O	and	_	0	SENT_79	[p6l9t1315r134b1377],
26	tumour	NN	O	tumour	nn	27	SENT_79	[p6l175t1327r436b1377],
27	necrosis	NN	O	necrosis	dep	19	SENT_79	[p6l478t1317r748b1377],
28	factor-or	NN	O	factor-or	nn	30	SENT_79	[p6l791t1315r1065b1377],
29	(	CD	NUMBER	(	num	30	SENT_79	[p6l1111t1315r1365b1390],
30	Pawlik	NNP	PERSON	Pawlik	dep	24	SENT_79	[p6l1111t1315r1365b1390],
31	et	FW	O	et	nn	32	SENT_79	[p6l1406t1328r1465b1377],
32	al	FW	O	al	dep	13	SENT_79	[p6l1492t1315r1568b1386],
33	,	,	O	,	_	0	SENT_79	[p6l1492t1315r1568b1386],
34	2005	CD	DATE	2005	num	35	SENT_79	[p6l1613t1315r1820b1390],
35	)	NN	O	)	appos	32	SENT_79	[p6l1613t1315r1820b1390],
36	.	.	O	.	_	0	SENT_79	[p6l1613t1315r1820b1390],

1	Furthermore	RB	O	furthermore	advmod	12	SENT_80	[p6l1867t1315r2147b1377, p6l8t1441r203b1490],
2	,	,	O	,	_	0	SENT_80	[p6l1867t1315r2147b1377, p6l8t1441r203b1490],
3	a	DT	O	a	det	8	SENT_80	[p6l257t1441r291b1480],
4	drug	NN	O	drug	nn	8	SENT_80	[p6l341t1419r498b1499],
5	efﬂuX	NNP	O	efﬂuX	dep	7	SENT_80	[p6l549t1419r1195b1498],
6	—	CD	NUMBER	—	num	5	SENT_80	[p6l549t1419r1195b1498],
7	independent	JJ	O	independent	amod	8	SENT_80	[p6l549t1419r1195b1498],
8	mechanism	NN	O	mechanism	nsubj	12	SENT_80	[p6l1246t1419r1633b1480],
9	of	IN	O	of	_	0	SENT_80	[p6l1685t1419r1759b1480],
10	conferring	VBG	O	confer	prepc_of	8	SENT_80	[p6l1801t1419r2152b1499],
11	resistance	NN	O	resistance	dobj	10	SENT_80	[p6l9t1526r334b1585],
12	seems	VBZ	O	seem	_	0	SENT_80	[p6l380t1546r575b1585],
13	to	TO	O	to	aux	15	SENT_80	[p6l621t1536r687b1585],
14	be	VB	O	be	auxpass	15	SENT_80	[p6l732t1523r809b1585],
15	mediated	VBN	O	mediate	xcomp	12	SENT_80	[p6l855t1524r1168b1585],
16	by	IN	O	by	_	0	SENT_80	[p6l1211t1524r1294b1605],
17	P	NN	O	p	nn	19	SENT_80	[p6l1337t1528r1513b1605],
18	—	CD	NUMBER	—	num	19	SENT_80	[p6l1337t1528r1513b1605],
19	gp	NN	O	gp	agent	15	SENT_80	[p6l1337t1528r1513b1605],
20	,	,	O	,	_	0	SENT_80	[p6l1337t1528r1513b1605],
21	which	WDT	O	which	nsubj	30	SENT_80	[p6l1559t1523r1763b1585],
22	transports	VBZ	O	transport	rcmod	19	SENT_80	[p6l1807t1536r2150b1604],
23	phospholipids	NNS	O	phospholipid	dobj	22	SENT_80	[p6l8t1628r489b1707],
24	across	IN	O	across	_	0	SENT_80	[p6l524t1649r726b1689],
25	the	DT	O	the	det	27	SENT_80	[p6l760t1628r864b1689],
26	cell	NN	O	cell	nn	27	SENT_80	[p6l898t1628r1007b1689],
27	membrane	NN	O	membrane	prep_across	22	SENT_80	[p6l1039t1628r1402b1689],
28	and	CC	O	and	_	0	SENT_80	[p6l1436t1628r1560b1689],
29	may	MD	O	may	aux	30	SENT_80	[p6l1593t1649r1737b1708],
30	function	VB	O	function	conj_and	22	SENT_80	[p6l1766t1628r2054b1689],
31	as	IN	O	as	_	0	SENT_80	[p6l2088t1649r2151b1689],
32	an	DT	O	a	det	34	SENT_80	[p6l9t1753r88b1793],
33	antiapoptotic	JJ	O	antiapoptotic	amod	34	SENT_80	[p6l121t1734r575b1811],
34	molecule	NN	O	molecule	prep_as	30	SENT_80	[p6l607t1732r911b1793],
35	(	CD	NUMBER	(	num	34	SENT_80	[p6l948t1731r1290b1811],
36	Gollapud	NNP	ORGANIZATION	Gollapud	dep	34	SENT_80	[p6l948t1731r1290b1811],
37	&	CC	ORGANIZATION	&	_	0	SENT_80	[p6l1323t1736r1379b1793],
38	Gupta	NNP	ORGANIZATION	Gupta	conj_and	36	SENT_80	[p6l1410t1735r1636b1811],
39	,	,	O	,	_	0	SENT_80	[p6l1410t1735r1636b1811],
40	2001	CD	DATE	2001	num	41	SENT_80	[p6l1671t1732r1878b1805],
41	)	NN	O	)	appos	34	SENT_80	[p6l1671t1732r1878b1805],
42	.	.	O	.	_	0	SENT_80	[p6l1671t1732r1878b1805],

1	The	DT	O	the	det	3	SENT_81	[p6l91t1836r219b1897],
2	T	NN	O	t	nn	3	SENT_81	[p6l250t1839r298b1896],
3	allele	NN	O	allele	nsubjpass	5	SENT_81	[p6l330t1836r497b1897],
4	is	VBZ	O	be	auxpass	5	SENT_81	[p6l529t1838r577b1897],
5	associated	VBN	O	associate	dep	12	SENT_81	[p6l610t1836r949b1897],
6	with	IN	O	with	_	0	SENT_81	[p6l977t1836r1128b1897],
7	weaker	JJR	O	weaker	amod	8	SENT_81	[p6l1157t1836r1394b1897],
8	expression/activity	NN	O	expression/activity	prep_with	5	SENT_81	[p6l1425t1838r2058b1916],
9	in	IN	O	in	_	0	SENT_81	[p6l2086t1838r2151b1896],
10	lymphoid	JJ	O	lymphoid	amod	11	SENT_81	[p6l7t1940r336b2020],
11	cells	NNS	O	cell	prep_in	8	SENT_81	[p6l367t1940r505b2001],
12	(	VBP	O	(	_	0	SENT_81	[p6l541t1940r913b2014],
13	Iamroziak	NNP	O	Iamroziak	dobj	12	SENT_81	[p6l541t1940r913b2014],
14	et	FW	O	et	nn	15	SENT_81	[p6l942t1953r1001b2001],
15	al	FW	O	al	nsubj	12	SENT_81	[p6l1028t1940r1104b2011],
16	,	,	O	,	_	0	SENT_81	[p6l1028t1940r1104b2011],
17	2004	CD	DATE	2004	num	18	SENT_81	[p6l1137t1940r1344b2014],
18	)	NN	O	)	appos	15	SENT_81	[p6l1137t1940r1344b2014],
19	.	.	O	.	_	0	SENT_81	[p6l1137t1940r1344b2014],

1	Consequently	RB	O	consequently	advmod	9	SENT_82	[p6l1379t1940r1859b2020],
2	,	,	O	,	_	0	SENT_82	[p6l1379t1940r1859b2020],
3	tumour	NN	O	tumour	nn	4	SENT_82	[p6l1891t1952r2152b2001],
4	cells	NNS	O	cell	nsubj	9	SENT_82	[p6l9t2044r148b2106],
5	carrying	VBG	O	carry	partmod	4	SENT_82	[p6l186t2047r462b2126],
6	T	NN	O	t	nn	7	SENT_82	[p6l498t2047r547b2106],
7	allele/s	NNS	O	allele/s	dobj	5	SENT_82	[p6l584t2044r807b2109],
8	would	MD	O	would	aux	9	SENT_82	[p6l843t2044r1056b2107],
9	experience	VB	O	experience	_	0	SENT_82	[p6l1093t2047r1449b2125],
10	greater	JJR	O	greater	amod	12	SENT_82	[p6l1487t2057r1719b2126],
11	cytotoxicity	NN	O	cytotoxicity	nn	12	SENT_82	[p6l1756t2047r2154b2126],
12	(	NN	O	(	dobj	9	SENT_82	[p6l14t2149r299b2223],
13	because	IN	O	because	_	0	SENT_82	[p6l14t2149r299b2223],
14	of	IN	O	of	_	0	SENT_82	[p6l324t2149r398b2210],
15	a	DT	O	a	det	19	SENT_82	[p6l413t2171r447b2210],
16	less	RBR	O	less	advmod	17	SENT_82	[p6l468t2149r582b2210],
17	efﬁcient	JJ	O	efﬁcient	amod	19	SENT_82	[p6l607t2149r876b2210],
18	drug	NN	O	drug	nn	19	SENT_82	[p6l900t2149r1057b2229],
19	efflux	NN	O	efflux	prep_because_of	9	SENT_82	[p6l1081t2149r1271b2210],
20	resulting	VBG	O	result	partmod	19	SENT_82	[p6l1294t2149r1588b2229],
21	in	IN	O	in	_	0	SENT_82	[p6l1611t2151r1676b2209],
22	a	DT	O	a	det	26	SENT_82	[p6l1701t2171r1734b2210],
23	longer	RBR	O	longer	amod	26	SENT_82	[p6l1756t2149r1971b2229],
24	drug	NN	O	drug	nn	26	SENT_82	[p6l1995t2149r2152b2229],
25	effect	NN	O	effect	nn	26	SENT_82	[p6l9t2253r212b2327],
26	)	NN	O	)	prep_in	20	SENT_82	[p6l9t2253r212b2327],
27	than	IN	O	than	_	0	SENT_82	[p6l250t2253r402b2314],
28	the	DT	O	the	det	30	SENT_82	[p6l433t2253r538b2314],
29	tumour	NN	O	tumour	nn	30	SENT_82	[p6l569t2265r830b2314],
30	cells	NNS	O	cell	prep_than	26	SENT_82	[p6l863t2253r1001b2314],
31	with	IN	O	with	_	0	SENT_82	[p6l1032t2253r1183b2314],
32	C/C	NN	O	c/c	nn	33	SENT_82	[p6l1216t2256r1350b2317],
33	genotype	NN	O	genotype	prep_with	20	SENT_82	[p6l1383t2265r1704b2333],
34	.	.	O	.	_	0	SENT_82	[p6l1383t2265r1704b2333],

1	In	IN	O	in	_	0	SENT_83	[p6l1740t2257r1811b2313],
2	this	DT	O	this	det	3	SENT_83	[p6l1842t2253r1964b2314],
3	case	NN	O	case	prep_in	9	SENT_83	[p6l1997t2275r2149b2323],
4	,	,	O	,	_	0	SENT_83	[p6l1997t2275r2149b2323],
5	T	NN	O	t	nn	7	SENT_83	[p6l8t2360r56b2419],
6	allele	NN	O	allele	nn	7	SENT_83	[p6l87t2357r254b2419],
7	carriers	NNS	O	carrier	nsubj	9	SENT_83	[p6l285t2360r532b2419],
8	would	MD	O	would	aux	9	SENT_83	[p6l561t2358r774b2419],
9	show	VB	O	show	_	0	SENT_83	[p6l804t2357r979b2419],
10	a	DT	O	a	det	12	SENT_83	[p6l1007t2380r1040b2419],
11	longer	RBR	O	longer	amod	12	SENT_83	[p6l1068t2358r1282b2439],
12	survival	NN	O	survival	dobj	9	SENT_83	[p6l1313t2357r1590b2419],
13	.	.	O	.	_	0	SENT_83	[p6l1313t2357r1590b2419],

1	MDR	NN	O	mdr	nsubjpass	3	SENT_84	[p6l1623t2362r1813b2419],
2	is	VBZ	O	be	auxpass	3	SENT_84	[p6l1841t2360r1889b2419],
3	known	VBN	O	know	_	0	SENT_84	[p6l1918t2357r2151b2419],
4	to	TO	O	to	aux	6	SENT_84	[p6l8t2474r74b2523],
5	be	VB	O	be	cop	6	SENT_84	[p6l107t2462r184b2523],
6	important	JJ	O	important	xcomp	3	SENT_84	[p6l218t2464r563b2541],
7	in	IN	O	in	_	0	SENT_84	[p6l597t2464r662b2522],
8	the	DT	O	the	det	9	SENT_84	[p6l695t2462r799b2523],
9	efﬂux	NN	O	efﬂux	prep_in	6	SENT_84	[p6l834t2462r1024b2523],
10	of	IN	O	of	_	0	SENT_84	[p6l1056t2462r1130b2523],
11	vincristine	NN	O	vincristine	prep_of	9	SENT_84	[p6l1152t2464r1507b2523],
12	and	CC	O	and	_	0	SENT_84	[p6l1542t2462r1666b2523],
13	doxorubicine	NN	O	doxorubicine	conj_and	11	SENT_84	[p6l1700t2462r2150b2523],
14	and	CC	O	and	cc	6	SENT_84	[p6l9t2567r151b2638],
15	,	,	O	,	_	0	SENT_84	[p6l9t2567r151b2638],
16	although	IN	O	although	mark	20	SENT_84	[p6l191t2566r490b2648],
17	we	PRP	O	we	nsubj	20	SENT_84	[p6l525t2589r616b2628],
18	did	VBD	O	do	aux	20	SENT_84	[p6l654t2566r763b2628],
19	not	RB	O	not	neg	20	SENT_84	[p6l799t2579r913b2628],
20	observe	VB	O	observe	advcl	6	SENT_84	[p6l949t2567r1202b2628],
21	any	DT	O	any	det	23	SENT_84	[p6l1240t2589r1360b2648],
22	signiﬁcant	JJ	O	signiﬁcant	amod	23	SENT_84	[p6l1394t2566r1743b2648],
23	association	NN	O	association	dobj	20	SENT_84	[p6l1779t2569r2151b2628],

1	Journal	NNP	O	Journal	nn	2	SENT_85	[p6l84t2724r182b2750],
2	Compilation	NNP	O	Compilation	nsubj	31	SENT_85	[p6l197t2724r365b2757],
3	©	CD	NUMBER	©	num	7	SENT_85	[p6l380t2726r404b2750],
4	2007	CD	DATE	2007	num	7	SENT_85	[p6l418t2725r488b2750],
5	Blackwell	NNP	ORGANIZATION	Blackwell	nn	7	SENT_85	[p6l503t2724r629b2750],
6	Publishing	NNP	ORGANIZATION	Publishing	nn	7	SENT_85	[p6l644t2724r782b2757],
7	Ltd	NNP	ORGANIZATION	Ltd	dep	2	SENT_85	[p6l798t2724r846b2754],
8	,	,	O	,	_	0	SENT_85	[p6l798t2724r846b2754],
9	British	NNP	O	British	nn	10	SENT_85	[p6l861t2724r945b2750],
10	Journal	NNP	O	Journal	appos	2	SENT_85	[p6l956t2724r1059b2750],
11	of	IN	O	of	_	0	SENT_85	[p6l1070t2724r1102b2750],
12	Haematology	NNP	O	Haematology	prep_of	10	SENT_85	[p6l1110t2724r1303b2757],
13	,	,	O	,	_	0	SENT_85	[p6l1110t2724r1303b2757],
14	137	CD	NUMBER	137	num	12	SENT_85	[p6l1320t2725r1378b2754],
15	,	,	O	,	_	0	SENT_85	[p6l1320t2725r1378b2754],
16	454-456 455	CD	NUMBER	454-456 455	num	12	SENT_85	[p6l2015t2723r2075b2750],[p6l1393t2725r1517b2750],
17	Short	JJ	O	short	amod	22	SENT_85	[p6l85t2781r167b2810],
18	Report	NNP	O	Report	nn	22	SENT_85	[p6l183t2783r285b2817],
19	Table	NNP	O	Table	nn	22	SENT_85	[p6l84t2818r158b2842],
20	I.	NNP	O	I.	nn	22	SENT_85	[p6l170t2820r187b2842],
21	Overall	NNP	O	Overall	nn	22	SENT_85	[p6l207t2818r302b2842],
22	survival	NN	O	survival	dep	10	SENT_85	[p6l315t2818r417b2842],
23	at	IN	O	at	_	0	SENT_85	[p6l429t2823r453b2842],
24	60	CD	DURATION	60	num	25	SENT_85	[p6l465t2820r495b2842],
25	months	NNS	NUMBER	month	prep_at	22	SENT_85	[p6l508t2818r609b2842],
26	from	IN	O	from	_	0	SENT_85	[p6l621t2818r686b2842],
27	multiple	JJ	O	multiple	amod	29	SENT_85	[p6l698t2818r810b2849],
28	myeloma	NN	O	myeloma	nn	29	SENT_85	[p6l822t2818r944b2850],
29	diagnosis	NN	O	diagnosis	prep_from	25	SENT_85	[p6l956t2818r1086b2850],
30	,	,	O	,	_	0	SENT_85	[p6l956t2818r1086b2850],
31	based	VBN	O	base	_	0	SENT_85	[p6l1098t2818r1173b2842],
32	on	IN	O	on	_	0	SENT_85	[p6l1185t2827r1219b2842],
33	the	DT	O	the	det	36	SENT_85	[p6l1231t2818r1271b2842],
34	Cox	NN	O	cox	nn	36	SENT_85	[p6l1284t2819r1338b2842],
35	regression	NN	O	regression	nn	36	SENT_85	[p6l1349t2819r1483b2850],
36	model	NN	O	model	prep_on	31	SENT_85	[p6l1495t2818r1585b2842],
37	.	.	O	.	_	0	SENT_85	[p6l1495t2818r1585b2842],

1	Log	VB	O	log	_	0	SENT_86	[p6l9t2929r113b2992],
2	likelihood	NN	O	likelihood	nsubj	3	SENT_86	[p6l137t2925r422b2976],
3	=	JJ	O	=	ccomp	1	SENT_86	[p6l449t2949r496b2966],
4	—	CD	NUMBER	—	num	5	SENT_86	[p6l526t2930r749b2976],
5	44-427	CD	NUMBER	44-427	dobj	3	SENT_86	[p6l526t2930r749b2976],

1	-1	CD	NUMBER	-1	_	0	SENT_87	[p6l11t3097r76b3137],
2	?	.	O	?	_	0	SENT_87	[p6l11t3097r76b3137],

1	Hazard	NN	O	hazard	nn	2	SENT_88	[p6l1481t3086r1686b3137],
2	ratio	NN	O	ratio	_	0	SENT_88	[p6l1712t3088r1842b3137],
3	(	CD	NUMBER	(	num	5	SENT_88	[p6l1873t3086r2013b3148],
4	HR	NN	DURATION	hr	nn	5	SENT_88	[p6l1873t3086r2013b3148],
5	)	NN	O	)	dep	2	SENT_88	[p6l1873t3086r2013b3148],

1	Age	NNP	O	Age	_	0	SENT_89	[p6l7t3259r142b3324],
2	*	CD	NUMBER	*	number	3	SENT_89	[p6l7t3259r142b3324],
3	096	CD	NUMBER	096	num	4	SENT_89	[p6l1515t3261r1627b3308],
4	Gender	NN	O	gender	dep	1	SENT_89	[p6l10t3342r216b3393],
5	1	CD	NUMBER	1	number	6	SENT_89	[p6l1521t3347r1627b3393],
6	°	CD	NUMBER	°	dep	1	SENT_89	[p6l1521t3347r1627b3393],
7	59	CD	NUMBER	59	num	8	SENT_89	[p6l1521t3347r1627b3393],
8	Dexamethasone	NN	O	dexamethasone	dep	6	SENT_89	[p6l9t3427r472b3485],
9	,	,	O	,	_	0	SENT_89	[p6l9t3427r472b3485],
10	doxorubicin	NN	O	doxorubicin	appos	6	SENT_89	[p6l500t3427r846b3478],
11	3	CD	NUMBER	3	num	10	SENT_89	[p6l1516t3431r1628b3478],
12	‘	NN	O	‘	dep	10	SENT_89	[p6l1516t3431r1628b3478],
13	66	CD	NUMBER	66	num	12	SENT_89	[p6l1516t3431r1628b3478],

1	[	NN	O	[	nn	3	SENT_90	[p7l51t19r405b87],
2	adryamicin	NN	O	adryamicin	nn	3	SENT_90	[p7l51t19r405b87],
3	]	NN	O	]	_	0	SENT_90	[p7l51t19r405b87],
4	and	CC	O	and	_	0	SENT_90	[p7l440t19r544b71],
5	Vincristine	NN	O	vincristine	nn	6	SENT_90	[p7l567t21r863b70],
6	response	NN	O	response	conj_and	3	SENT_90	[p7l890t37r1133b86],
7	Autologous	JJ	O	autologous	amod	10	SENT_90	[p7l7t105r333b172],
8	stem	NN	O	stem	nn	10	SENT_90	[p7l361t115r492b156],
9	cell	NN	O	cell	nn	10	SENT_90	[p7l519t105r610b156],
10	transplantation	NN	O	transplantation	dep	3	SENT_90	[p7l635t105r1066b171],
11	2	CD	NUMBER	2	number	12	SENT_90	[p7l1515t109r1628b156],
12	°	CD	NUMBER	°	dep	10	SENT_90	[p7l1515t109r1628b156],
13	07	CD	NUMBER	07	number	14	SENT_90	[p7l1515t109r1628b156],
14	(	CD	NUMBER	(	dep	3	SENT_90	[p7l48t190r257b252],
15	ASCT	NN	O	asct	nn	17	SENT_90	[p7l48t190r257b252],
16	)	NN	O	)	nn	17	SENT_90	[p7l48t190r257b252],
17	response	NN	O	response	dep	14	SENT_90	[p7l288t208r531b256],
18	11	CD	NUMBER	11	num	20	SENT_90	[p7l9t279r52b325],
19	ASCT	NN	O	asct	nn	20	SENT_90	[p7l77t277r244b326],
20	pres/abs	NNS	O	pres/abs	dep	3	SENT_90	[p7l270t275r499b342],
21	1	CD	NUMBER	1	number	22	SENT_90	[p7l1521t280r1628b326],
22	'06	CD	NUMBER	'06	num	24	SENT_90	[p7l1521t280r1628b326],
23	Haemoglobin	NN	O	haemoglobin	nn	24	SENT_90	[p7l9t360r423b427],
24	*	NN	O	*	dep	20	SENT_90	[p7l9t360r423b427],
25	0	CD	NUMBER	0	dep	3	SENT_90	[p7l1515t364r1589b411],
26	'	''	O	'	_	0	SENT_90	[p7l1515t364r1589b411],
27	1	CD	NUMBER	1	dep	25	SENT_90	[p7l1515t364r1589b411],
28	1	CD	NUMBER	1	num	29	SENT_90	[p7l1604t365r1623b410],
29	Creatinine	NN	O	creatinine	dep	3	SENT_90	[p7l10t447r332b496],
30	*	CD	NUMBER	*	dep	29	SENT_90	[p7l10t447r332b496],
31	1-32	CD	NUMBER	1-32	num	32	SENT_90	[p7l1521t450r1627b496],
32	[	NN	O	[	dep	3	SENT_90	[p7l13t530r541b597],
33	32	CD	NUMBER	32	dep	32	SENT_90	[p7l13t530r541b597],
34	.	.	O	.	_	0	SENT_90	[p7l13t530r541b597],

1	—	NN	O	—	_	0	SENT_91	[p7l13t530r541b597],
2	.	.	O	.	_	0	SENT_91	[p7l13t530r541b597],

1	Microglobulin	NNP	O	Microglobulin	dep	10	SENT_92	[p7l13t530r541b597],
2	*	CD	NUMBER	*	num	1	SENT_92	[p7l13t530r541b597],
3	46-04	CD	NUMBER	46-04	num	4	SENT_92	[p7l1481t535r1628b581],
4	Albumin	NN	O	albumin	dep	1	SENT_92	[p7l7t615r287b666],
5	*	NN	O	*	dep	10	SENT_92	[p7l7t615r287b666],
6	0	CD	NUMBER	0	num	5	SENT_92	[p7l1515t619r1628b666],
7	°	NN	O	°	nn	10	SENT_92	[p7l1515t619r1628b666],
8	37	CD	NUMBER	37	num	10	SENT_92	[p7l1515t619r1628b666],
9	MDR1	NN	O	mdr1	nn	10	SENT_92	[p7l6t704r187b751],
10	3435C	NN	O	3435c	dep	14	SENT_92	[p7l220t703r398b751],
11	>	JJR	O	>	amod	12	SENT_92	[p7l425t711r462b750],
12	T1	NN	O	t1	dep	10	SENT_92	[p7l489t700r564b764],
13	‘	CD	NUMBER	‘	num	14	SENT_92	[p7l489t700r564b764],
14	0-12	CD	NUMBER	0-12	_	0	SENT_92	[p7l1515t705r1627b751],

1	LR	NNP	ORGANIZATION	LR	nn	2	SENT_93	[p7l225t823r308b872],
2	X2	NN	O	x2	_	0	SENT_93	[p7l333t807r391b886],
3	=	JJ	O	=	amod	5	SENT_93	[p7l421t844r470b862],
4	33-02	CD	NUMBER	33-02	tmod	3	SENT_93	[p7l500t824r649b872],
5	Prob	NNP	O	Prob	dep	2	SENT_93	[p7l1257t819r1394b872],
6	>	JJR	O	>	amod	7	SENT_93	[p7l1425t831r1461b871],
7	X2	NN	O	x2	dep	2	SENT_93	[p7l1491t807r1549b886],
8	=	JJ	O	=	amod	7	SENT_93	[p7l1579t844r1628b862],
9	00003	CD	NUMBER	00003	tmod	8	SENT_93	[p7l1658t824r1841b872],

1	SE	NN	O	se	_	0	SENT_94	[p7l226t987r297b1037],
2	z	SYM	O	z	dep	3	SENT_94	[p7l734t1003r764b1037],
3	P	NN	O	p	dep	1	SENT_94	[p7l1254t988r1296b1036],
4	>	JJR	O	>	dobj	3	SENT_94	[p7l1322t996r1359b1036],
5	|	CD	NUMBER	|	dep	4	SENT_94	[p7l1394t981r1446b1054],
6	z	SYM	O	z	dep	4	SENT_94	[p7l1394t981r1446b1054],
7	|	SYM	O	|	dep	9	SENT_94	[p7l1394t981r1446b1054],
8	95	CD	PERCENT	95	num	9	SENT_94	[p7l1810t988r1936b1039],
9	%	NN	PERCENT	%	dep	1	SENT_94	[p7l1810t988r1936b1039],
10	CI	NN	O	ci	dep	9	SENT_94	[p7l1965t987r2032b1037],

1	*	NN	O	*	_	0	SENT_95	[p7l84t2343r129b2367],
2	At	IN	O	at	dep	1	SENT_95	[p7l84t2343r129b2367],
3	the	DT	O	the	det	4	SENT_95	[p7l140t2342r181b2367],
4	time	NN	O	time	pobj	2	SENT_95	[p7l193t2343r253b2367],
5	of	IN	O	of	_	0	SENT_95	[p7l265t2342r294b2367],
6	diagnosis	NN	O	diagnosis	prep_of	4	SENT_95	[p7l303t2342r432b2374],
7	.	.	O	.	_	0	SENT_95	[p7l303t2342r432b2374],

1	TThe	NNP	O	TThe	nn	2	SENT_96	[p7l85t2383r151b2414],
2	HR	NN	DURATION	hr	nsubj	3	SENT_96	[p7l163t2385r209b2407],
3	shows	VBZ	O	show	_	0	SENT_96	[p7l220t2383r300b2407],
4	the	DT	O	the	det	6	SENT_96	[p7l312t2383r353b2407],
5	relative	JJ	O	relative	amod	6	SENT_96	[p7l365t2383r461b2407],
6	risk	NN	O	risk	dobj	3	SENT_96	[p7l473t2383r522b2407],
7	of	IN	O	of	_	0	SENT_96	[p7l533t2383r562b2407],
8	death	NN	O	death	prep_of	6	SENT_96	[p7l571t2383r644b2407],
9	of	IN	O	of	_	0	SENT_96	[p7l656t2383r685b2407],
10	patients	NNS	O	patient	prep_of	8	SENT_96	[p7l693t2384r798b2415],
11	with	IN	O	with	_	0	SENT_96	[p7l809t2383r868b2407],
12	C/T	NN	O	c/t	nn	15	SENT_96	[p7l881t2384r932b2408],
13	+	CC	O	+	_	0	SENT_96	[p7l944t2389r962b2407],
14	T/T	NN	O	t/t	nn	15	SENT_96	[p7l975t2384r1025b2408],
15	genotypes	NNS	O	genotype	prep_with	10	SENT_96	[p7l1037t2388r1168b2415],
16	relative	JJ	O	relative	advmod	15	SENT_96	[p7l1181t2383r1276b2407],
17	to	TO	O	to	_	0	SENT_96	[p7l1288t2388r1314b2407],
18	patients	NNS	O	patient	prep_to	16	SENT_96	[p7l1327t2384r1431b2415],
19	with	IN	O	with	_	0	SENT_96	[p7l1443t2383r1502b2407],
20	Cl	NN	O	cl	nn	22	SENT_96	[p7l1514t2384r1545b2408],
21	C	NN	O	c	nn	22	SENT_96	[p7l1547t2384r1567b2407],
22	genotypes	NNS	O	genotype	prep_with	3	SENT_96	[p7l1579t2388r1717b2415],
23	.	.	O	.	_	0	SENT_96	[p7l1579t2388r1717b2415],

1	between	IN	O	between	_	0	SENT_97	[p7l8t2584r284b2645],
2	genotype	NN	O	genotype	nn	3	SENT_97	[p7l345t2596r648b2665],
3	distributions	NNS	O	distribution	prep_between	10	SENT_97	[p7l710t2584r1139b2645],
4	and	CC	O	and	_	0	SENT_97	[p7l1201t2584r1324b2645],
5	DAV	NN	O	dav	conj_and	3	SENT_97	[p7l1385t2588r1571b2655],
6	,	,	O	,	_	0	SENT_97	[p7l1385t2588r1571b2655],
7	we	PRP	O	we	nsubj	10	SENT_97	[p7l1632t2606r1722b2645],
8	could	MD	O	could	aux	10	SENT_97	[p7l1784t2584r1970b2645],
9	not	RB	O	not	neg	10	SENT_97	[p7l2030t2596r2143b2645],
10	exclude	VB	O	exclude	_	0	SENT_97	[p7l11t2689r263b2750],
11	this	DT	O	this	det	12	SENT_97	[p7l303t2688r424b2750],
12	mechanism	NN	O	mechanism	dobj	10	SENT_97	[p7l465t2688r850b2750],
13	because	IN	O	because	mark	19	SENT_97	[p7l889t2688r1148b2750],
14	the	DT	O	the	det	16	SENT_97	[p7l1188t2688r1292b2750],
15	statistical	JJ	O	statistical	amod	16	SENT_97	[p7l1334t2689r1644b2750],
16	power	NN	O	power	nsubjpass	19	SENT_97	[p7l1684t2710r1894b2768],
17	would	MD	O	would	aux	19	SENT_97	[p7l1931t2688r2143b2750],
18	be	VB	O	be	auxpass	19	SENT_97	[p7l8t2793r85b2854],
19	reduced	VBN	O	reduce	advcl	10	SENT_97	[p7l132t2793r416b2854],
20	.	.	O	.	_	0	SENT_97	[p7l132t2793r416b2854],

1	In	IN	O	in	_	0	SENT_98	[p7l466t2798r536b2853],
2	contrast	NN	O	contrast	prep_in	7	SENT_98	[p7l583t2805r872b2864],
3	,	,	O	,	_	0	SENT_98	[p7l583t2805r872b2864],
4	MDR1	NN	O	mdr1	nsubj	7	SENT_98	[p7l920t2798r1141b2854],
5	should	MD	O	should	aux	7	SENT_98	[p7l1194t2793r1421b2854],
6	not	RB	O	not	neg	7	SENT_98	[p7l1467t2805r1579b2854],
7	have	VB	O	have	_	0	SENT_98	[p7l1625t2793r1777b2854],
8	a	DT	O	a	det	9	SENT_98	[p7l1825t2815r1858b2854],
9	role	NN	O	role	dobj	7	SENT_98	[p7l1904t2793r2031b2854],
10	in	IN	O	in	_	0	SENT_98	[p7l2077t2795r2143b2853],
11	melphalan	JJ	O	melphalan	amod	12	SENT_98	[p7l10t2897r362b2976],
12	extrusion	NN	O	extrusion	prep_in	9	SENT_98	[p7l395t2899r727b2958],
13	.	.	O	.	_	0	SENT_98	[p7l395t2899r727b2958],

1	Therefore	RB	O	therefore	advmod	21	SENT_99	[p7l93t3000r438b3071],
2	,	,	O	,	_	0	SENT_99	[p7l93t3000r438b3071],
3	studies	NNS	O	study	nsubj	21	SENT_99	[p7l472t3001r701b3062],
4	regarding	VBG	O	regard	_	0	SENT_99	[p7l733t3001r1054b3081],
5	the	DT	O	the	det	6	SENT_99	[p7l1082t3000r1186b3062],
6	association	NN	O	association	prep_regarding	3	SENT_99	[p7l1217t3003r1587b3062],
7	between	IN	O	between	_	0	SENT_99	[p7l1616t3001r1891b3062],
8	MDR1	NN	O	mdr1	nn	9	SENT_99	[p7l1919t3005r2135b3061],
9	polymorphisms	NNS	O	polymorphism	prep_between	6	SENT_99	[p7l9t3104r539b3185],
10	and	CC	O	and	_	0	SENT_99	[p7l569t3104r692b3165],
11	the	DT	O	the	det	12	SENT_99	[p7l719t3104r822b3165],
12	outcome	NN	O	outcome	prep_regarding	3	SENT_99	[p7l851t3116r1146b3165],
13	of	IN	O	of	_	0	SENT_99	[p7l1176t3104r1249b3165],
14	MM	NN	O	mm	nn	15	SENT_99	[p7l1267t3109r1413b3165],
15	patients	NNS	O	patient	prep_of	12	SENT_99	[p7l1442t3106r1706b3184],
16	treated	VBN	O	treat	partmod	15	SENT_99	[p7l1734t3104r1967b3165],
17	with	IN	O	with	_	0	SENT_99	[p7l1993t3104r2142b3165],
18	newer	JJR	O	newer	amod	20	SENT_99	[p7l10t3231r211b3270],
19	chemotherapy	NN	O	chemotherapy	nn	20	SENT_99	[p7l236t3209r719b3289],
20	regimens	NNS	O	regimen	prep_with	16	SENT_99	[p7l742t3211r1044b3289],
21	(	VBP	O	(	_	0	SENT_99	[p7l1075t3209r1509b3283],
22	bortezomib	NN	O	bortezomib	nn	25	SENT_99	[p7l1075t3209r1509b3283],
23	,	,	O	,	_	0	SENT_99	[p7l1075t3209r1509b3283],
24	thalidomide	NN	O	thalidomide	dep	25	SENT_99	[p7l1536t3209r1971b3283],
25	)	NN	O	)	nsubj	27	SENT_99	[p7l1536t3209r1971b3283],
26	may	MD	O	may	aux	27	SENT_99	[p7l2002t3231r2146b3289],
27	clarify	VB	O	clarify	ccomp	21	SENT_99	[p7l11t3313r219b3393],
28	the	DT	O	the	det	29	SENT_99	[p7l267t3313r371b3374],
29	mechanism	NN	O	mechanism	dobj	27	SENT_99	[p7l423t3313r808b3374],
30	and	CC	O	and	_	0	SENT_99	[p7l862t3313r985b3374],
31	conﬁrm	VBP	O	conﬁrm	ccomp	21	SENT_99	[p7l1038t3313r1305b3374],
32	the	DT	O	the	det	34	SENT_99	[p7l1356t3313r1460b3374],
33	predictive	JJ	O	predictive	amod	34	SENT_99	[p7l1511t3313r1845b3392],
34	role	NN	O	role	dobj	31	SENT_99	[p7l1898t3313r2025b3374],
35	of	IN	O	of	_	0	SENT_99	[p7l2078t3313r2152b3374],
36	MDR1	NN	O	mdr1	nn	37	SENT_99	[p7l7t3422r224b3478],
37	genotype	NN	O	genotype	prep_of	34	SENT_99	[p7l263t3429r583b3498],
38	.	.	O	.	_	0	SENT_99	[p7l263t3429r583b3498],

1	Further	JJ	O	further	amod	2	SENT_100	[p7l94t3521r347b3582],
2	studies	NNS	O	study	nsubj	18	SENT_100	[p7l381t3521r611b3582],
3	that	WDT	O	that	nsubj	4	SENT_100	[p7l645t3520r778b3582],
4	include	VBP	O	include	rcmod	2	SENT_100	[p7l813t3520r1059b3582],
5	the	DT	O	the	det	6	SENT_100	[p7l1093t3520r1197b3582],
6	analysis	NN	O	analysis	dobj	4	SENT_100	[p7l1233t3520r1489b3601],
7	of	IN	O	of	_	0	SENT_100	[p7l1526t3520r1599b3582],
8	more	JJR	O	more	amod	10	SENT_100	[p7l1624t3542r1800b3582],
9	complete	JJ	O	complete	amod	10	SENT_100	[p7l1836t3520r2142b3600],
10	haplotypes	NNS	O	haplotype	prep_of	6	SENT_100	[p7l9t3625r371b3705],
11	of	IN	O	of	_	0	SENT_100	[p7l412t3625r485b3686],
12	MDR1	NN	O	mdr1	prep_of	10	SENT_100	[p7l510t3630r727b3686],
13	could	MD	O	could	aux	14	SENT_100	[p7l773t3625r960b3686],
14	improve	VB	O	improve	_	0	SENT_100	[p7l998t3627r1280b3705],
15	these	DT	O	these	det	16	SENT_100	[p7l1317t3625r1485b3686],
16	data	NNS	O	datum	dobj	14	SENT_100	[p7l1525t3625r1666b3686],
17	and	CC	O	and	_	0	SENT_100	[p7l1704t3625r1828b3686],
18	produce	VBP	O	produce	conj_and	14	SENT_100	[p7l1865t3625r2142b3705],
19	a	DT	O	a	det	21	SENT_100	[p7l11t3751r44b3790],
20	signiﬁcant	JJ	O	signiﬁcant	amod	21	SENT_100	[p7l76t3729r422b3809],
21	impact	NN	O	impact	dobj	18	SENT_100	[p7l454t3731r686b3808],
22	on	IN	O	on	_	0	SENT_100	[p7l718t3751r803b3790],
23	the	DT	O	the	det	24	SENT_100	[p7l834t3729r938b3790],
24	management	NN	O	management	prep_on	18	SENT_100	[p7l969t3741r1405b3809],
25	of	IN	O	of	_	0	SENT_100	[p7l1437t3729r1511b3790],
26	MM	NN	O	mm	nn	27	SENT_100	[p7l1532t3733r1679b3789],
27	patients	NNS	O	patient	prep_of	24	SENT_100	[p7l1711t3731r1993b3808],
28	.	.	O	.	_	0	SENT_100	[p7l1711t3731r1993b3808],

1	References	NNS	O	reference	_	0	SENT_101	[p8l14t163r483b235],

1	Barlogie	NNP	PERSON	Barlogie	nn	5	SENT_102	[p8l10t335r270b407],
2	,	,	O	,	_	0	SENT_102	[p8l10t335r270b407],
3	B.	NNP	O	B.	appos	5	SENT_102	[p8l313t339r387b398],
4	,	,	O	,	_	0	SENT_102	[p8l313t339r387b398],
5	Shaughnessy	NNP	PERSON	Shaughnessy	_	0	SENT_102	[p8l430t335r822b407],
6	,	,	O	,	_	0	SENT_102	[p8l430t335r822b407],
7	]	CD	NUMBER	]	appos	5	SENT_102	[p8l864t339r921b399],
8	.	.	O	.	_	0	SENT_102	[p8l864t339r921b399],

1	,	,	O	,	_	0	SENT_103	[p8l864t339r921b399],
2	Tricot	NNP	O	Tricot	dep	25	SENT_103	[p8l963t337r1163b398],
3	,	,	O	,	_	0	SENT_103	[p8l963t337r1163b398],
4	G.	NNP	O	G.	appos	2	SENT_103	[p8l1205t338r1288b398],
5	,	,	O	,	_	0	SENT_103	[p8l1205t338r1288b398],
6	Jacobson	NNP	PERSON	Jacobson	conj_and	4	SENT_103	[p8l1329t335r1614b399],
7	,	,	O	,	_	0	SENT_103	[p8l1329t335r1614b399],
8	I.	NNP	O	I.	conj_and	4	SENT_103	[p8l1656t339r1712b399],
9	,	,	O	,	_	0	SENT_103	[p8l1656t339r1712b399],
10	Zangari	NNP	PERSON	Zangari	conj_and	4	SENT_103	[p8l1754t337r2001b407],
11	,	,	O	,	_	0	SENT_103	[p8l1754t337r2001b407],
12	M.	NNP	O	M.	conj_and	4	SENT_103	[p8l2042t339r2141b398],
13	,	,	O	,	_	0	SENT_103	[p8l2042t339r2141b398],
14	Anaissie	NNP	PERSON	Anaissie	conj_and	4	SENT_103	[p8l83t429r344b489],
15	,	,	O	,	_	0	SENT_103	[p8l83t429r344b489],
16	E.	NNP	O	E.	conj_and	4	SENT_103	[p8l371t431r444b489],
17	,	,	O	,	_	0	SENT_103	[p8l371t431r444b489],
18	Walker	NNP	PERSON	Walker	conj_and	4	SENT_103	[p8l469t427r702b489],
19	,	,	O	,	_	0	SENT_103	[p8l469t427r702b489],
20	R.	NNP	ORGANIZATION	R.	conj_and	4	SENT_103	[p8l730t431r788b481],
21	&	CC	ORGANIZATION	&	_	0	SENT_103	[p8l819t431r868b481],
22	Crowley	NNP	ORGANIZATION	Crowley	conj_and	4	SENT_103	[p8l893t427r1155b498],
23	,	,	O	,	_	0	SENT_103	[p8l893t427r1155b498],
24	J.	NNP	O	J.	nn	25	SENT_103	[p8l1181t431r1218b490],
25	(	NNP	O	(	_	0	SENT_103	[p8l1251t427r1439b493],
26	2004	CD	DATE	2004	num	28	SENT_103	[p8l1251t427r1439b493],
27	)	NNP	O	)	nn	28	SENT_103	[p8l1251t427r1439b493],
28	Treatment	NN	O	treatment	dep	25	SENT_103	[p8l1469t429r1784b481],
29	of	IN	O	of	_	0	SENT_103	[p8l1809t427r1875b481],
30	multiple	JJ	O	multiple	amod	31	SENT_103	[p8l1892t427r2143b497],
31	myeloma	NN	O	myeloma	prep_of	28	SENT_103	[p8l85t518r375b589],
32	.	.	O	.	_	0	SENT_103	[p8l85t518r375b589],

1	Blood	NN	O	blood	_	0	SENT_104	[p8l403t518r584b581],
2	,	,	O	,	_	0	SENT_104	[p8l403t518r584b581],
3	103	CD	NUMBER	103	appos	1	SENT_104	[p8l619t523r738b581],
4	,	,	O	,	_	0	SENT_104	[p8l619t523r738b581],
5	20-32	CD	NUMBER	20-32	appos	3	SENT_104	[p8l768t523r961b572],
6	.	.	O	.	_	0	SENT_104	[p8l768t523r961b572],

1	Galimberti	NNP	PERSON	Galimberti	nsubj	22	SENT_105	[p8l11t608r348b671],
2	,	,	O	,	_	0	SENT_105	[p8l11t608r348b671],
3	S.	NNP	O	S.	nsubj	22	SENT_105	[p8l372t611r438b671],
4	,	,	O	,	_	0	SENT_105	[p8l372t611r438b671],
5	Testi	NNP	PERSON	Testi	nsubj	22	SENT_105	[p8l460t610r620b671],
6	,	,	O	,	_	0	SENT_105	[p8l460t610r620b671],
7	R.	NNP	O	R.	nsubj	22	SENT_105	[p8l643t612r720b671],
8	,	,	O	,	_	0	SENT_105	[p8l643t612r720b671],
9	Guerrini	NNP	PERSON	Guerrini	nsubj	22	SENT_105	[p8l744t610r1016b671],
10	,	,	O	,	_	0	SENT_105	[p8l744t610r1016b671],
11	F.	NNP	O	F.	nsubj	22	SENT_105	[p8l1038t612r1107b671],
12	,	,	O	,	_	0	SENT_105	[p8l1038t612r1107b671],
13	Fazzi	NNP	PERSON	Fazzi	nsubj	22	SENT_105	[p8l1130t610r1295b671],
14	,	,	O	,	_	0	SENT_105	[p8l1130t610r1295b671],
15	R.	NNP	ORGANIZATION	R.	nsubj	22	SENT_105	[p8l1317t612r1376b662],
16	&	CC	ORGANIZATION	&	_	0	SENT_105	[p8l1401t612r1451b663],
17	Petrini	NNP	ORGANIZATION	Petrini	nsubj	22	SENT_105	[p8l1470t610r1687b671],
18	,	,	O	,	_	0	SENT_105	[p8l1470t610r1687b671],
19	M.	NNP	O	M.	nn	20	SENT_105	[p8l1709t612r1789b662],
20	(	NNP	O	(	appos	1	SENT_105	[p8l1817t608r2004b673],
21	2003	CD	DATE	2003	num	22	SENT_105	[p8l1817t608r2004b673],
22	)	CD	NUMBER	)	_	0	SENT_105	[p8l1817t608r2004b673],
23	The	DT	O	the	det	25	SENT_105	[p8l2029t608r2143b662],
24	clinical	JJ	O	clinical	amod	25	SENT_105	[p8l86t699r296b753],
25	relevance	NN	O	relevance	dobj	22	SENT_105	[p8l331t699r605b754],
26	of	IN	O	of	_	0	SENT_105	[p8l641t699r707b753],
27	the	DT	O	the	det	28	SENT_105	[p8l732t699r824b753],
28	expression	NN	O	expression	prep_of	25	SENT_105	[p8l860t701r1174b770],
29	of	IN	O	of	_	0	SENT_105	[p8l1209t699r1274b753],
30	several	JJ	O	several	amod	32	SENT_105	[p8l1301t699r1500b753],
31	multidrugresistantrelated	JJ	O	multidrugresistantrelated	amod	32	SENT_105	[p8l1534t699r2140b771, p8l86t791r287b845],
32	genes	NNS	O	gene	prep_of	28	SENT_105	[p8l330t810r490b862],
33	in	IN	O	in	_	0	SENT_105	[p8l534t793r592b844],
34	patients	NNS	O	patient	prep_in	22	SENT_105	[p8l634t793r869b862],
35	with	IN	O	with	_	0	SENT_105	[p8l912t791r1045b845],
36	primary	JJ	O	primary	amod	39	SENT_105	[p8l1088t793r1331b862],
37	acute	JJ	O	acute	amod	39	SENT_105	[p8l1372t802r1527b845],
38	myeloid	JJ	O	myeloid	amod	39	SENT_105	[p8l1571t791r1812b862],
39	leukemia	NN	O	leukemia	prep_with	34	SENT_105	[p8l1854t791r2140b845],
40	.	.	O	.	_	0	SENT_105	[p8l1854t791r2140b845],

1	Iournal	NNP	O	Iournal	_	0	SENT_106	[p8l80t881r301b944],
2	of	IN	O	of	_	0	SENT_106	[p8l327t881r391b953],
3	Chemotherapy	NNP	O	Chemotherapy	prep_of	1	SENT_106	[p8l408t881r843b952],
4	,	,	O	,	_	0	SENT_106	[p8l408t881r843b952],
5	15	CD	NUMBER	15	num	3	SENT_106	[p8l878t887r961b944],
6	,	,	O	,	_	0	SENT_106	[p8l878t887r961b944],
7	374-379	CD	NUMBER	374-379	num	3	SENT_106	[p8l991t886r1254b936],
8	.	.	O	.	_	0	SENT_106	[p8l991t886r1254b936],

1	Gollapud	NNP	O	Gollapud	nn	3	SENT_107	[p8l11t972r304b1043],
2	,	,	O	,	_	0	SENT_107	[p8l11t972r304b1043],
3	S.	NNP	O	S.	_	0	SENT_107	[p8l328t975r375b1027],
4	8	CD	NUMBER	8	num	3	SENT_107	[p8l401t976r451b1027],
5	:	:	O	:	_	0	SENT_107	[p8l401t976r451b1027],
6	Gupta	NNP	PERSON	Gupta	nn	9	SENT_107	[p8l471t975r671b1043],
7	,	,	O	,	_	0	SENT_107	[p8l471t975r671b1043],
8	S.	NNP	O	S.	appos	9	SENT_107	[p8l695t975r742b1027],
9	(	NNP	O	(	dep	3	SENT_107	[p8l771t973r958b1038],
10	2001	CD	DATE	2001	num	9	SENT_107	[p8l771t973r958b1038],
11	)	CD	NUMBER	)	num	12	SENT_107	[p8l771t973r958b1038],
12	Anti	NNP	O	Anti	dep	9	SENT_107	[p8l982t972r1588b1044],
13	.	.	O	.	_	0	SENT_107	[p8l982t972r1588b1044],

1	—	NN	O	—	_	0	SENT_108	[p8l982t972r1588b1044],
2	.	.	O	.	_	0	SENT_108	[p8l982t972r1588b1044],

1	P	NN	O	p	_	0	SENT_109	[p8l982t972r1588b1044],
2	.	.	O	.	_	0	SENT_109	[p8l982t972r1588b1044],

1	—	NN	O	—	_	0	SENT_110	[p8l982t972r1588b1044],
2	.	.	O	.	_	0	SENT_110	[p8l982t972r1588b1044],

1	glycoprotein	NN	O	glycoprotein	nn	3	SENT_111	[p8l982t972r1588b1044],
2	antibody	NN	O	antibody	nn	3	SENT_111	[p8l1609t972r2143b1044],
3	—	NN	O	—	nsubj	4	SENT_111	[p8l1609t972r2143b1044],
4	induced	VBD	O	induce	_	0	SENT_111	[p8l1609t972r2143b1044],
5	apoptosis	NN	O	apoptosis	dobj	4	SENT_111	[p8l86t1065r367b1134],
6	of	IN	O	of	_	0	SENT_111	[p8l394t1063r460b1117],
7	activated	VBN	O	activate	amod	14	SENT_111	[p8l477t1063r743b1117],
8	peripheral	JJ	O	peripheral	amod	10	SENT_111	[p8l767t1063r1074b1134],
9	blood	NN	O	blood	nn	10	SENT_111	[p8l1096t1063r1270b1117],
10	lymphocytes	NNS	O	lymphocyte	dep	14	SENT_111	[p8l1294t1063r1684b1135],
11	:	:	O	:	_	0	SENT_111	[p8l1294t1063r1684b1135],
12	a	DT	O	a	det	14	SENT_111	[p8l1713t1083r1743b1117],
13	possible	JJ	O	possible	amod	14	SENT_111	[p8l1767t1063r2004b1134],
14	role	NN	O	role	prep_of	5	SENT_111	[p8l2030t1063r2143b1117],
15	of	IN	O	of	_	0	SENT_111	[p8l86t1154r152b1208],
16	P	NN	O	p	nn	18	SENT_111	[p8l202t1154r646b1226],
17	—	CD	NUMBER	—	num	18	SENT_111	[p8l202t1154r646b1226],
18	glycoprotein	NN	O	glycoprotein	prep_of	14	SENT_111	[p8l202t1154r646b1226],
19	in	IN	O	in	_	0	SENT_111	[p8l704t1156r762b1208],
20	lymphocyte	NN	O	lymphocyte	nn	21	SENT_111	[p8l820t1154r1169b1225],
21	survival	NN	O	survival	prep_in	14	SENT_111	[p8l1228t1154r1474b1208],
22	.	.	O	.	_	0	SENT_111	[p8l1228t1154r1474b1208],

1	Iournal	NNP	O	Iournal	_	0	SENT_112	[p8l1531t1154r1751b1217],
2	of	IN	O	of	_	0	SENT_112	[p8l1809t1154r1872b1226],
3	Clinical	JJ	O	clinical	amod	4	SENT_112	[p8l1921t1154r2145b1208],
4	Immunology	NN	O	immunology	prep_of	1	SENT_112	[p8l83t1245r466b1317],
5	,	,	O	,	_	0	SENT_112	[p8l83t1245r466b1317],
6	21	CD	NUMBER	21	appos	1	SENT_112	[p8l496t1251r584b1308],
7	,	,	O	,	_	0	SENT_112	[p8l496t1251r584b1308],
8	420-430	CD	NUMBER	420-430	appos	1	SENT_112	[p8l612t1251r877b1300],
9	.	.	O	.	_	0	SENT_112	[p8l612t1251r877b1300],

1	Illmer	NNP	O	Illmer	nn	35	SENT_113	[p8l10t1336r206b1399],
2	,	,	O	,	_	0	SENT_113	[p8l10t1336r206b1399],
3	T.	NNP	O	T.	appos	35	SENT_113	[p8l240t1338r316b1399],
4	,	,	O	,	_	0	SENT_113	[p8l240t1338r316b1399],
5	Schuler	NNP	PERSON	Schuler	appos	35	SENT_113	[p8l352t1336r589b1399],
6	,	,	O	,	_	0	SENT_113	[p8l352t1336r589b1399],
7	U.S.	NNP	LOCATION	U.S.	appos	35	SENT_113	[p8l624t1339r763b1399],
8	,	,	O	,	_	0	SENT_113	[p8l624t1339r763b1399],
9	Thiede	NNP	PERSON	Thiede	appos	35	SENT_113	[p8l798t1336r1019b1399],
10	,	,	O	,	_	0	SENT_113	[p8l798t1336r1019b1399],
11	C.	NNP	O	C.	appos	35	SENT_113	[p8l1054t1339r1133b1399],
12	,	,	O	,	_	0	SENT_113	[p8l1054t1339r1133b1399],
13	Schwarz	NNP	PERSON	Schwarz	appos	35	SENT_113	[p8l1169t1336r1429b1399],
14	,	,	O	,	_	0	SENT_113	[p8l1169t1336r1429b1399],
15	U.I.	NNP	LOCATION	U.I.	appos	35	SENT_113	[p8l1464t1340r1593b1399],
16	,	,	O	,	_	0	SENT_113	[p8l1464t1340r1593b1399],
17	Kim	NNP	PERSON	Kim	appos	35	SENT_113	[p8l1628t1338r1771b1399],
18	,	,	O	,	_	0	SENT_113	[p8l1628t1338r1771b1399],
19	R.B.	NNP	LOCATION	R.B.	appos	35	SENT_113	[p8l1807t1340r1946b1399],
20	,	,	O	,	_	0	SENT_113	[p8l1807t1340r1946b1399],
21	Gotthard	NNP	PERSON	Gotthard	appos	35	SENT_113	[p8l1982t1339r2140b1391, p8l85t1427r237b1490],
22	,	,	O	,	_	0	SENT_113	[p8l1982t1339r2140b1391, p8l85t1427r237b1490],
23	S.	NNP	O	S.	appos	35	SENT_113	[p8l263t1430r330b1490],
24	,	,	O	,	_	0	SENT_113	[p8l263t1430r330b1490],
25	Freund	NNP	PERSON	Freund	appos	35	SENT_113	[p8l355t1427r585b1490],
26	,	,	O	,	_	0	SENT_113	[p8l355t1427r585b1490],
27	D.	NNP	O	D.	appos	35	SENT_113	[p8l610t1431r696b1490],
28	,	,	O	,	_	0	SENT_113	[p8l610t1431r696b1490],
29	Schakel	NNP	O	Schakel	appos	35	SENT_113	[p8l722t1427r960b1490],
30	,	,	O	,	_	0	SENT_113	[p8l722t1427r960b1490],
31	U.	NNP	O	U.	appos	35	SENT_113	[p8l985t1431r1070b1490],
32	,	,	O	,	_	0	SENT_113	[p8l985t1431r1070b1490],
33	Ehninger	NNP	O	Ehninger	appos	35	SENT_113	[p8l1096t1427r1384b1499],
34	,	,	O	,	_	0	SENT_113	[p8l1096t1427r1384b1499],
35	G.	NNP	O	G.	nsubj	47	SENT_113	[p8l1410t1430r1473b1482],
36	8	CD	NUMBER	8	num	35	SENT_113	[p8l1502t1431r1551b1482],
37	(	CD	NUMBER	(	dep	35	SENT_113	[p8l1502t1431r1551b1482],
38	Schaich	NNP	PERSON	Schaich	nn	41	SENT_113	[p8l1573t1427r1816b1490],
39	,	,	O	,	_	0	SENT_113	[p8l1573t1427r1816b1490],
40	M.	NNP	O	M.	appos	41	SENT_113	[p8l1840t1431r1920b1481],
41	(	NNP	O	(	dep	35	SENT_113	[p8l1951t1427r2138b1493],
42	2002	CD	DATE	2002	num	41	SENT_113	[p8l1951t1427r2138b1493],
43	)	CD	NUMBER	)	num	46	SENT_113	[p8l1951t1427r2138b1493],
44	MDR1	NN	O	mdr1	nn	46	SENT_113	[p8l85t1522r281b1572],
45	gene	NN	O	gene	nn	46	SENT_113	[p8l342t1538r476b1590],
46	polymorphisms	NNS	O	polymorphism	dep	41	SENT_113	[p8l532t1518r1001b1590],
47	affect	VBP	O	affect	_	0	SENT_113	[p8l1059t1518r1218b1572],
48	therapy	NN	O	therapy	nn	49	SENT_113	[p8l1273t1518r1501b1590],
49	outcome	NN	O	outcome	dobj	47	SENT_113	[p8l1555t1529r1817b1573],
50	in	IN	O	in	_	0	SENT_113	[p8l1873t1520r1931b1572],
51	acute	JJ	O	acute	amod	52	SENT_113	[p8l1988t1529r2143b1573],
52	myeloid	JJ	O	myeloid	amod	54	SENT_113	[p8l85t1609r327b1680],
53	leukemia	NN	O	leukemia	nn	54	SENT_113	[p8l352t1609r624b1663],
54	patients	NNS	O	patient	prep_in	49	SENT_113	[p8l650t1611r901b1680],
55	.	.	O	.	_	0	SENT_113	[p8l650t1611r901b1680],

1	Cancer	NNP	O	Cancer	nn	2	SENT_114	[p8l934t1612r1137b1664],
2	Research	NNP	O	Research	_	0	SENT_114	[p8l1160t1609r1429b1672],
3	,	,	O	,	_	0	SENT_114	[p8l1160t1609r1429b1672],
4	62	CD	NUMBER	62	appos	2	SENT_114	[p8l1458t1614r1546b1672],
5	,	,	O	,	_	0	SENT_114	[p8l1458t1614r1546b1672],
6	4955-4962	CD	DURATION	4955-4962	appos	4	SENT_114	[p8l1574t1614r1912b1663],
7	.	.	O	.	_	0	SENT_114	[p8l1574t1614r1912b1663],

1	Iamroziak	NNP	PERSON	Iamroziak	nn	17	SENT_115	[p8l9t1700r328b1764],
2	,	,	O	,	_	0	SENT_115	[p8l9t1700r328b1764],
3	K.	NNP	O	K.	appos	17	SENT_115	[p8l355t1704r435b1763],
4	,	,	O	,	_	0	SENT_115	[p8l355t1704r435b1763],
5	Mlynarski	NNP	PERSON	Mlynarski	appos	17	SENT_115	[p8l461t1700r778b1772],
6	,	,	O	,	_	0	SENT_115	[p8l461t1700r778b1772],
7	W.	NNP	O	W.	appos	17	SENT_115	[p8l801t1704r905b1763],
8	,	,	O	,	_	0	SENT_115	[p8l801t1704r905b1763],
9	Balcerczak	NNP	PERSON	Balcerczak	appos	17	SENT_115	[p8l932t1700r1261b1763],
10	,	,	O	,	_	0	SENT_115	[p8l932t1700r1261b1763],
11	E.	NNP	O	E.	appos	17	SENT_115	[p8l1287t1704r1359b1763],
12	,	,	O	,	_	0	SENT_115	[p8l1287t1704r1359b1763],
13	Mistygacz	NNP	LOCATION	Mistygacz	appos	17	SENT_115	[p8l1386t1702r1698b1772],
14	,	,	O	,	_	0	SENT_115	[p8l1386t1702r1698b1772],
15	M.	NNP	O	M.	appos	17	SENT_115	[p8l1724t1704r1823b1763],
16	,	,	O	,	_	0	SENT_115	[p8l1724t1704r1823b1763],
17	Trelinska	NNP	LOCATION	Trelinska	_	0	SENT_115	[p8l1848t1700r2141b1763],
18	,	,	O	,	_	0	SENT_115	[p8l1848t1700r2141b1763],
19	]	CD	NUMBER	]	appos	17	SENT_115	[p8l85t1796r141b1857],
20	.	.	O	.	_	0	SENT_115	[p8l85t1796r141b1857],

1	,	,	O	,	_	0	SENT_116	[p8l85t1796r141b1857],
2	Mirowski	NNP	PERSON	Mirowski	dep	13	SENT_116	[p8l164t1792r464b1856],
3	,	,	O	,	_	0	SENT_116	[p8l164t1792r464b1856],
4	M.	NNP	O	M.	appos	2	SENT_116	[p8l488t1797r586b1856],
5	,	,	O	,	_	0	SENT_116	[p8l488t1797r586b1856],
6	Bodalski	NNP	PERSON	Bodalski	appos	2	SENT_116	[p8l610t1792r880b1856],
7	,	,	O	,	_	0	SENT_116	[p8l610t1792r880b1856],
8	I.	NNP	ORGANIZATION	I.	conj_and	4	SENT_116	[p8l903t1796r940b1857],
9	&	CC	ORGANIZATION	&	_	0	SENT_116	[p8l966t1796r1016b1848],
10	Robak	NNP	ORGANIZATION	Robak	conj_and	4	SENT_116	[p8l1036t1792r1242b1856],
11	,	,	O	,	_	0	SENT_116	[p8l1036t1792r1242b1856],
12	T.	NNP	O	T.	nn	13	SENT_116	[p8l1265t1795r1323b1847],
13	(	NNP	O	(	_	0	SENT_116	[p8l1351t1793r1538b1859],
14	2004	CD	DATE	2004	num	15	SENT_116	[p8l1351t1793r1538b1859],
15	)	CD	NUMBER	)	dep	13	SENT_116	[p8l1351t1793r1538b1859],
16	Functional	JJ	O	functional	amod	18	SENT_116	[p8l1565t1792r1888b1847],
17	C3435T	NN	O	c3435t	nn	18	SENT_116	[p8l1909t1795r2143b1848],
18	polymorphism	NN	O	polymorphism	dep	13	SENT_116	[p8l85t1884r528b1955],
19	of	IN	O	of	_	0	SENT_116	[p8l560t1884r626b1938],
20	MDR1	NN	O	mdr1	nn	21	SENT_116	[p8l649t1888r845b1938],
21	gene	NN	O	gene	prep_of	18	SENT_116	[p8l882t1903r1031b1955],
22	:	:	O	:	_	0	SENT_116	[p8l882t1903r1031b1955],
23	an	DT	O	a	det	24	SENT_116	[p8l1065t1903r1136b1938],
24	impact	NN	O	impact	dep	13	SENT_116	[p8l1167t1885r1373b1954],
25	on	IN	O	on	_	0	SENT_116	[p8l1405t1903r1481b1938],
26	genetic	JJ	O	genetic	amod	27	SENT_116	[p8l1512t1885r1722b1955],
27	susceptibility	NN	O	susceptibility	prep_on	24	SENT_116	[p8l1753t1884r2146b1955],
28	and	CC	O	and	_	0	SENT_116	[p8l84t1976r194b2031],
29	clinical	JJ	O	clinical	amod	30	SENT_116	[p8l230t1976r442b2031],
30	outcome	NN	O	outcome	dep	13	SENT_116	[p8l478t1987r741b2031],
31	of	IN	O	of	_	0	SENT_116	[p8l778t1975r844b2031],
32	childhood	NN	O	childhood	nn	35	SENT_116	[p8l871t1976r1177b2031],
33	acute	JJ	O	acute	amod	35	SENT_116	[p8l1212t1986r1368b2031],
34	lymphoblastic	JJ	O	lymphoblastic	amod	35	SENT_116	[p8l1404t1976r1827b2048],
35	leukemia	NN	O	leukemia	prep_of	30	SENT_116	[p8l1861t1976r2148b2031],
36	.	.	O	.	_	0	SENT_116	[p8l1861t1976r2148b2031],

1	European	JJ	MISC	european	amod	2	SENT_117	[p8l82t2073r360b2141],
2	Iournal	NNP	MISC	Iournal	_	0	SENT_117	[p8l383t2069r605b2133],
3	of	IN	O	of	_	0	SENT_117	[p8l632t2068r695b2141],
4	Haematology	NNP	LOCATION	Haematology	prep_of	2	SENT_117	[p8l708t2068r1111b2141],
5	,	,	O	,	_	0	SENT_117	[p8l708t2068r1111b2141],
6	72	CD	NUMBER	72	num	4	SENT_117	[p8l1142t2074r1229b2132],
7	,	,	O	,	_	0	SENT_117	[p8l1142t2074r1229b2132],
8	314-321	CD	NUMBER	314-321	num	4	SENT_117	[p8l1260t2074r1524b2124],
9	.	.	O	.	_	0	SENT_117	[p8l1260t2074r1524b2124],

1	Kim	NNP	PERSON	Kim	nn	10	SENT_118	[p8l8t2163r152b2223],
2	,	,	O	,	_	0	SENT_118	[p8l8t2163r152b2223],
3	D.H.	NNP	PERSON	D.H.	appos	10	SENT_118	[p8l177t2165r339b2223],
4	,	,	O	,	_	0	SENT_118	[p8l177t2165r339b2223],
5	Lee	NNP	PERSON	Lee	appos	10	SENT_118	[p8l365t2165r480b2223],
6	,	,	O	,	_	0	SENT_118	[p8l365t2165r480b2223],
7	N.Y.	NNP	LOCATION	N.Y.	appos	10	SENT_118	[p8l505t2165r655b2223],
8	,	,	O	,	_	0	SENT_118	[p8l505t2165r655b2223],
9	Sung	NNP	PERSON	Sung	appos	10	SENT_118	[p8l681t2164r830b2232],
10	W.I.	NNP	PERSON	W.I.	_	0	SENT_118	[p8l849t2165r997b2224],
11	,	,	O	,	_	0	SENT_118	[p8l849t2165r997b2224],
12	Baek	NNP	PERSON	Baek	nn	13	SENT_118	[p8l1023t2161r1167b2215],
13	I.H.	NNP	PERSON	I.H.	appos	10	SENT_118	[p8l1187t2165r1319b2224],
14	,	,	O	,	_	0	SENT_118	[p8l1187t2165r1319b2224],
15	Kim	NNP	PERSON	Kim	appos	10	SENT_118	[p8l1345t2163r1489b2223],
16	,	,	O	,	_	0	SENT_118	[p8l1345t2163r1489b2223],
17	]	CD	NUMBER	]	appos	10	SENT_118	[p8l1514t2164r1641b2224],
18	.	.	O	.	_	0	SENT_118	[p8l1514t2164r1641b2224],

1	G.	NNP	O	G.	nn	7	SENT_119	[p8l1514t2164r1641b2224],
2	,	,	O	,	_	0	SENT_119	[p8l1514t2164r1641b2224],
3	Sohn	NNP	PERSON	Sohn	appos	7	SENT_119	[p8l1667t2161r1835b2223],
4	,	,	O	,	_	0	SENT_119	[p8l1667t2161r1835b2223],
5	S.K.	NNP	PERSON	S.K.	appos	7	SENT_119	[p8l1861t2164r1994b2223],
6	,	,	O	,	_	0	SENT_119	[p8l1861t2164r1994b2223],
7	Suh	NNP	PERSON	Suh	_	0	SENT_119	[p8l2020t2161r2149b2223],
8	,	,	O	,	_	0	SENT_119	[p8l2020t2161r2149b2223],
9	]	CD	NUMBER	]	appos	7	SENT_119	[p8l83t2255r193b2315],
10	.	.	O	.	_	0	SENT_119	[p8l83t2255r193b2315],

1	S.	NNP	O	S.	nn	7	SENT_120	[p8l83t2255r193b2315],
2	,	,	O	,	_	0	SENT_120	[p8l83t2255r193b2315],
3	Lee	NNP	PERSON	Lee	appos	7	SENT_120	[p8l221t2256r336b2314],
4	,	,	O	,	_	0	SENT_120	[p8l221t2256r336b2314],
5	K.S.	NNP	PERSON	K.S.	appos	7	SENT_120	[p8l364t2255r479b2306],
6	8c	NNP	PERSON	8c	nn	7	SENT_120	[p8l509t2255r558b2306],
7	Lee	NNP	PERSON	Lee	_	0	SENT_120	[p8l582t2256r697b2314],
8	,	,	O	,	_	0	SENT_120	[p8l582t2256r697b2314],
9	K.B.	NNP	PERSON	K.B.	nn	10	SENT_120	[p8l725t2256r847b2306],
10	(	NNP	O	(	appos	7	SENT_120	[p8l880t2252r1068b2317],
11	2005	CD	DATE	2005	num	14	SENT_120	[p8l880t2252r1068b2317],
12	)	NNP	O	)	nn	14	SENT_120	[p8l880t2252r1068b2317],
13	Multidrug	NNP	O	Multidrug	nn	14	SENT_120	[p8l1098t2252r1410b2323],
14	resistance	NN	O	resistance	dep	10	SENT_120	[p8l1433t2253r1722b2306],
15	as	IN	O	as	_	0	SENT_120	[p8l1748t2271r1803b2306],
16	a	DT	O	a	det	19	SENT_120	[p8l1830t2271r1859b2306],
17	potential	JJ	O	potential	amod	19	SENT_120	[p8l1883t2252r2152b2322],
18	prognostic	JJ	O	prognostic	amod	19	SENT_120	[p8l83t2345r404b2414],
19	indicator	NN	O	indicator	prep_as	14	SENT_120	[p8l460t2343r733b2397],
20	in	IN	O	in	_	0	SENT_120	[p8l789t2345r847b2396],
21	acute	JJ	O	acute	amod	23	SENT_120	[p8l905t2354r1061b2397],
22	myeloid	JJ	O	myeloid	amod	23	SENT_120	[p8l1118t2343r1361b2414],
23	leukemia	NN	O	leukemia	prep_in	19	SENT_120	[p8l1416t2343r1689b2397],
24	with	IN	O	with	_	0	SENT_120	[p8l1743t2343r1877b2397],
25	normal	JJ	O	normal	amod	26	SENT_120	[p8l1933t2343r2152b2397],
26	karyotypes	NNS	O	karyotype	prep_with	23	SENT_120	[p8l82t2434r420b2505],
27	.	.	O	.	_	0	SENT_120	[p8l82t2434r420b2505],

1	Acta	NNP	PERSON	Acta	nn	2	SENT_121	[p8l446t2437r581b2488],
2	Haematologica	NNP	PERSON	Haematologica	_	0	SENT_121	[p8l608t2434r1063b2505],
3	,	,	O	,	_	0	SENT_121	[p8l608t2434r1063b2505],
4	114	CD	NUMBER	114	appos	2	SENT_121	[p8l1097t2439r1217b2497],
5	,	,	O	,	_	0	SENT_121	[p8l1097t2439r1217b2497],
6	78-83	CD	NUMBER	78-83	appos	4	SENT_121	[p8l1248t2439r1440b2488],
7	.	.	O	.	_	0	SENT_121	[p8l1248t2439r1440b2488],

1	Kimchi	NNP	O	Kimchi	_	0	SENT_122	[p8l8t2525r479b2596],
2	.	.	O	.	_	0	SENT_122	[p8l8t2525r479b2596],

1	—	NN	O	—	_	0	SENT_123	[p8l8t2525r479b2596],
2	.	.	O	.	_	0	SENT_123	[p8l8t2525r479b2596],

1	Sarfaty	NNP	PERSON	Sarfaty	nn	3	SENT_124	[p8l8t2525r479b2596],
2	,	,	O	,	_	0	SENT_124	[p8l8t2525r479b2596],
3	C.	NNP	O	C.	nsubj	5	SENT_124	[p8l509t2528r589b2588],
4	,	,	O	,	_	0	SENT_124	[p8l509t2528r589b2588],
5	Oh	UH	O	oh	_	0	SENT_124	[p8l618t2525r727b2588],
6	,	,	O	,	_	0	SENT_124	[p8l618t2525r727b2588],
7	I.M.	NNP	O	I.M.	nn	23	SENT_124	[p8l755t2529r897b2588],
8	,	,	O	,	_	0	SENT_124	[p8l755t2529r897b2588],
9	Kim	NNP	PERSON	Kim	appos	23	SENT_124	[p8l926t2527r1071b2588],
10	,	,	O	,	_	0	SENT_124	[p8l926t2527r1071b2588],
11	I.W.	NNP	LOCATION	I.W.	appos	23	SENT_124	[p8l1100t2529r1245b2588],
12	,	,	O	,	_	0	SENT_124	[p8l1100t2529r1245b2588],
13	Sauna	NNP	LOCATION	Sauna	appos	23	SENT_124	[p8l1274t2528r1470b2588],
14	,	,	O	,	_	0	SENT_124	[p8l1274t2528r1470b2588],
15	Z.E.	NNP	O	Z.E.	appos	23	SENT_124	[p8l1498t2527r1634b2588],
16	,	,	O	,	_	0	SENT_124	[p8l1498t2527r1634b2588],
17	Calcagno	NNP	PERSON	Calcagno	appos	23	SENT_124	[p8l1664t2525r1956b2596],
18	,	,	O	,	_	0	SENT_124	[p8l1664t2525r1956b2596],
19	A.M.	NNP	O	A.M.	appos	23	SENT_124	[p8l1982t2528r2149b2588],
20	,	,	O	,	_	0	SENT_124	[p8l1982t2528r2149b2588],
21	Ambudkar	NNP	LOCATION	Ambudkar	appos	23	SENT_124	[p8l81t2617r423b2680],
22	,	,	O	,	_	0	SENT_124	[p8l81t2617r423b2680],
23	S.V.	NNP	O	S.V.	dep	33	SENT_124	[p8l506t2620r622b2672],
24	8	CD	NUMBER	8	num	23	SENT_124	[p8l707t2621r758b2672],
25	<	JJR	O	<	dep	23	SENT_124	[p8l707t2621r758b2672],
26	Gottesman	NNP	PERSON	Gottesman	nn	29	SENT_124	[p8l837t2620r1182b2680],
27	,	,	O	,	_	0	SENT_124	[p8l837t2620r1182b2680],
28	M.M.	NNP	O	M.M.	appos	29	SENT_124	[p8l1263t2621r1429b2672],
29	(	NNP	O	(	dep	25	SENT_124	[p8l1517t2617r1705b2683],
30	2007	CD	DATE	2007	num	29	SENT_124	[p8l1517t2617r1705b2683],
31	)	CD	NUMBER	)	dep	33	SENT_124	[p8l1517t2617r1705b2683],
32	A	DT	O	a	det	33	SENT_124	[p8l1789t2620r1838b2671],
33	“	NN	O	“	dep	5	SENT_124	[p8l1919t2616r2149b2672],
34	silent	JJ	O	silent	amod	36	SENT_124	[p8l1919t2616r2149b2672],
35	”	NN	O	”	nn	36	SENT_124	[p8l1919t2616r2149b2672],
36	polymorphism	NN	O	polymorphism	dep	33	SENT_124	[p8l83t2708r529b2779],
37	in	IN	O	in	_	0	SENT_124	[p8l574t2710r632b2761],
38	the	DT	O	the	det	41	SENT_124	[p8l677t2708r769b2762],
39	MDR1	NN	O	mdr1	nn	41	SENT_124	[p8l815t2712r1012b2762],
40	gene	NN	O	gene	nn	41	SENT_124	[p8l1063t2727r1198b2779],
41	changes	NNS	O	change	prep_in	5	SENT_124	[p8l1244t2708r1477b2779],
42	substrate	JJ	O	substrate	amod	43	SENT_124	[p8l1524t2708r1791b2762],
43	speciﬁcity	NN	O	speciﬁcity	dep	41	SENT_124	[p8l1837t2708r2148b2779],
44	.	.	O	.	_	0	SENT_124	[p8l1837t2708r2148b2779],

1	Science	NNP	O	Science	_	0	SENT_125	[p8l84t2802r304b2863],
2	,	,	O	,	_	0	SENT_125	[p8l84t2802r304b2863],
3	315	CD	NUMBER	315	appos	1	SENT_125	[p8l335t2805r459b2863],
4	,	,	O	,	_	0	SENT_125	[p8l335t2805r459b2863],
5	525-528	CD	NUMBER	525-528	appos	3	SENT_125	[p8l490t2805r754b2854],
6	.	.	O	.	_	0	SENT_125	[p8l490t2805r754b2854],

1	Pawlik	NNP	PERSON	Pawlik	_	0	SENT_126	[p8l8t2891r223b2953],
2	,	,	O	,	_	0	SENT_126	[p8l8t2891r223b2953],
3	A.	NN	O	a.	appos	1	SENT_126	[p8l252t2894r333b2953],
4	,	,	O	,	_	0	SENT_126	[p8l252t2894r333b2953],
5	Baskiewicz	NNP	PERSON	Baskiewicz	appos	3	SENT_126	[p8l364t2891r954b2953],
6	.	.	O	.	_	0	SENT_126	[p8l364t2891r954b2953],

1	—	NN	O	—	_	0	SENT_127	[p8l364t2891r954b2953],
2	.	.	O	.	_	0	SENT_127	[p8l364t2891r954b2953],

1	Masiuk	NNP	PERSON	Masiuk	nn	11	SENT_128	[p8l364t2891r954b2953],
2	,	,	O	,	_	0	SENT_128	[p8l364t2891r954b2953],
3	M.	NNP	O	M.	appos	11	SENT_128	[p8l984t2895r1083b2953],
4	,	,	O	,	_	0	SENT_128	[p8l984t2895r1083b2953],
5	Machalinski	NNP	PERSON	Machalinski	appos	11	SENT_128	[p8l1113t2891r1494b2953],
6	,	,	O	,	_	0	SENT_128	[p8l1113t2891r1494b2953],
7	B.	NNP	O	B.	appos	11	SENT_128	[p8l1525t2895r1600b2953],
8	,	,	O	,	_	0	SENT_128	[p8l1525t2895r1600b2953],
9	Kurzawski	NNP	PERSON	Kurzawski	appos	11	SENT_128	[p8l1631t2891r1959b2953],
10	,	,	O	,	_	0	SENT_128	[p8l1631t2891r1959b2953],
11	M.	NNP	O	M.	_	0	SENT_128	[p8l1989t2895r2069b2945],
12	8	CD	NUMBER	8	num	11	SENT_128	[p8l2103t2895r2153b2945],
13	:	:	O	:	_	0	SENT_128	[p8l2103t2895r2153b2945],
14	Gawronska	NNP	PERSON	Gawronska	dep	11	SENT_128	[p8l84t2983r676b3046],
15	.	.	O	.	_	0	SENT_128	[p8l84t2983r676b3046],

1	—	NN	O	—	_	0	SENT_129	[p8l84t2983r676b3046],
2	.	.	O	.	_	0	SENT_129	[p8l84t2983r676b3046],

1	Szklarz	NNP	PERSON	Szklarz	nsubj	25	SENT_130	[p8l84t2983r676b3046],
2	,	,	O	,	_	0	SENT_130	[p8l84t2983r676b3046],
3	B.	NNP	O	B.	nn	4	SENT_130	[p8l706t2987r761b3038],
4	(	NNP	O	(	appos	1	SENT_130	[p8l797t2983r985b3049],
5	2005	CD	DATE	2005	num	24	SENT_130	[p8l797t2983r985b3049],
6	)	CD	NUMBER	)	num	7	SENT_130	[p8l797t2983r985b3049],
7	Involvement	NN	O	involvement	dep	24	SENT_130	[p8l1018t2983r1397b3038],
8	of	IN	O	of	_	0	SENT_130	[p8l1424t2983r1490b3038],
9	C3435T	NN	O	c3435t	nn	15	SENT_130	[p8l1511t2985r1746b3038],
10	and	CC	O	and	_	0	SENT_130	[p8l1774t2983r1885b3038],
11	G2677T	NN	O	g2677t	nn	15	SENT_130	[p8l1914t2985r2151b3038],
12	multidrug	JJ	O	multidrug	amod	15	SENT_130	[p8l83t3074r389b3145],
13	resistance	NN	O	resistance	nn	15	SENT_130	[p8l427t3076r716b3128],
14	gene	NN	O	gene	nn	15	SENT_130	[p8l755t3093r889b3145],
15	polymorphisms	NNS	O	polymorphism	prep_of	7	SENT_130	[p8l928t3074r1400b3145],
16	in	IN	O	in	_	0	SENT_130	[p8l1440t3076r1498b3127],
17	release	NN	O	release	prep_in	7	SENT_130	[p8l1537t3074r1734b3128],
18	of	IN	O	of	_	0	SENT_130	[p8l1774t3074r1840b3128],
19	cytokines	NNS	O	cytokine	prep_of	17	SENT_130	[p8l1871t3074r2150b3145],
20	from	IN	O	from	_	0	SENT_130	[p8l84t3166r231b3220],
21	peripheral	JJ	O	peripheral	amod	22	SENT_130	[p8l255t3166r564b3236],
22	blood	NN	O	blood	prep_from	19	SENT_130	[p8l586t3166r761b3220],
23	mononuclear	JJ	O	mononuclear	amod	24	SENT_130	[p8l786t3166r1188b3220],
24	cells	NNS	O	cell	dep	4	SENT_130	[p8l1214t3166r1337b3220],
25	treated	VBN	O	treat	_	0	SENT_130	[p8l1363t3166r1571b3220],
26	with	IN	O	with	_	0	SENT_130	[p8l1594t3166r1728b3220],
27	methotrexate	NN	O	methotrexate	prep_with	25	SENT_130	[p8l1753t3166r2151b3220],
28	and	CC	O	and	_	0	SENT_130	[p8l84t3257r194b3311],
29	dexamethasone	NN	O	dexamethasone	conj_and	27	SENT_130	[p8l221t3257r698b3311],
30	.	.	O	.	_	0	SENT_130	[p8l221t3257r698b3311],

1	European	JJ	O	european	amod	2	SENT_131	[p8l725t3261r1004b3328],
2	Iournal	NNP	O	Iournal	_	0	SENT_131	[p8l1025t3257r1246b3320],
3	of	IN	O	of	_	0	SENT_131	[p8l1272t3257r1335b3328],
4	Pharmacology	NNP	O	Pharmacology	prep_of	2	SENT_131	[p8l1346t3257r1774b3328],
5	,	,	O	,	_	0	SENT_131	[p8l1346t3257r1774b3328],
6	528	CD	NUMBER	528	num	4	SENT_131	[p8l1803t3262r1926b3320],
7	,	,	O	,	_	0	SENT_131	[p8l1803t3262r1926b3320],
8	27-36	CD	NUMBER	27-36	num	4	SENT_131	[p8l1954t3262r2149b3311],
9	.	.	O	.	_	0	SENT_131	[p8l1954t3262r2149b3311],

1	Schaich	NNP	PERSON	Schaich	nsubj	30	SENT_132	[p8l9t3348r253b3411],
2	,	,	O	,	_	0	SENT_132	[p8l9t3348r253b3411],
3	M.	NNP	O	M.	conj_and	1	SENT_132	[p8l286t3352r385b3410],
4	,	,	O	,	_	0	SENT_132	[p8l286t3352r385b3410],
5	Soucek	NNP	PERSON	Soucek	nsubj	30	SENT_132	[p8l419t3348r647b3411],
6	,	,	O	,	_	0	SENT_132	[p8l419t3348r647b3411],
7	S.	NNP	O	S.	nsubj	30	SENT_132	[p8l680t3351r746b3411],
8	,	,	O	,	_	0	SENT_132	[p8l680t3351r746b3411],
9	Thiede	NNP	PERSON	Thiede	nsubj	30	SENT_132	[p8l780t3348r1001b3411],
10	,	,	O	,	_	0	SENT_132	[p8l780t3348r1001b3411],
11	C.	NNP	O	C.	conj_and	1	SENT_132	[p8l1035t3351r1115b3410],
12	,	,	O	,	_	0	SENT_132	[p8l1035t3351r1115b3410],
13	Ehninger	NNP	O	Ehninger	conj_and	1	SENT_132	[p8l1148t3348r1438b3419],
14	,	,	O	,	_	0	SENT_132	[p8l1148t3348r1438b3419],
15	G.	NNP	ORGANIZATION	G.	nsubj	30	SENT_132	[p8l1472t3351r1535b3402],
16	&	CC	ORGANIZATION	&	_	0	SENT_132	[p8l1572t3352r1621b3403],
17	Ilmer	NNP	ORGANIZATION	Ilmer	nsubj	30	SENT_132	[p8l1651t3348r1829b3411],
18	,	,	O	,	_	0	SENT_132	[p8l1651t3348r1829b3411],
19	T.	NNP	O	T.	nn	20	SENT_132	[p8l1862t3350r1919b3402],
20	(	NNP	O	(	appos	1	SENT_132	[p8l1958t3348r2146b3414],
21	2005	CD	DATE	2005	num	23	SENT_132	[p8l1958t3348r2146b3414],
22	)	CD	NUMBER	)	num	23	SENT_132	[p8l1958t3348r2146b3414],
23	MDR1	NN	O	mdr1	dep	20	SENT_132	[p8l83t3443r280b3494],
24	and	CC	O	and	_	0	SENT_132	[p8l319t3439r429b3494],
25	MRP1	NN	O	mrp1	nn	27	SENT_132	[p8l460t3443r645b3494],
26	gene	NN	O	gene	nn	27	SENT_132	[p8l684t3459r818b3512],
27	expression	NN	O	expression	dep	20	SENT_132	[p8l852t3441r1167b3511],
28	are	VBP	O	be	cop	30	SENT_132	[p8l1199t3459r1287b3494],
29	independent	JJ	O	independent	amod	30	SENT_132	[p8l1320t3439r1697b3511],
30	predictors	NNS	O	predictor	_	0	SENT_132	[p8l1728t3439r2033b3511],
31	for	IN	O	for	_	0	SENT_132	[p8l2065t3439r2152b3494],
32	treatment	NN	O	treatment	nn	33	SENT_132	[p8l83t3543r377b3586],
33	outcome	NN	O	outcome	prep_for	30	SENT_132	[p8l398t3543r661b3586],
34	in	IN	O	in	_	0	SENT_132	[p8l683t3534r742b3585],
35	adult	JJ	O	adult	amod	38	SENT_132	[p8l763t3532r916b3586],
36	acute	JJ	O	acute	amod	38	SENT_132	[p8l938t3543r1094b3586],
37	myeloid	JJ	O	myeloid	amod	38	SENT_132	[p8l1116t3532r1358b3603],
38	leukaemia	NN	O	leukaemia	prep_in	33	SENT_132	[p8l1378t3532r1699b3586],
39	.	.	O	.	_	0	SENT_132	[p8l1378t3532r1699b3586],

1	British	JJ	O	british	amod	2	SENT_133	[p8l1721t3532r1914b3586],
2	Iournal	NN	O	iournal	_	0	SENT_133	[p8l1932t3532r2153b3595],
3	of	IN	O	of	_	0	SENT_133	[p8l84t3623r148b3696],
4	Haematology	NNP	O	Haematology	prep_of	2	SENT_133	[p8l161t3623r564b3696],
5	,	,	O	,	_	0	SENT_133	[p8l161t3623r564b3696],
6	128	CD	NUMBER	128	num	4	SENT_133	[p8l598t3629r718b3687],
7	,	,	O	,	_	0	SENT_133	[p8l598t3629r718b3687],
8	324-332	CD	NUMBER	324-332	num	4	SENT_133	[p8l749t3629r1013b3678],
9	.	.	O	.	_	0	SENT_133	[p8l749t3629r1013b3678],

1	Tribalto	NNP	O	Tribalto	nn	18	SENT_134	[p8l7t3715r267b3778],
2	,	,	O	,	_	0	SENT_134	[p8l7t3715r267b3778],
3	M.	NNP	O	M.	appos	18	SENT_134	[p8l307t3719r407b3778],
4	,	,	O	,	_	0	SENT_134	[p8l307t3719r407b3778],
5	Amadori	NNP	PERSON	Amadori	appos	18	SENT_134	[p8l446t3715r731b3778],
6	,	,	O	,	_	0	SENT_134	[p8l446t3715r731b3778],
7	S.	NNP	O	S.	appos	18	SENT_134	[p8l773t3718r839b3778],
8	,	,	O	,	_	0	SENT_134	[p8l773t3718r839b3778],
9	Cudillo	NNP	O	Cudillo	appos	18	SENT_134	[p8l882t3715r1121b3778],
10	,	,	O	,	_	0	SENT_134	[p8l882t3715r1121b3778],
11	L.	NNP	O	L.	appos	18	SENT_134	[p8l1163t3719r1234b3778],
12	,	,	O	,	_	0	SENT_134	[p8l1163t3719r1234b3778],
13	Caravita	NNP	LOCATION	Caravita	appos	18	SENT_134	[p8l1275t3717r1541b3778],
14	,	,	O	,	_	0	SENT_134	[p8l1275t3717r1541b3778],
15	T.	NNP	O	T.	appos	18	SENT_134	[p8l1583t3717r1659b3778],
16	,	,	O	,	_	0	SENT_134	[p8l1583t3717r1659b3778],
17	Del	NNP	PERSON	Del	appos	18	SENT_134	[p8l1701t3715r1804b3769],
18	Poeta	NNP	PERSON	Poeta	_	0	SENT_134	[p8l1842t3719r2024b3778],
19	,	,	O	,	_	0	SENT_134	[p8l1842t3719r2024b3778],
20	G.	NNP	O	G.	dep	18	SENT_134	[p8l2067t3718r2149b3778],
21	,	,	O	,	_	0	SENT_134	[p8l2067t3718r2149b3778],

1	Meloni	NNP	PERSON	Meloni	nn	13	SENT_135	[p9l83t21r314b84],
2	,	,	O	,	_	0	SENT_135	[p9l83t21r314b84],
3	G.	NNP	O	G.	appos	13	SENT_135	[p9l341t24r423b84],
4	,	,	O	,	_	0	SENT_135	[p9l341t24r423b84],
5	Avvisati	NNP	O	Avvisati	appos	13	SENT_135	[p9l447t23r703b84],
6	,	,	O	,	_	0	SENT_135	[p9l447t23r703b84],
7	G.	NNP	O	G.	appos	13	SENT_135	[p9l730t24r812b84],
8	,	,	O	,	_	0	SENT_135	[p9l730t24r812b84],
9	Petrucci	NNP	PERSON	Petrucci	appos	13	SENT_135	[p9l838t23r1099b84],
10	,	,	O	,	_	0	SENT_135	[p9l838t23r1099b84],
11	M.T.	NNP	LOCATION	M.T.	appos	13	SENT_135	[p9l1124t23r1287b84],
12	,	,	O	,	_	0	SENT_135	[p9l1124t23r1287b84],
13	Pulsoni	NNP	LOCATION	Pulsoni	dep	52	SENT_135	[p9l1313t21r1554b84],
14	,	,	O	,	_	0	SENT_135	[p9l1313t21r1554b84],
15	A.	NN	O	a.	appos	13	SENT_135	[p9l1577t24r1659b84],
16	,	,	O	,	_	0	SENT_135	[p9l1577t24r1659b84],
17	Leone	NNP	PERSON	Leone	appos	13	SENT_135	[p9l1686t25r1881b84],
18	,	,	O	,	_	0	SENT_135	[p9l1686t25r1881b84],
19	G.	NNP	O	G.	appos	13	SENT_135	[p9l1907t24r1989b84],
20	,	,	O	,	_	0	SENT_135	[p9l1907t24r1989b84],
21	Sica	NNP	PERSON	Sica	appos	13	SENT_135	[p9l2017t23r2150b84],
22	,	,	O	,	_	0	SENT_135	[p9l2017t23r2150b84],
23	S.	NNP	O	S.	appos	13	SENT_135	[p9l84t115r150b176],
24	,	,	O	,	_	0	SENT_135	[p9l84t115r150b176],
25	Martelli	NNP	PERSON	Martelli	appos	13	SENT_135	[p9l174t112r428b176],
26	,	,	O	,	_	0	SENT_135	[p9l174t112r428b176],
27	M.	NNP	O	M.	appos	13	SENT_135	[p9l451t116r549b176],
28	,	,	O	,	_	0	SENT_135	[p9l451t116r549b176],
29	Tabilio	NNP	PERSON	Tabilio	appos	13	SENT_135	[p9l574t112r802b176],
30	,	,	O	,	_	0	SENT_135	[p9l574t112r802b176],
31	A.	NNP	O	A.	conj_and	17	SENT_135	[p9l824t115r906b176],
32	,	,	O	,	_	0	SENT_135	[p9l824t115r906b176],
33	Fioritoni	NNP	O	Fioritoni	appos	13	SENT_135	[p9l930t114r1212b176],
34	,	,	O	,	_	0	SENT_135	[p9l930t114r1212b176],
35	G.	NNP	O	G.	appos	13	SENT_135	[p9l1237t115r1319b176],
36	,	,	O	,	_	0	SENT_135	[p9l1237t115r1319b176],
37	Majolino	NNP	O	Majolino	appos	13	SENT_135	[p9l1342t112r1633b184],
38	,	,	O	,	_	0	SENT_135	[p9l1342t112r1633b184],
39	I.	NNP	ORGANIZATION	I.	appos	13	SENT_135	[p9l1657t116r1694b167],
40	&	CC	ORGANIZATION	&	_	0	SENT_135	[p9l1721t116r1771b168],
41	Mandelli	NNP	ORGANIZATION	Mandelli	appos	13	SENT_135	[p9l1790t112r2074b176],
42	,	,	O	,	_	0	SENT_135	[p9l1790t112r2074b176],
43	F.	NNP	O	F.	nn	44	SENT_135	[p9l2098t116r2148b167],
44	(	NNP	O	(	appos	13	SENT_135	[p9l87t205r276b271],
45	2000	CD	DATE	2000	dep	52	SENT_135	[p9l87t205r276b271],
46	)	CD	NUMBER	)	num	52	SENT_135	[p9l87t205r276b271],
47	Autologous	JJ	O	autologous	amod	52	SENT_135	[p9l300t205r650b278],
48	peripheral	JJ	O	peripheral	amod	52	SENT_135	[p9l671t205r978b277],
49	blood	NN	O	blood	nn	52	SENT_135	[p9l998t205r1173b260],
50	stem	NN	O	stem	nn	52	SENT_135	[p9l1194t216r1334b260],
51	cell	NN	O	cell	nn	52	SENT_135	[p9l1356t205r1454b260],
52	transplantation	NN	O	transplantation	dep	64	SENT_135	[p9l1474t205r1935b277],
53	as	IN	O	as	_	0	SENT_135	[p9l1958t225r2013b260],
54	ﬁrst	NN	O	ﬁrst	nn	56	SENT_135	[p9l2035t205r2152b260],
55	line	NN	O	line	nn	56	SENT_135	[p9l82t298r191b352],
56	treatment	NN	O	treatment	prep_as	52	SENT_135	[p9l223t309r517b352],
57	of	IN	O	of	_	0	SENT_135	[p9l550t298r615b352],
58	multiple	JJ	O	multiple	amod	59	SENT_135	[p9l639t298r891b369],
59	myeloma	NN	O	myeloma	prep_of	56	SENT_135	[p9l923t298r1215b369],
60	:	:	O	:	_	0	SENT_135	[p9l923t298r1215b369],
61	an	DT	O	a	det	64	SENT_135	[p9l1251t317r1321b352],
62	Italian	JJ	MISC	italian	amod	64	SENT_135	[p9l1354t298r1545b352],
63	Multicenter	NNP	O	Multicenter	nn	64	SENT_135	[p9l1576t298r1931b352],
64	Study	NNP	O	Study	_	0	SENT_135	[p9l1963t298r2148b369],
65	.	.	O	.	_	0	SENT_135	[p9l1963t298r2148b369],

1	Haematologica	NNP	PERSON	Haematologica	_	0	SENT_136	[p9l82t389r536b462],
2	,	,	O	,	_	0	SENT_136	[p9l82t389r536b462],
3	85	CD	NUMBER	85	appos	1	SENT_136	[p9l566t395r654b453],
4	,	,	O	,	_	0	SENT_136	[p9l566t395r654b453],
5	52-58	CD	NUMBER	52-58	appos	3	SENT_136	[p9l685t395r877b444],
6	.	.	O	.	_	0	SENT_136	[p9l685t395r877b444],

1	Van	NNP	PERSON	Van	nn	3	SENT_137	[p9l6t486r129b537],
2	der	NNP	PERSON	der	nn	3	SENT_137	[p9l162t482r258b537],
3	Holt	NNP	PERSON	Holt	_	0	SENT_137	[p9l290t482r442b546],
4	,	,	O	,	_	0	SENT_137	[p9l290t482r442b546],
5	B.	NNP	O	B.	nn	30	SENT_137	[p9l477t486r551b546],
6	,	,	O	,	_	0	SENT_137	[p9l477t486r551b546],
7	Lowenberg	NNP	PERSON	Lowenberg	appos	30	SENT_137	[p9l586t482r933b555],
8	,	,	O	,	_	0	SENT_137	[p9l586t482r933b555],
9	B.	NNP	O	B.	appos	30	SENT_137	[p9l967t486r1042b546],
10	,	,	O	,	_	0	SENT_137	[p9l967t486r1042b546],
11	Burnett	NNP	PERSON	Burnett	appos	30	SENT_137	[p9l1077t486r1321b546],
12	,	,	O	,	_	0	SENT_137	[p9l1077t486r1321b546],
13	A.K.	NNP	PERSON	A.K.	appos	30	SENT_137	[p9l1353t485r1502b546],
14	,	,	O	,	_	0	SENT_137	[p9l1353t485r1502b546],
15	Knauf	NNP	PERSON	Knauf	appos	30	SENT_137	[p9l1537t482r1736b546],
16	,	,	O	,	_	0	SENT_137	[p9l1537t482r1736b546],
17	W.U.	NNP	LOCATION	W.U.	appos	30	SENT_137	[p9l1767t486r1945b546],
18	,	,	O	,	_	0	SENT_137	[p9l1767t486r1945b546],
19	Shepherd	NNP	PERSON	Shepherd	appos	30	SENT_137	[p9l1980t482r2148b554, p9l83t575r235b638],
20	,	,	O	,	_	0	SENT_137	[p9l1980t482r2148b554, p9l83t575r235b638],
21	I.	NNP	O	I.	appos	30	SENT_137	[p9l264t579r320b639],
22	,	,	O	,	_	0	SENT_137	[p9l264t579r320b639],
23	Piccaluga	NNP	LOCATION	Piccaluga	appos	30	SENT_137	[p9l350t575r648b646],
24	,	,	O	,	_	0	SENT_137	[p9l350t575r648b646],
25	P.P.	NNP	O	P.P.	appos	30	SENT_137	[p9l678t579r812b638],
26	,	,	O	,	_	0	SENT_137	[p9l678t579r812b638],
27	Ossenkoppele	NNP	O	Ossenkoppele	appos	30	SENT_137	[p9l842t575r1272b646],
28	,	,	O	,	_	0	SENT_137	[p9l842t575r1272b646],
29	G.	NNP	O	G.	appos	30	SENT_137	[p9l1303t578r1429b639],
30	]	NNP	O	]	appos	3	SENT_137	[p9l1303t578r1429b639],
31	.	.	O	.	_	0	SENT_137	[p9l1303t578r1429b639],

1	,	,	O	,	_	0	SENT_138	[p9l1303t578r1429b639],
2	Verhoef	NNP	O	Verhoef	dep	37	SENT_138	[p9l1456t575r1712b638],
3	,	,	O	,	_	0	SENT_138	[p9l1456t575r1712b638],
4	G.E.	NNP	ORGANIZATION	G.E.	appos	2	SENT_138	[p9l1743t578r1885b638],
5	,	,	O	,	_	0	SENT_138	[p9l1743t578r1885b638],
6	Ferrant	NNP	PERSON	Ferrant	appos	2	SENT_138	[p9l1915t579r2149b638],
7	,	,	O	,	_	0	SENT_138	[p9l1915t579r2149b638],
8	A.	NN	O	a.	appos	2	SENT_138	[p9l81t669r163b730],
9	,	,	O	,	_	0	SENT_138	[p9l81t669r163b730],
10	Crump	NNP	PERSON	Crump	appos	2	SENT_138	[p9l194t669r425b738],
11	,	,	O	,	_	0	SENT_138	[p9l194t669r425b738],
12	M.	NNP	O	M.	conj_and	10	SENT_138	[p9l454t670r553b730],
13	,	,	O	,	_	0	SENT_138	[p9l454t670r553b730],
14	Selleslag	NNP	O	Selleslag	conj_and	10	SENT_138	[p9l583t666r845b739],
15	,	,	O	,	_	0	SENT_138	[p9l583t666r845b739],
16	D.	NNP	O	D.	conj_and	10	SENT_138	[p9l874t670r960b730],
17	,	,	O	,	_	0	SENT_138	[p9l874t670r960b730],
18	Theobald	NNP	PERSON	Theobald	conj_and	10	SENT_138	[p9l989t666r1288b730],
19	,	,	O	,	_	0	SENT_138	[p9l989t666r1288b730],
20	M.	NNP	O	M.	conj_and	10	SENT_138	[p9l1316t670r1416b730],
21	,	,	O	,	_	0	SENT_138	[p9l1316t670r1416b730],
22	Fey	NNP	LOCATION	Fey	conj_and	10	SENT_138	[p9l1446t670r1562b738],
23	,	,	O	,	_	0	SENT_138	[p9l1446t670r1562b738],
24	M.F.	NNP	LOCATION	M.F.	conj_and	10	SENT_138	[p9l1591t670r1746b730],
25	,	,	O	,	_	0	SENT_138	[p9l1591t670r1746b730],
26	Vellenga	NNP	PERSON	Vellenga	conj_and	10	SENT_138	[p9l1773t666r2048b739],
27	,	,	O	,	_	0	SENT_138	[p9l1773t666r2048b739],
28	E.	NNP	O	E.	conj_and	10	SENT_138	[p9l2076t670r2149b730],
29	,	,	O	,	_	0	SENT_138	[p9l2076t670r2149b730],
30	Dugan	NNP	PERSON	Dugan	conj_and	10	SENT_138	[p9l84t764r300b832],
31	,	,	O	,	_	0	SENT_138	[p9l84t764r300b832],
32	M.	NNP	ORGANIZATION	M.	appos	2	SENT_138	[p9l328t764r407b814],
33	&	CC	ORGANIZATION	&	_	0	SENT_138	[p9l438t763r488b815],
34	Sonneveld	NNP	ORGANIZATION	Sonneveld	conj_and	10	SENT_138	[p9l513t759r837b823],
35	,	,	O	,	_	0	SENT_138	[p9l513t759r837b823],
36	P.	NNP	O	P.	nn	37	SENT_138	[p9l866t764r920b814],
37	(	NNP	O	(	_	0	SENT_138	[p9l953t759r1141b826],
38	2005	CD	DATE	2005	num	39	SENT_138	[p9l953t759r1141b826],
39	)	CD	NUMBER	)	dep	37	SENT_138	[p9l953t759r1141b826],
40	The	DT	O	the	det	41	SENT_138	[p9l1172t759r1286b814],
41	Value	NN	O	value	dep	37	SENT_138	[p9l1310t759r1467b814],
42	of	IN	O	of	dep	48	SENT_138	[p9l1494t759r1560b814],
43	the	DT	O	the	det	47	SENT_138	[p9l1577t759r1669b814],
44	MDR1	NN	O	mdr1	nn	47	SENT_138	[p9l1695t764r1892b814],
45	reversal	NN	O	reversal	nn	47	SENT_138	[p9l1924t759r2152b814],
46	agent	NN	O	agent	nn	47	SENT_138	[p9l84t863r244b925],
47	PSC	NN	ORGANIZATION	psc	pobj	42	SENT_138	[p9l277t855r533b908],
48	—	NN	O	—	rcmod	41	SENT_138	[p9l277t855r533b908],
49	833	CD	NUMBER	833	num	48	SENT_138	[p9l277t855r533b908],
50	in	IN	O	in	dep	48	SENT_138	[p9l569t854r627b907],
51	addition	NN	O	addition	conj_and	51	SENT_138	[p9l661t852r914b907],
52	to	TO	O	to	_	0	SENT_138	[p9l946t863r1005b907],
53	daunorubicin	NN	O	daunorubicin	prep_to	51	SENT_138	[p9l1041t852r1450b907],
54	and	CC	O	and	_	0	SENT_138	[p9l1483t852r1593b907],
55	cytarabine	NN	O	cytarabine	npadvmod	51	SENT_138	[p9l1627t852r1935b925],
56	in	IN	O	in	_	0	SENT_138	[p9l1968t854r2026b907],
57	the	DT	O	the	det	58	SENT_138	[p9l2058t852r2151b907],
58	treatment	NN	O	treatment	prep_in	55	SENT_138	[p9l83t956r377b1000],
59	of	IN	O	of	_	0	SENT_138	[p9l434t945r500b1000],
60	elderly	JJ	O	elderly	amod	61	SENT_138	[p9l549t945r749b1017],
61	patients	NNS	O	patient	prep_of	58	SENT_138	[p9l802t947r1038b1017],
62	with	IN	O	with	_	0	SENT_138	[p9l1093t945r1227b1000],
63	previously	RB	DATE	previously	advmod	64	SENT_138	[p9l1283t945r1596b1018],
64	untreated	JJ	O	untreated	amod	67	SENT_138	[p9l1650t945r1938b1000],
65	acute	JJ	O	acute	amod	66	SENT_138	[p9l1995t956r2151b1000],
66	myeloid	JJ	O	myeloid	amod	67	SENT_138	[p9l83t1038r326b1111],
67	leukemia	NN	O	leukemia	prep_with	51	SENT_138	[p9l353t1038r626b1093],
68	(	CD	NUMBER	(	num	70	SENT_138	[p9l657t1039r879b1105],
69	AML	NN	ORGANIZATION	aml	nn	70	SENT_138	[p9l657t1039r879b1105],
70	)	NN	O	)	dep	51	SENT_138	[p9l657t1039r879b1105],
71	,	,	O	,	_	0	SENT_138	[p9l657t1039r879b1105],
72	in	IN	O	in	dep	48	SENT_138	[p9l909t1040r967b1093],
73	relation	NN	O	relation	pobj	72	SENT_138	[p9l996t1038r1227b1093],
74	to	TO	O	to	_	0	SENT_138	[p9l1254t1049r1313b1093],
75	MDR1	NN	O	mdr1	nn	76	SENT_138	[p9l1342t1043r1540b1093],
76	status	NN	O	status	prep_to	72	SENT_138	[p9l1575t1049r1744b1093],
77	at	IN	O	at	_	0	SENT_138	[p9l1774t1049r1827b1093],
78	diagnosis	NN	O	diagnosis	prep_at	72	SENT_138	[p9l1856t1038r2148b1111],
79	.	.	O	.	_	0	SENT_138	[p9l1856t1038r2148b1111],

1	Blood	NN	O	blood	_	0	SENT_139	[p9l82t1130r263b1193],
2	,	,	O	,	_	0	SENT_139	[p9l82t1130r263b1193],
3	106	CD	NUMBER	106	appos	1	SENT_139	[p9l297t1135r418b1193],
4	,	,	O	,	_	0	SENT_139	[p9l297t1135r418b1193],
5	2646-2654	CD	DATE	2646-2654	appos	3	SENT_139	[p9l447t1135r785b1184],
6	.	.	O	.	_	0	SENT_139	[p9l447t1135r785b1184],

1	456	CD	NUMBER	456	num	3	SENT_140	[p9l84t1435r144b1462],
2	Journal	NNP	O	Journal	nn	3	SENT_140	[p9l642t1436r740b1462],
3	Compilation	NN	O	compilation	_	0	SENT_140	[p9l755t1436r923b1469],
4	©	CD	NUMBER	©	num	8	SENT_140	[p9l938t1439r961b1462],
5	2007	CD	DATE	2007	num	8	SENT_140	[p9l975t1438r1045b1462],
6	Blackwell	NNP	ORGANIZATION	Blackwell	nn	8	SENT_140	[p9l1061t1436r1186b1462],
7	Publishing	NNP	ORGANIZATION	Publishing	nn	8	SENT_140	[p9l1202t1436r1340b1469],
8	Ltd	NNP	ORGANIZATION	Ltd	dep	3	SENT_140	[p9l1356t1436r1404b1466],
9	,	,	O	,	_	0	SENT_140	[p9l1356t1436r1404b1466],
10	British	NNP	O	British	nn	11	SENT_140	[p9l1419t1436r1502b1462],
11	Journal	NNP	O	Journal	appos	8	SENT_140	[p9l1514t1436r1617b1462],
12	of	IN	O	of	_	0	SENT_140	[p9l1628t1436r1659b1462],
13	Haematology	NNP	O	Haematology	prep_of	11	SENT_140	[p9l1668t1436r1861b1469],
14	,	,	O	,	_	0	SENT_140	[p9l1668t1436r1861b1469],
15	137	CD	NUMBER	137	num	13	SENT_140	[p9l1877t1438r1936b1466],
16	,	,	O	,	_	0	SENT_140	[p9l1877t1438r1936b1466],
17	454-456	CD	NUMBER	454-456	num	13	SENT_140	[p9l1950t1438r2075b1462],

